<SEC-DOCUMENT>0001437749-21-006394.txt : 20210318
<SEC-HEADER>0001437749-21-006394.hdr.sgml : 20210318
<ACCEPTANCE-DATETIME>20210318070026
ACCESSION NUMBER:		0001437749-21-006394
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20210317
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210318
DATE AS OF CHANGE:		20210318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NextDecade Corp.
		CENTRAL INDEX KEY:			0001612720
		STANDARD INDUSTRIAL CLASSIFICATION:	NATURAL GAS TRANSMISSION & DISTRIBUTION [4923]
		IRS NUMBER:				465723951
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36842
		FILM NUMBER:		21753049

	BUSINESS ADDRESS:	
		STREET 1:		1000 LOUISIANA STREET
		STREET 2:		SUITE 3900
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77002
		BUSINESS PHONE:		7135741880

	MAIL ADDRESS:	
		STREET 1:		1000 LOUISIANA STREET
		STREET 2:		SUITE 3900
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Harmony Merger Corp.
		DATE OF NAME CHANGE:	20140703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>next20210311_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:next="http://www.next.com/20210317"><head>
	<title>next20191018_8k.htm</title>
	<!-- Generated by ThunderDome Portal - 3/18/2021 10:54:53 AM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20218K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20218K" name="dei:EntityCentralIndexKey">0001612720</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="next-20210317.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20218K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2021-03-17</xbrli:startDate>
<xbrli:endDate>2021-03-17</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:Times New Roman;font-size:1pt;margin:0pt;text-align:left;">&#xa0;</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION<br />
WASHINGTON, D.C. 20549</b></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&#xa0;</div>

<hr style="width: 25%; height: 0.75px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); border: none; text-align: center; margin: 0 auto" />
<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>FORM&#xa0;<ix:nonNumeric contextRef="d20218K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric><br />
CURRENT REPORT</b></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>PURSUANT TO SECTION&#xa0;13 OR 15(D) OF THE<br />
SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="d20218K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><span style="text-decoration: underline;">March 17, 2021</span></ix:nonNumeric></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityRegistrantName"><span style="text-decoration: underline;">NEXTDECADE CORPORATION</span></ix:nonNumeric><br />
(Exact Name of Registrant as Specified in Charter)</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:33.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:33.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:33.3%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:33.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;width:33.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityFileNumber">001-36842</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;width:33.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityTaxIdentificationNumber">46-5723951</ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(State or Other Jurisdiction of Incorporation)</div>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Commission File Number)</div>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(IRS Employer Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressAddressLine1"><span style="text-decoration: underline;">1000 Louisiana Street</span><span style="text-decoration: underline;">, Suite 3900</span></ix:nonNumeric><span style="text-decoration: underline;">, <ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressCityOrTown"><span style="text-decoration: underline;">Houston</span></ix:nonNumeric>, <ix:nonNumeric contextRef="d20218K" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince"><span style="text-decoration: underline;">Texas</span></ix:nonNumeric> <ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressPostalZipCode"><span style="text-decoration: underline;">77002</span></ix:nonNumeric></span><br />
(Address of Principal Executive Offices) (Zip Code)</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><span style="text-decoration: underline;">(<ix:nonNumeric contextRef="d20218K" name="dei:CityAreaCode"><span style="text-decoration: underline;">713</span></ix:nonNumeric>) <ix:nonNumeric contextRef="d20218K" name="dei:LocalPhoneNumber"><span style="text-decoration: underline;">574-1880</span></ix:nonNumeric></span><br />
(Registrant&#8217;s Telephone Number, Including Area Code)</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><span style="text-decoration: underline;">N/A</span><br />
(Former Name or Former Address, if Changed Since Last Report)</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Check the appropriate box below if the Form&#xa0;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction&#xa0;A.2. below):</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:7.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:7.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:85.2%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:7.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:7.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:85.2%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Written communications pursuant to Rule&#xa0;425 under the Securities Act (17&#xa0;CFR&#xa0;230.425)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:7.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:7.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:85.2%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:7.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:7.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:85.2%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Soliciting material pursuant to Rule&#xa0;14a-12 under the Exchange Act (17&#xa0;CFR&#xa0;240.14a-12)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:7.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:7.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:85.2%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:7.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:7.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:85.2%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pre-commencement communications pursuant to Rule&#xa0;14d-2(b) under the Exchange Act (17&#xa0;CFR&#xa0;240.14d-2(b))</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:7.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:7.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:85.2%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:7.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:7.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:85.2%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pre-commencement communications pursuant to Rule&#xa0;13e-4(c) under the Exchange Act (17&#xa0;CFR&#xa0;240.13e&#xa0;4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Securities registered pursuant to Section 12(b) of the Act:</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:29.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:2.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:26.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:2.1%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:39%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:29.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:7.2pt;margin-right:0pt;margin-top:0pt;text-align:center;text-indent:-7.2pt;"><b>Title&#xa0;of&#xa0;each&#xa0;class:</b></div>
			</td>
			<td style="vertical-align:top;width:2.1%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&#xa0;&#xa0;&#xa0;&#xa0;</b></div>
			</td>
			<td style="vertical-align:top;border-bottom:solid 1px #000000;;width:26.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Trading Symbol</b></div>
			</td>
			<td style="vertical-align:bottom;width:2.1%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&#xa0;&#xa0;&#xa0;&#xa0;</b></div>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:39%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Name&#xa0;of&#xa0;each&#xa0;exchange&#xa0;on&#xa0;which&#xa0;registered:</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:29.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric>, $0.0001 par value</div>
			</td>
			<td style="vertical-align:top;width:2.1%;">&#xa0;</td>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:26.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20218K" name="dei:TradingSymbol">NEXT</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;width:2.1%;">&#xa0;</td>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:39%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">The <ix:nonNumeric contextRef="d20218K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> Stock Market LLC</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#xa0;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#xa0;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Emerging growth company&#xa0;<ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#xa0;13(a) of the Exchange Act.&#xa0;&#9744;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"><br />
<!--Created on 3/11/2021 10:14:04 AM --><b>Item 1.01.</b>&#8195;<b> Entry into a Material Definitive Agreement.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><i>Series C&#xa0;Convertible Preferred Stock Purchase Agreements</i></b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><!--Created on 3/11/2021 3:31:04 PM -->On March 17, 2021, &#xa0;NextDecade Corporation (the &#8220;<span style="text-decoration: underline;">Company</span>&#8221;) entered into a&#xa0;Series C&#xa0;Convertible Preferred Stock Purchase Agreement (collectively, the &#8220;<span style="text-decoration: underline;">Series C&#xa0;Stock Purchase Agreements</span>&#8221;) with&#xa0;each of (i)&#xa0;York Capital Management, L.P. and certain of its affiliates (&#8220;<span style="text-decoration: underline;">York</span>&#8221;), (ii)&#xa0;certain affiliates of Bardin Hill Investment Partners LP&#xa0;(&#8220;<span style="text-decoration: underline;">Bardin Hill</span>&#8221;), and (iii)&#xa0;<!--Created on 3/11/2021 6:14:18 PM -->Avenue Energy Opportunities Fund II, L.P&#xa0;(&#8220;<span style="text-decoration: underline;">Avenue</span>&#8221; and together with York&#xa0;and Bardin Hill, the &#8220;<span style="text-decoration: underline;">Purchasers</span>&#8221;)&#xa0;pursuant to which the Company agreed to sell, and&#xa0;the Purchasers&#xa0;agreed to purchase&#xa0;shares of the Company&#8217;s Series C&#xa0;Convertible Preferred Stock, par value $0.0001 per share (the &#8220;<span style="text-decoration: underline;">Series C&#xa0;Preferred Stock</span>&#8221;), together with associated Warrants (as defined below), for an aggregate purchase price of $24.5&#xa0;million.&#xa0; The consummation of the&#xa0;transactions contemplated by the Series C&#xa0;Stock Purchase Agreements are expected to occur at multiple closings on or prior to March 22, 2021&#xa0;(the &#8220;<span style="text-decoration: underline;">Closing Date</span>&#8221;),<!--Created on 3/12/2021 10:28:45 AM -->&#xa0;subject to customary closing conditions.&#xa0; York&#xa0;and Bardin Hill, or their affiliates, are each stockholders of the Company having the right to appoint one or more directors to the Company&#8217;s board of directors.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Company is conducting the offering of the Series C Preferred Stock (the &#8220;<span style="text-decoration: underline;">Offering</span>&#8221;)&#xa0;in reliance on the exemption from registration requirements provided by Regulation D promulgated under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline;">Securities Act</span>&#8221;), or any other applicable Securities Act exemptions available to the Company.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The following summary of the material terms of the Series C&#xa0;Stock Purchase Agreements&#xa0;<!--Created on 3/15/2021 12:27:00 PM -->does not purport to be complete and&#xa0;is qualified in its entirety by reference to the full text of the form of Series C&#xa0;Stock Purchase Agreement attached hereto as <span style="text-decoration: underline;">Exhibit 10.1</span>.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt; text-align: justify;"><i>Purchase Price</i>. The purchase price of the Series C&#xa0;Preferred Stock is $1,000 per share, for a total purchase price of $24.5&#xa0;million (the &#8220;<span style="text-decoration: underline;">Aggregate Purchase Price</span>&#8221;).<!--Created on 3/11/2021 3:28:59 PM --></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt; text-align: justify;"><i>Number of Shares of Series C&#xa0;Preferred Stock</i>.&#xa0;&#xa0;The Purchasers have agreed to purchase an aggregate of 24,500 shares of&#xa0;Series C Preferred Stock&#xa0;for the Aggregate Purchase Price, excluding additional shares of Series C Preferred Stock to be issued to the Purchasers as origination fees for the Offering (described below) .</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt; text-align: justify;"><!--Created on 3/15/2021 12:28:00 PM --></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt; text-align: justify;"><i>Origination Fees.</i>&#xa0;&#xa0;The Company will issue as an origination fee to each of the Purchasers a number of additional shares of Series C&#xa0;Preferred Stock equal to approximately two percent (2%) of the shares of Series C Preferred Stock&#xa0;purchased by such Purchaser under its&#xa0;Series C&#xa0;Stock Purchase Agreement.&#xa0; York, Bardin Hill, and Avenue&#xa0;will receive 240, 50, and 200&#xa0;shares of Series C&#xa0;Preferred Stock, respectively, as origination fees.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt; text-align: justify;"><i>Representations, Warranties and Covenants</i>.&#xa0;&#xa0;The Series C&#xa0;Stock Purchase Agreements contain customary representations, warranties and covenants from the Company and the Purchasers.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt; text-align: justify;"><i>Other Agreements</i>.&#xa0; Additional agreements are required to be executed and delivered on the Closing Date, including the Warrant Agreements and&#xa0;the Registration Rights Agreements.&#xa0;&#xa0;Forms of these agreements are summarized below and are attached as exhibits hereto.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt; text-align: justify;"><!--Created on 3/11/2021 5:48:15 PM --><b><i>Certificate of Designations of Series C&#xa0;Preferred Stock</i></b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The rights and designations of the Series C&#xa0;Preferred Stock are&#xa0;set forth in&#xa0;the Certificate of Designations of Series C&#xa0;Convertible Preferred Stock (the &#8220;<span style="text-decoration: underline;">Series C&#xa0;Certificate of Designations</span>&#8221;).&#xa0; Pursuant to the Series C&#xa0;Certificate of Designations, the Company is authorized to issue<!--Created on 3/11/2021 5:52:22 PM -->&#xa0;up to 166,364&#xa0;shares of Series C&#xa0;Preferred Stock.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 27pt; text-align: justify;">The following&#xa0;summary of the material terms of the Series C&#xa0;Certificate of Designations&#xa0;<!--Created on 3/15/2021 12:28:50 PM -->does not purport to be complete&#xa0;and is qualified in its entirety&#xa0;by reference to the full text of the&#xa0;Series C&#xa0;Certificate of Designations, which is attached hereto as&#xa0;<span style="text-decoration: underline;">Exhibit 3.1</span>.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 63pt;"><i>Optional Conversion</i>.&#xa0;&#xa0;The Company has the option to convert all, but not less than all, of the Series C&#xa0;Preferred Stock into shares of common stock, par value $0.0001 per share (the &#8220;<span style="text-decoration: underline;">Common Stock</span>&#8221;), at a conversion price of $2.9632&#xa0;per share of Common Stock (the &#8220;<span style="text-decoration: underline;">Conversion Price</span>&#8221;) on any date on which the volume weighted average trading price of shares of Common Stock for each trading day during any sixty (60) of the prior ninety (90) trading days is equal to or greater than 175% of the conversion price of the Company&#8217;s Series A Convertible Preferred Stock (the &#8220;<span style="text-decoration: underline;">Series A Preferred Stock</span>&#8221;) and Series B Convertible Preferred Stock (the &#8220;<span style="text-decoration: underline;">Series B&#xa0;Preferred Stock</span>&#8221;), in each case subject to certain terms and conditions.&#xa0; In the event that the Company elects to convert the Series C&#xa0;Preferred Stock, the Company must also convert each series of then-issued and outstanding Parity Stock (as defined in the Series C&#xa0;Certificate of Designations) at the same time (if, with respect to any&#xa0;Parity Stock&#xa0;issued after the Closing Date. &#xa0; &#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 63pt;"><i>Mandatory Conversion</i>.&#xa0;&#xa0;The Company must convert all of the Series C&#xa0;Preferred Stock into shares of Common Stock at the Conversion Price on the earlier of (i) ten (10) Business Days (as defined in the Series C&#xa0;Certificate of Designations) following a FID Event (as defined in the Series C&#xa0;Certificate of Designations) and (ii) March 17, 2031, the tenth (10th) anniversary of the date of the Series C Certificate of Designations.&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 63pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 63pt;"><i>Dividends</i>.&#xa0;&#xa0;The Series C&#xa0;Preferred Stock accrues dividends on the Series C&#xa0;Liquidation Preference (as defined in the Series C&#xa0;Certificate of Designations), which&#xa0;will be cumulative and accrue at a rate of twelve percent (12%) per annum.&#xa0; The dividends will&#xa0;be payable quarterly in cash or in-kind, at the Company&#8217;s option.&#xa0;&#xa0;The Series C&#xa0;Preferred Stock will also participate, on an as-converted basis, in any dividends paid to the holders of shares of Common Stock.&#xa0;&#xa0;The Company currently anticipates that it will elect to pay dividends on the Series C&#xa0;Preferred Stock in-kind, rather than in cash.</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 63pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 63pt;"><i>Anti-Dilution</i>.&#xa0;&#xa0;The Conversion Price and the exercise price for the Warrants (as described below) will be subject to proportional adjustment for certain transactions relating to the Company&#8217;s capital stock, including stock splits, stock dividends and similar transactions and the Conversion Price will be subject to adjustments to reflect additional issuances of Common Stock, subject to certain exceptions.</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 63pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 63pt;"><i>Limitation on Conversion</i>.&#xa0; Unless and until the Company has obtained stockholder approval in accordance with Nasdaq Listing Rule 5635(d) to permit the issuance of the maximum number of shares of Common Stock issuable upon conversion of the Series C Preferred Stock and exercise of the Warrants (as defined below) issued in the Offering&#xa0;(the &#8220;<span style="text-decoration: underline;">Required Approval</span>&#8221;),&#xa0;the number of shares of Common Stock that may be issued (i) under the Series C Certificate of Designations, including upon the conversion of&#xa0;dividends paid-in-kind as shares of Series C Preferred Stock (&#8220;<span style="text-decoration: underline;">PIK Shares</span>&#8221;), and (ii) upon the exercise of Warrants issued in connection with the Series C Convertible Preferred Stock, in the aggregate, may not exceed 19.99% of the total shares of Common Stock issued and outstanding as of the effective date of the Series C Purchase Agreements (the &#8220;<span style="text-decoration: underline;">Maximum Amount</span>&#8221;). The holders of Series C Preferred Stock shall not be entitled to vote any shares of Series C Preferred Stock for the Required Approval.</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 63pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 63pt;">Pursuant to the Series C Certificate of Designations, the Company will use commercially reasonable best efforts to obtain the Required Approval at its annual meeting of stockholders to be held on or before June 30, 2021.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt;"><!--Created on 3/12/2021 10:47:44 AM --></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt;"><b><i>Warrant Agreements</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">The following summary of the material terms of the Warrant Agreements&#xa0;<!--Created on 3/15/2021 12:33:15 PM -->does not purport to be complete&#xa0;and is qualified in its entirety&#xa0;by reference to the full text of the Form of Warrant Agreement, which is&#xa0;attached hereto as&#xa0;<span style="text-decoration: underline;">Exhibit 4.1</span>.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;"><i>Warrants</i>.&#xa0;&#xa0;The Series C&#xa0;Preferred Stock will be issued with detached warrants (the &#8220;<span style="text-decoration: underline;">Warrants</span>&#8221;).&#xa0;&#xa0;The Warrants&#xa0;will represent the right to acquire in the aggregate a number of shares of&#xa0;Common Stock&#xa0;equal to&#xa0;approximately 35&#xa0;basis points (0.35%)&#xa0;of all outstanding shares of Common Stock, measured on a fully diluted basis, on the exercise date for an exercise&#xa0;price of $0.01 per share<!--Created on 3/11/2021 5:59:19 PM -->.&#xa0;&#xa0; The Warrants will have a fixed three-year term commencing on the Closing Date.&#xa0;<!--Created on 3/11/2021 6:02:46 PM --></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;"><i>Warrant Exercise</i>.&#xa0;&#xa0;The Warrants may only be exercised by holders of Warrants at the expiration of such three-year term, except that the Company can force exercise of the Warrants prior to the expiration of the term if (i) &#xa0;the&#xa0;volume weighted average&#xa0;trading price of shares of&#xa0;Common Stock for&#xa0;each trading day during any sixty (60) of the prior ninety (90) trading&#xa0;days is equal to or greater than 175% of the conversion price&#xa0;of the Series A Preferred Stock&#xa0;and the&#xa0;Series B&#xa0;Preferred Stock&#xa0;and (ii) the Company simultaneously elects to force a mandatory exercise of all other warrants then-outstanding and unexercised and held by any holder of Parity Stock (as defined in the Series C&#xa0;Certificate of Designations).</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;"><i>Limitation on Exercise</i>.&#xa0; Unless and until the Company has obtained the Required Approval,&#xa0;the number of shares of Common Stock that may be issued (i) under the Series C Certificate of Designations, including upon conversion of PIK Shares, and (ii) upon the exercise of Warrants issued in the Offering, in the aggregate, may not exceed the Maximum Amount.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt;"><b><i>Registration Rights Agreements</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">The holders of shares of Series C&#xa0;Preferred Stock will have customary demand and piggy-back registration rights covering shares of Common Stock underlying (i) the&#xa0;Series C&#xa0;Preferred Stock (including any Common Stock underlying the Series C&#xa0;Preferred Stock issued (a) as PIK Shares,&#xa0;and (b) in respect of the origination fees), and (ii) the Warrants pursuant to the Registration Rights Agreements.&#xa0;&#xa0;The foregoing summary of the material terms of the Registration Rights Agreements&#xa0;<!--Created on 3/15/2021 12:34:21 PM -->does not purport to be complete&#xa0;and is qualified in its entirety&#xa0;by reference to the full text of the&#xa0;Form of Registration Rights Agreement, which is attached hereto as&#xa0;<span style="text-decoration: underline;">Exhibit 10.2</span>.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt;"><b><i>No Offer or Solicitation</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><b>THE INFORMATION CONTAINED IN THIS CURRENT REPORT ON FORM 8-K IS NOT AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY SHARES OF SERIES C&#xa0;PREFERRED STOCK OR ANY OTHER SECURITIES OF THE COMPANY. THE SHARES OF SERIES C&#xa0;PREFERRED STOCK AND THE WARRANTS HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION UNDER THE SECURITIES ACT OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. THE COMPANY IS FILING THIS CURRENT REPORT ON FORM 8-K WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION FOR THE SOLE PURPOSE OF REPORTING ITS ENTRY INTO THE SERIES C&#xa0;STOCK PURCHASE AGREEMENTS, AS REQUIRED BY THE RULES AND REGULATIONS OF THE COMMISSION.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt;"><b>Item 3.02.</b>&#8195;<b>&#xa0;Unregistered Sales of Equity Securities.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference in response to this Item 3.02.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt;"><b>Item 7.01.</b>&#8195;<b>Regulation FD Disclosure.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">On March 18, 2021, the Company issued a press release regarding the transactions described above under Item 1.01 of this Current Report on Form 8-K.&#xa0;A copy of the press release is attached hereto as <span style="text-decoration: underline;">Exhibit 99.1</span></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The information furnished in Item 7.01 of this Current Report on Form 8-K, including <span style="text-decoration: underline;">Exhibit 99.1</span> attached hereto, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 0pt;"><b>Item 9.01.</b>&#8195;<b> </b><b>Financial Statements and Exhibits.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">(d) Exhibits.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 93px;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 18pt;">&#xa0;3.1</div>
			</td>
			<td style="vertical-align: middle; width: 1662px;"><a href="ex_234721.htm" style="-sec-extract:exhibit;">Certificate of Designations of Series C Convertible Preferred Stock, dated as of March 17, 2021</a></td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 93px; text-indent: 18pt;">&#xa0;4.1</td>
			<td style="vertical-align: middle; width: 1662px;"><a href="ex_234759.htm" style="-sec-extract:exhibit;">Form of Warrant</a></td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 93px; text-indent: 18pt;">10.1</td>
			<td style="vertical-align: middle; width: 1662px;"><a href="ex_234853.htm" style="-sec-extract:exhibit;">Form of Series C Convertible Preferred Stock Purchase Agreement, dated as of March 17, 2021</a></td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 93px; text-indent: 18pt;">10.2</td>
			<td style="vertical-align: middle; width: 1662px;"><a href="ex_234785.htm" style="-sec-extract:exhibit;">Form of Registration Rights Agreement</a></td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 93px;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 18pt;">99.1</div>
			</td>
			<td style="vertical-align: middle; width: 1662px;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_234768.htm" style="-sec-extract:exhibit;">Press Release, dated March 18, 2021</a></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><b>SIGNATURE</b></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Dated: March 18,&#xa0;2021</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:50%;">&#xa0;</td>
			<td style="vertical-align:top;width:4%;">&#xa0;</td>
			<td style="vertical-align:top;width:46%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:50%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:50%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">NEXTDECADE CORPORATION</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:50%;">&#xa0;</td>
			<td style="vertical-align:top;width:4%;">&#xa0;</td>
			<td style="vertical-align:top;width:46%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:50%;">&#xa0;</td>
			<td style="vertical-align:top;width:4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">By:</div>
			</td>
			<td style="vertical-align:top;border-bottom:solid 1px #000000;;width:46%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">/s/ Krysta De Lima</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:50%;">&#xa0;</td>
			<td style="vertical-align:top;width:4%;">&#xa0;</td>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:46%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Name: Krysta De Lima</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:50%;">&#xa0;</td>
			<td style="vertical-align:top;width:4%;">&#xa0;</td>
			<td style="vertical-align:top;width:46%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Title: General Counsel</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex_234721.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<html><head><meta charset="utf-8"><meta name="format-detection" content="telephone=no"><!--Created on 3/17/2021 7:02:23 AM --><meta name="generator" content="RDG HTML Converter 3.4.3.0">
	<title>ex_234721.htm</title>


</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>Exhibit 3.1</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CERTIFICATE OF DESIGNATIONS </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>OF</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SERIES C CONVERTIBLE PREFERRED STOCK </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>OF</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NEXTDECADE CORPORATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NEXTDECADE CORPORATION, a Delaware corporation (the &#8220;<u>Corporation</u>&#8221;), certifies that, pursuant to the authority contained in Article Fourth of its Second Amended and Restated Certificate of Incorporation, as amended prior to the date hereof (the &#8220;<u>Certificate of Incorporation</u>&#8221;), and in accordance with the provisions of Section 151 of the Delaware General Corporation Law (the &#8220;<u>DGCL</u>&#8221;), the board of directors of the Corporation duly approved and adopted on March 15, 2021 the following resolution, which resolution remains in full force and effect on the date hereof:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">WHEREAS, the Certificate of Incorporation authorizes the issuance of up to 480,000,000 shares of Common Stock and up to 1,000,000 shares of preferred stock, par value $.0001 per share, of the Corporation (&#8220;<u>Preferred Stock</u>&#8221;) in one or more series, and expressly authorizes the board of directors of the Corporation, subject to limitations prescribed by law, to establish and fix for each such series such voting powers, full or limited, and such designations, preferences and relative, participating, optional or other special rights and such qualifications, limitations and restrictions of the shares of such series; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">WHEREAS, pursuant to Section 3.10 of the Amended and Restated Bylaws of the Corporation, as amended (the &#8220;<u>Bylaws</u>&#8221;), the board of directors of the Corporation may designate one or more committees, each such committee to consist of one or more of the directors of the Corporation in compliance with the Bylaws and all applicable laws, rules and regulations, including, but not limited to, the rules of the exchange on which the Corporation&#8217;s common stock is listed. Any such committee, to the extent provided by law and in the resolution of the board of directors of the Corporation establishing such committee, shall have and may exercise all the powers and authority of the board of directors of the Corporation in the management of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers which may require it and, so long as the resolutions expressly so provides, such committee shall have the power or authority to declare a dividend or to authorize the issuance of stock; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">WHEREAS, the board of directors of the Corporation established a special committee (the &#8220;<u>Special Committee</u>&#8221;) upon a determination by the board of directors of the Corporation that doing so was in the best interests of the Corporation and its stockholders, and by resolutions expressly authorized the Special Committee to negotiate and recommend to the board of directors of the Corporation for approval the designations, preferences and relative, participating, optional or other special rights and such qualifications, limitations and restrictions of the Series C Preferred Stock defined below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NOW, THEREFORE, BE IT RESOLVED, consistent with the recommendation of the Special Committee, that the Series C Convertible Preferred Stock be, and hereby is, created, and that the number of shares thereof, the voting powers thereof and the designations, preferences and relative, participating, optional and other special rights thereof and the qualifications, limitations and restrictions thereof be, and hereby are, as follows:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:0pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>General</u></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The shares of such series are designated the Series C Convertible Preferred Stock (hereinafter referred to as the &#8220;<u>Series C Preferred Stock</u>&#8221;). The number of authorized shares constituting the Series C Preferred Stock shall be one hundred sixty-six thousand three hundred sixty-four (166,364) shares of Series C Preferred Stock. Subject to Section 6, that number from time to time may be increased or decreased (but not below the number of shares of Series C Preferred Stock then outstanding) by (i) further resolution duly adopted by the board of directors of the Corporation, or any duly authorized committee thereof, and (ii) the filing of amendments to the Certificate of Incorporation pursuant to the provisions of the DGCL stating that such increase or decrease, as applicable, has been so authorized. The Corporation shall not have the authority to issue fractional shares of Series C Preferred Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Holders of shares of Series C Preferred Stock shall have equivalent rights, powers and preferences.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Shares of Series C Preferred Stock converted into Common Stock (as defined below) will be cancelled and will revert to authorized but unissued Preferred Stock, undesignated as to series.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;In any case where any Dividend Payment Date is not a Business Day, then (notwithstanding any other provision of this Certificate of Designations) payment of dividends need not be made on such date, but may be made on the next succeeding Business Day with the same force and effect as if made on the Dividend Payment Date; <u>provided</u>, <u>however</u>, that no interest will accrue on such amount of dividends for the period from and after such Dividend Payment Date, as the case may be.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Series C Preferred Stock, with respect to payment of dividends and rights upon Liquidation (defined below), ranks: (i) senior in all respects to all Junior Stock; (ii) on a parity in all respects with all Parity Stock; and (iii) junior in all respects to all Senior Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:0pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Certain Defined Terms</u></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;text-indent:-36pt;">As used in this Certificate of Designations, the following terms have the respective meanings set forth below:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(a)&nbsp; &nbsp;&#8220;<u>Affiliate</u>&#8221;<b> </b>shall have the meaning ascribed to such term as of the date hereof in Rule 405 under the Securities Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp; &nbsp;&#8220;<u>Business Day</u>&#8221;<b> </b>means any day other than a Saturday, Sunday, any federal legal holiday or day on which banking institutions in the State of New York or the State of Texas are authorized or required by law or other governmental action to close.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(c)&nbsp; &nbsp;&#8220;<u>Cash Dividends</u>&#8221; has the meaning specified in <u>Section 3(a)</u>.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(d)&nbsp; &nbsp;&#8220;<u>Certificate of Designations</u>&#8221; means this Certificate of Designations of the Series C Convertible Preferred Stock of the Corporation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(e)&nbsp; &nbsp;&#8220;<u>Certificate of Incorporation</u>&#8221; has the meaning specified in the first paragraph of this Certificate of Designations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(f)&nbsp; &nbsp;&#8220;<u>Change of Control</u>&#8221; means the occurrence of any of the following: (i) any sale, lease or transfer or series of sales, leases or transfers of all or substantially all of the assets of the Corporation and its Subsidiaries; (ii) any direct or indirect transfer of the Corporation&#8217;s securities (including pursuant to any merger, consolidation, share exchange, recapitalization or reorganization of the Corporation in which the Corporation is the surviving corporation) such that after such transfer a Person or group of Persons (other than the holders of the Corporation&#8217;s capital stock immediately prior to such transfer and their respective Affiliates) would own, directly or indirectly, 50% or more of the outstanding voting stock of the Corporation; (iii) any merger, consolidation, share exchange, recapitalization or reorganization of the Corporation with or into another Person where the Corporation is not the surviving corporation; or (iv) a majority of the board of directors of the Corporation ceases to be comprised of Incumbent Directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(g)&nbsp; &nbsp;&#8220;<u>Common Stock</u>&#8221; means common stock of the Corporation, par value $.0001 per share.</p>

<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="2" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="2" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(h)&nbsp; &nbsp;&#8220;<u>Conversion Price</u>&#8221; has the meaning specified in each Series C Purchase Agreement by and between the Corporation and applicable Purchaser, a copy of which shall be made available to any stockholder of the Corporation upon request to the Corporate Secretary of the Corporation, subject to adjustment in accordance with the provisions of <u>Section 5(g)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(i)&nbsp; &nbsp;&#8220;<u>Conversion Ratio</u>&#8221; means, with respect to any share of Series C Preferred Stock, an amount (subject to adjustment in accordance with the provisions of <u>Section 5(g)</u>) equal to the quotient of (i) the sum of (A) the Series C Issue Price, <u>plus</u> (B) any accrued but unpaid dividends on such share of Series C Preferred Stock as of immediately prior to the conversion thereof in accordance with <u>Section 5</u>, <u>divided by</u> (ii) the Conversion Price.<u> </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(j)&nbsp; &nbsp;&#8220;<u>Corporation</u>&#8221; has the meaning specified in the first paragraph of this Certificate of Designations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(k)&nbsp; &nbsp;&#8220;<u>DGCL</u>&#8221; has the meaning specified in the first paragraph of this Certificate of Designations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(l)&nbsp; &nbsp;&#8220;<u>Dividend Payment Date</u>&#8221;<b> </b>means January 15, April 15, July 15 and October 15 of each year, commencing on the date stipulated in <u>Section 3(c)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(m)&nbsp; &#8220;<u>Dividend Rate</u>&#8221;<b> </b>means a rate per annum equal to 12%.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(n)&nbsp; &#8220;<u>Dividend Record Date</u>&#8221;<b> </b>means, with respect to any Dividend Payment Date, the March 15, June 15, September 15 or December 15, as applicable, immediately preceding such Dividend Payment Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(o)&nbsp; &#8220;<u>FID Event</u>&#8221; means (i) the issuance of the notice to proceed in accordance with the engineering, procurement and construction contract for the Terminal with all conditions precedent thereunder for the issuance of such notice to proceed having been satisfied, and (ii) the procurement of all necessary debt or equity financing arrangements to engineer, procure and construct the Terminal under said agreement, with all conditions precedent thereunder for initial draw of funds having been satisfied.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(p)&nbsp; &#8220;<u>Holder</u>&#8221; means, with respect to shares of Series C Preferred Stock, the stockholder in whose name such Series C Preferred Stock is registered in the stock books of the Corporation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(q)&nbsp; &#8220;<u>Incumbent Directors</u>&#8221; means the individuals who, as of the Original Issue Date, are directors of the Corporation and any individual becoming a director subsequent to the Original Issue Date whose election, nomination for election by the Corporation&#8217;s stockholders, or appointment was approved by a vote of at least a majority of the then Incumbent Directors (either by a specific vote or by approval of the proxy statement of the Corporation in which such person is named as a nominee for director, without objection to such nomination); <u>provided</u>, <u>however</u>, that an individual shall not be an Incumbent Director if such individual&#8217;s election or appointment to the board of directors of the Corporation occurs as a result of an actual or threatened election contest (as described in Rule&nbsp;14a-12(c) under the Securities Exchange Act of 1934, as amended) with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the board of directors of the Corporation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(r)&nbsp; &nbsp;&#8220;<u>Junior Stock</u>&#8221; means the Common Stock and any other class or series of shares of capital stock of the Corporation hereafter authorized or established by the board of directors of the Corporation over which the Series C Preferred Stock has priority in the payment of dividends and in the distribution of assets upon any Liquidation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(s)&nbsp; &#8220;<u>Liquidation</u>&#8221; means: (A) any voluntary or involuntary liquidation, dissolution, winding up of the Corporation; or (B) a Change of Control; <u>provided</u>, <u>however</u>, that for the purposes of this definition and <u>Section 4</u>, the following shall not be deemed a Liquidation: (i) a consolidation of the Corporation with a Subsidiary, so long as the ownership of the Corporation remains substantially the same immediately following such consolidation; (ii) a merger effected to change the jurisdiction of incorporation of the Corporation so long as the ownership of the Corporation remains substantially the same immediately the merger; or (iii) a public or private equity offering by the Corporation that does not result in a Change of Control.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(t)&nbsp; &nbsp;&#8220;<u>Mandatory Conversion Date</u>&#8221; has the meaning specified in <u>Section 5(b)(i)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(u)&nbsp; &#8220;<u>NASDAQ</u>&#8221; means any of the national securities exchanges owned or operated by NASDAQ, Inc.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(v)&nbsp; &#8220;<u>Optional Conversion Date</u>&#8221; has the meaning specified in <u>Section 5(a)(ii)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(w)&nbsp; &#8220;<u>Original Issue Date</u>&#8221; means the date of this Certificate of Designations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(x)&nbsp; &nbsp;&#8220;<u>Parity Stock</u>&#8221; means any class or series of shares of the Corporation that have <i>pari passu</i> priority with the Series C Preferred Stock in the payment of dividends or in the distribution of assets upon any Liquidation (including, for the avoidance of doubt, the Series A Preferred Stock and the Series B Preferred Stock).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(y)&nbsp; &nbsp;&#8220;<u>Person</u>&#8221; means an individual, a corporation, a limited liability company, a partnership, an association, a trust or any other entity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(z)&nbsp; &nbsp;&#8220;<u>PIK Dividend</u>&#8221; has the meaning specified in <u>Section 3(b)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(aa)&nbsp; &nbsp;&#8220;<u>PIK Dividend Amount</u>&#8221; has the meaning specified in <u>Section 3(b)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(bb)&nbsp; &nbsp;&#8220;<u>PIK Share</u>&#8221; has the meaning specified in <u>Section 3(b)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(cc)&nbsp; &nbsp;&#8220;<u>Preferred Holder</u>&#8221; has the meaning specified in <u>Section 4(a)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(dd)&nbsp; &nbsp;&#8220;<u>Preferred Stock</u>&#8221; has the meaning specified in the recitals to this Certificate of Designations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(ee)&nbsp; &nbsp;&#8220;<u>Purchasers</u>&#8221; means the purchasers of Series C Preferred Stock pursuant to the Series C Purchase Agreements and their respective successors and permitted assigns.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(ff)&nbsp; &nbsp;&#8220;<u>Required Approval</u>&#8221; means such approval of the Corporation&#8217;s stockholders as is necessary under the rules and regulations of NASDAQ (including NASDAQ Rule 5635(d)) to permit the issuance of the maximum number of shares of Common Stock issuable upon conversion of the Series C Preferred Stock and exercise of the warrants issued in connection therewith.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(gg)&nbsp; &#8220;<u>Quarter</u>&#8221;<b> </b>means the three-month period ending on each of March 31, June 30, September 30 and December 31 of each year, <u>provided</u> that, with respect to the first period following the Original Issue Date, such Quarter shall be deemed to include solely the portion of such period after the Original Issue Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(hh)&nbsp; &#8220;<u>Quarterly Dividends</u>&#8221; has the meaning specified in <u>Section 3(b)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(ii)&nbsp; &nbsp;&#8220;<u>Securities Act</u>&#8221; means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(jj)&nbsp;&nbsp;&nbsp;&nbsp; &#8220;<u>Senior Stock</u>&#8221;<b> </b>means each class of capital stock or series of preferred stock established after the Original Issue Date by the board of directors of the Corporation, the terms of which expressly provide that such class or series will rank senior to the Series C Preferred Stock as to payment of dividends or in the distribution of assets upon any Liquidation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(kk)&nbsp; &nbsp;&#8220;<u>Series A Preferred Stock</u>&#8221; means the Series A Convertible Preferred Stock, par value $.0001 per share, of the Corporation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(ll)&nbsp; &nbsp;&#8220;<u>Series B Preferred Stock</u>&#8221; means the Series B Convertible Preferred Stock, par value $.0001 per share, of the Corporation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(mm)&nbsp; &nbsp;&#8220;<u>Series C Issue Price</u>&#8221; means an amount per share of Series C Preferred Stock equal to $1,000.00.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(nn)&nbsp; &nbsp;&#8220;<u>Series C Liquidation Preference</u>&#8221; means, with respect to each share of Series C Preferred Stock outstanding as of immediately prior to any Liquidation, an amount equal to the greater of (i) an amount equal to the sum of (A) the Series C Issue Price, <u>plus</u> (B) any accrued but unpaid dividends on such share of Series C Preferred Stock as of immediately prior to such Liquidation in accordance with <u>Section 3</u>, and (ii) the amount that would be distributable pursuant to such Liquidation in respect of the shares of Common Stock into which such share of Series C Preferred Stock would be converted pursuant to <u>Section 5</u> (without regard to any of the limitations on convertibility contained therein and plus any payment in respect of any fractional interest pursuant to <u>Section 5(c)</u>) if all outstanding shares of the Corporation&#8217;s Series C Preferred Stock were converted into shares of Common Stock as of immediately prior to such Liquidation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(oo)&nbsp; &nbsp;&#8220;<u>Series C Preferred Stock</u>&#8221; has the meaning specified in Section 1(a).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(pp)&nbsp; &nbsp;&#8220;<u>Series C Purchase Agreement</u>&#8221; means each of those certain Series C Convertible Preferred Stock Purchase Agreements by and between the Corporation and each of the Purchasers for the purchase of Series C Preferred Stock governed by this Certificate of Designations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(qq)&nbsp; &nbsp;&#8220;<u>Special Committee</u>&#8221; has the meaning specified in the first paragraph of this Certificate of Designations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(rr)&nbsp; &nbsp;&#8220;<u>Subsidiary</u>&#8221;&nbsp;means, with respect to any Person, any other Person of which a majority of the outstanding shares or other equity interests having the power to vote for directors or comparable managers are owned, directly or indirectly, by the first Person.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(ss)&nbsp; &nbsp;&#8220;<u>Terminal</u>&#8221; means two or more liquefaction trains at the Rio Grande LNG terminal facility at the Port of Brownsville in southern Texas.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(tt)&nbsp; &nbsp;&#8220;<u>Trading Day</u>&#8221; means a day during which trading in securities generally occurs on NASDAQ or, if the Common Stock is not listed on NASDAQ, on the New York Stock Exchange or, if the Common Stock is not listed on NASDAQ or the New York Stock Exchange, on the principal other market on which the Common Stock is then traded. If the Common Stock is not so listed or traded, &#8220;Trading Day&#8221; means a Business Day.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(uu)&nbsp; &nbsp;&#8220;<u>Transfer Agent</u>&#8221; means Continental Stock Transfer &amp; Trust Company, acting as the Corporation&#8217;s duly appointed transfer agent, registrar, conversion agent, dividend disbursing agent and paying agent for any securities of the Corporation, and its successors and assigns, or any other Person appointed to serve as transfer agent, registrar, conversion agent, dividend disbursing agent or paying agent by the Corporation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(vv)&nbsp;&nbsp;&nbsp;&nbsp; &#8220;<u>VWAP</u>&#8221; means the per share volume-weighted average price as displayed under the heading Bloomberg VWAP on Bloomberg page&nbsp;&#8220;NEXT:US &lt;equity&gt;&#8221; (or its equivalent successor if such page&nbsp;is not available) in respect of the period from the open of trading on the relevant trading day until the close of trading on such trading day.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:0pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Dividends</u></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Dividends will, with respect to each share of Series C Preferred Stock, accrue on the Series C Issue Price at the Dividend Rate for each Quarter for the portion of such Quarter for which such share is outstanding, to and including the last day of such Quarter. Dividends on the Series C Preferred Stock will accrue on a daily basis (at the Dividend Rate assuming a 365-day year), whether or not declared. Subject to the rights of holders of any Senior Stock, Holders will be entitled to receive, prior to any distributions made in respect of any Junior Stock in respect of the same Quarter, out of funds legally available for payment, cash dividends (&#8220;<u>Cash Dividends</u>&#8221;)<b> </b>on the Series C Issue Price at the Dividend Rate on each Dividend Payment Date in arrears in respect of the Quarter ending immediately prior to such Dividend Payment Date, <u>provided</u> that such Cash Dividends will be payable only when, as and if declared by the board of directors of the Corporation, and with respect to any Quarter, no Cash Dividend will be declared or payable to any holder of Junior Stock or Parity Stock unless a Cash Dividend is declared or paid to Holders of Series C Preferred Stock in such Quarter.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in <u>Section 3(a)</u>, if, at the election of the board of directors of the Corporation, the Corporation does not declare and pay all or any portion of a Cash Dividend payable on any Dividend Payment Date in accordance with <u>Section 3(a)</u> (with respect to each share of Series C Preferred Stock, the unpaid portion of such Cash Dividend, the &#8220;<u>PIK Dividend Amount</u>&#8221;), then the Corporation will deliver to each Holder of shares of Series C Preferred Stock, on such Dividend Payment Date, a number of shares of Series C Preferred Stock (each, a &#8220;<u>PIK Share</u>&#8221;) equal to the quotient of (i) the PIK Dividend Amount payable in respect of the shares of Series C Preferred Stock held by such Holder, <u>divided by</u> (ii) the Series C Issue Price (such dividend, a &#8220;<u>PIK Dividend</u>&#8221; and together with Cash Dividends, &#8220;<u>Quarterly Dividends</u>&#8221;). Any PIK Dividend declared and paid in accordance with this <u>Section 3(b)</u> will reduce, on a dollar-for-dollar basis, the amount of Cash Dividends otherwise required to be paid under <u>Section 3(a)</u> with respect to any Quarter. No fractional shares of Series C Preferred Stock shall be issued to any Holder pursuant to this <u>Section 3(b)</u> (after taking into account all shares of Series C Preferred Stock held by such Holder) and in lieu of any such fractional share, the Corporation shall pay to such Holder, at the Corporation&#8217;s option, either (1) an amount in cash equal to the applicable fraction of a share of Series C Preferred Stock multiplied by the Series C Liquidation Preference per share of Series C Preferred Stock or (2) one additional whole share of Series C Preferred Stock. Each share of Series C Preferred Stock paid as a PIK Dividend under this <u>Section 3(b)</u> shall have a deemed value equal to the Series C Issue Price. Notwithstanding anything to the contrary in this <u>Section 3(b)</u>, the Corporation shall not declare or pay a Cash Dividend to any holder of shares of Junior Stock or Parity Stock in any Quarter if, during such Quarter, the Corporation declares or pays a PIK Dividend to any Holder of Series C Preferred Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Quarterly Dividends will be payable in arrears on each Dividend Payment Date (commencing on the first Dividend Payment Date occurring at least forty-five (45) days after the Original Issue Date) for the Quarter ending immediately prior to such Dividend Payment Date, to the Holders of Series C Preferred Stock as they appear on the Corporation&#8217;s stock register at the close of business on the relevant Dividend Record Date. Notwithstanding the foregoing, the Corporation will not be required to pay Cash Dividends on the Series C Preferred Stock to the extent prohibited by any indebtedness of the Corporation or to pay any Quarterly Dividend on the Series C Preferred Stock to the extent not consistent with applicable law, but in such case, such unpaid amounts will be cumulative and will compound Quarterly on each Dividend Payment Date in arrears.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Subject to this <u>Section 3</u>, dividends (payable in cash, securities or other property) as may be determined by the board of directors of the Corporation may be declared and paid on any of the Corporation&#8217;s securities, including the Common Stock, from time to time out of funds legally available for such payment, <u>provided</u>, that in the event that the Corporation declares or pays any dividends upon the Common Stock, other than non-cash dividends that give rise to an adjustment to the Conversion Price pursuant to <u>Section 5(g)</u>, the Corporation shall also declare and pay to the Holders of the Series C Preferred Stock at the same time that it declares and pays such dividends to the holders of the Common Stock, the dividends which would have been declared and paid with respect to the Common Stock issuable upon conversion of the Series C Preferred Stock had all of the outstanding Series C Preferred Stock been converted immediately prior to the record date for such dividend, or if no record date is fixed, the date as of which the record holders of Common Stock entitled to such dividends are to be determined.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Corporation covenants that, so long as any shares of Series C Preferred Stock remain outstanding:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;the Corporation will, from time to time, take all steps necessary to increase the authorized number of shares of its Preferred Stock or Series C Preferred Stock, as applicable, if at any time the authorized number of shares of Preferred Stock or Series C Preferred Stock remaining unissued would otherwise be insufficient to allow delivery of all PIK Shares deliverable as of the next applicable Dividend Payment Date, assuming that the Quarterly Dividends then payable would be paid in their entirety as PIK Dividends; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;all PIK Shares will, upon issuance, be duly and validly issued, fully paid and nonassessable and will be free of restrictions on transfer (other than restrictions on transfer arising under federal and state securities laws and under the Series C Purchase Agreement) and will be free from all taxes, liens and charges in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously or otherwise specified herein and liens created by the Holder thereof).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:0pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Liquidation</u></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;In the event of any Liquidation, subject to the rights of holders of any Senior Stock and before any distribution is made to holders of shares of Junior Stock, the Holders of the Series C Preferred Stock and Parity Stock (the &#8220;Preferred Holders&#8221;) will be entitled to receive in respect of each share of Series C Preferred Stock and Parity Stock held by such Preferred Holder as of immediately prior to such Liquidation, from the assets of the Corporation, or proceeds thereof, distributable among the holders of the Corporation&#8217;s then-outstanding shares of capital stock, an amount equal to their respective Series C Liquidation Preference or liquidation preference applicable to such share of Parity Stock, as the case may be. If, upon such Liquidation, the assets of the Corporation, or proceeds thereof, are insufficient to pay the full Series C Liquidation Preference and/or liquidation preference applicable to such share of Parity Stock, as the case may be, of each Preferred Holder, then all such assets and proceeds of the Corporation so distributable will be distributed ratably in respect of the then-outstanding shares of Series C Preferred Stock and Parity Stock, in proportion to their respective Series C Liquidation Preferences for the Series C Preferred Stock or liquidation preferences, as applicable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notice of any Liquidation will be given by mail, postage prepaid, not less than thirty (30) days prior to the distribution or payment date stated therein, to each Preferred Holder appearing on the stock books of the Corporation as of the date of such notice at the address of said Preferred Holder shown therein. Such notice will state a distribution or payment date, the aggregate Series C Liquidation Preference and/or liquidation preference distributable in respect of all shares of Series C Preferred Stock and Parity Stock, as applicable, then held by such Preferred Holder and the place where such amount will be distributable or payable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;After the payment to the Preferred Holders of all amounts distributable pursuant to Section 4(a), the Holders of outstanding shares of Series C Preferred Stock will have no right or claim, based on their ownership of shares of Series C Preferred Stock, to any of the remaining assets of the Corporation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:0pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Conversion</u></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 0pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Optional Conversion by the Corporation</u>. Subject to the terms and conditions of this Section 5(a), the Corporation shall have the option to force the conversion of all, but not less than all, of the Series C Preferred Stock at the Conversion Price on any date with respect to which the volume weighted average trading price of the Common Stock for each Trading Day during any sixty (60) of the prior ninety (90) Trading Days is equal to or greater than 175% of the then applicable conversion prices of the Series A Preferred Stock and the Series B Preferred Stock, subject to the following terms and conditions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;The Corporation shall give written notice to each Holder of its election to force conversion of the Series C Preferred Stock plus any accrued but unpaid dividends on the Series C Preferred Stock as of immediately prior to the conversion thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Each share of Series C Preferred Stock will be convertible pursuant to this <u>Section 5(a)</u> into a number of shares of Common Stock equal to the Conversion Ratio applicable to such share of Series C Preferred Stock as of immediately prior to the close of business on the day of surrender (or, if not a Business Day, then the next Business Day thereafter) of the certificate for such share for conversion in accordance with <u>Section 5(a)(iii)</u> or the day designated by the Corporation which is no more than ten Business Days after the date on which the optional conversion is triggered pursuant to clause (a) above (the &#8220;<u>Optional Conversion Date</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Each Holder agrees to surrender at the office of the Corporation the certificate(s) therefor, duly endorsed or assigned to the Corporation or in blank.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;Shares of Series C Preferred Stock will be deemed to have been converted immediately prior to the close of business on the Optional Conversion Date, and at such time the rights of the Holder of such shares of Series C Preferred Stock as a holder thereof will cease and from and after such time the Person entitled to receive the Common Stock issuable upon such conversion will be treated for all purposes as the record holder of such Common Stock. As promptly as practicable on or after the Optional Conversion Date, the Corporation will issue and deliver at such office a certificate or certificates for the number of full shares of Common Stock issuable upon such conversion, together with payment in lieu of any fraction of a share, as provided in <u>Section</u>&nbsp;<u>5(c)</u>, to the Person or Persons entitled to receive the same.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(v)&nbsp;&nbsp;&nbsp;&nbsp;In the event that the Corporation elects to force the conversion of the Series C Preferred Stock pursuant to this Section 5(a), then the Corporation must also convert each series of then-issued and outstanding Parity Stock at the same time, except to the extent, with respect to any Parity Stock issued after the Original Issue Date, such forced conversion is not permitted in accordance with the terms of and with respect to such Parity Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Mandatory Conversion</u>. The Corporation must convert all, but not less than all, of the Series C Preferred Stock into shares of Common Stock, on and subject to the following terms and conditions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;The Corporation must convert all of the Series C Preferred Stock into shares of Common Stock on the date that is the earlier of (i) the tenth (10<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup>) Business Day following an FID Event, or (ii) the tenth anniversary of the Original Issue Date (the &#8220;<u>Mandatory Conversion Date</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Each share of Series C Preferred Stock will be convertible pursuant to this <u>Section 5(b)</u> into a number of shares of Common Stock equal to the Conversion Ratio applicable to such share of Series C Preferred Stock as of immediately prior to the close of business on the Mandatory Conversion Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Each share of Series C Preferred Stock will be deemed to have been converted immediately prior to the close of business on the Mandatory Conversion Date, and at such time the rights of the Holder of such shares of Series C Preferred Stock as a Holder thereof will cease and from and after such time the Person entitled to receive the Common Stock issuable upon such conversion will be treated for all purposes as the record holder of such Common Stock. As promptly as practicable on or after the conversion date and after surrender of the certificate(s) representing the converted Series C Preferred Stock, the Corporation will issue and deliver a certificate or certificates for the number of full shares of Common Stock issuable upon such conversion, together with payment in lieu of any fraction of a share, as provided in <u>Section</u>&nbsp;<u>5(c)</u>, to the Person or Persons entitled to receive the same.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Fractional Interests</u>. If more than one share of Series C Preferred Stock is presented for conversion at the same time by the same Holder (either pursuant to <u>Section 5(a)</u> or <u>Section 5(b)</u>), the number of full shares of Common Stock which will be issuable upon such conversion thereof will be computed on the basis of the aggregate number of shares of Series C Preferred Stock to be converted by such Holder. The Corporation will not be required upon the conversion of any shares of Series C Preferred Stock to issue any fractional shares of Common Stock, but may, in lieu of issuing any fractional share of Common Stock that would otherwise be issuable upon such conversion, pay a cash adjustment in respect of such fraction in an amount equal to the product of (i) such fraction, <u>multiplied by</u> (ii) the volume-weighted average trading price of the Common Stock for the ten (10) Trading Days immediately prior to the Mandatory Conversion Date. No Holder of Series C Preferred Stock will be entitled to receive any fraction of a share of Common Stock or a stock certificate representing a fraction of a share of Common Stock if such amount of cash is paid in lieu thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Reservation and Authorization of Common Stock</u>. The Corporation covenants that, so long as any shares of Series C Preferred Stock remain outstanding:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;the Corporation will at all times reserve and keep available, from its authorized and unissued Common Stock solely for issuance and delivery upon the conversion of the shares of Series C Preferred Stock, such number of shares of Common Stock as from time to time will be issuable upon the conversion in full of all outstanding shares of Series C Preferred Stock;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the Corporation will, from time to time, take all steps necessary to increase the authorized number of shares of its Common Stock if at any time the authorized number of shares of Common Stock remaining unissued would otherwise be insufficient to allow delivery of all the shares of Common Stock then deliverable upon the conversion of all outstanding shares of Series C Preferred Stock; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;all shares of Common Stock issuable upon conversion of shares of Series C Preferred Stock will, upon issuance, be duly and validly issued, fully paid and nonassessable and will be free of restrictions on transfer (other than restrictions on transfer arising under federal and state securities laws and the Series C Purchase Agreement) and will be free from all taxes, liens and charges in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously or otherwise specified herein and liens created by the Holder thereof).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Corporation hereby authorizes and directs the Transfer Agent for the Common Stock at all times to reserve stock certificates of deposit such stock certificates on behalf of the Corporation with the Depository Trust Company for such number of authorized shares of Common Stock as are required for such purpose.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Conversion Limitation</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained in this Certificate of Designations, prior to the Corporation&#8217;s receipt of the Required Approval, (1) the number of shares of Common Stock that may be issued (i) under this Certificate of Designations, including Common Stock issued upon conversion of PIK Shares, and/or (ii) upon the exercise of all warrants issued in connection with the Series C Convertible Preferred Stock, in the aggregate, may not exceed 19.99% of the total shares of Common Stock issued and outstanding as of the effective date of the applicable Series C Purchase Agreement and (2) the Holder shall not be entitled to vote any shares of Series C Preferred Stock for the Required Approval. If prior to the Corporation&#8217;s receipt of the Required Approval, any conversion of Series C Preferred Stock, individually, or in the aggregate with shares of Common Stock theretofore issued (x) under this Certificate of Designations and (y) upon the exercise of warrants issued in connection with the Series C Preferred Stock, would result in the issuance of a number of shares of Common Stock greater than 19.99% of the total shares of Common Stock issued and outstanding as of the effective date of the applicable Series C Purchase Agreement (the &#8220;<u>Maximum Amount</u>&#8221;), then, upon such conversion, the Corporation shall pay to the converting Holder cash in lieu of such number of shares of Common Stock in excess of the Maximum Amount in an amount equal to (i) the number of shares of Common Stock in excess of the Maximum Amount which would otherwise be issuable to the Holder, multiplied by (ii) the VWAP of the Common Stock based on a trailing ten (10) Trading Day period beginning at 9:30 a.m. Eastern time on the tenth Trading Day prior to the date of such conversion and ending at 4:00 p.m. Eastern time on the Trading Day immediately prior to the date of such conversion, determined on a pro rata basis in respect of all converting Holders and/or exercising holders of warrants in the event of the concurrent conversions of Series C Preferred Stock or exercises of warrants by multiple Holders of Series C Preferred Stock and/or holders of warrants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;The Corporation shall use its commercially reasonable best efforts to obtain the Required Approval at its annual meeting of stockholders to be held on or before June 30, 2021.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;<u>Payment of Taxes</u>. The Corporation will pay any and all taxes (other than income taxes) that may be payable in respect of the issue or delivery of shares of Common Stock on conversion of shares of Series C Preferred Stock pursuant hereto. The Corporation also will not impose any service charge in connection with any conversion of the shares of Series C Preferred Stock to shares of Common Stock. The Corporation will not be required, however, to pay any tax or other charge imposed in respect of any transfer involved in the issue and delivery of any certificates for shares of Common Stock or payment of cash or other property to any recipient other than any such Holder of a share of Series C Preferred Stock converted, and in the case of, any such transfer or payment, the Transfer Agent for the Series C Preferred Stock and the Corporation will not be required to issue or deliver any certificate or pay any cash until (i) such tax or charge has been paid or an amount sufficient for the payment thereof has been delivered to the Transfer Agent for the Series C Preferred Stock or the Corporation, or (ii) it has been established to the Corporation&#8217;s satisfaction that any such tax or other charge that is or may become due has been paid.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;<u>Conversion Price Adjustment</u>. The Conversion Price and the number and kind of shares of stock of the Corporation issuable on conversion shall be adjusted from time to time as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;<u>Subdivisions and Combinations</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">If the Corporation (a)&nbsp;subdivides its outstanding Common Stock into a greater number of shares or (b)&nbsp;combines its outstanding Common Stock into a smaller number of shares of Common Stock, then the Conversion Price in effect immediately after the effectiveness of such subdivision or combination shall be adjusted as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">CP<sub>1</sub>&nbsp;= CP<sub>0</sub>&nbsp;x (OS<sub>0</sub>&nbsp;/ OS<sub>1</sub>)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">Where:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">CP<sub>1</sub>&nbsp;= the Conversion Price in effect immediately after the effectiveness of such subdivision or combination;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">CP<sub>0</sub>&nbsp;= the Conversion Price in effect immediately before the effectiveness of such subdivision or combination;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">OS<sub>0</sub>&nbsp;= the number of shares of Common Stock outstanding immediately before the effectiveness of such subdivision or combination; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">OS<sub>1</sub>&nbsp;= the number of shares of Common Stock outstanding immediately after the effectiveness of such subdivision or combination.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<u>Dividends Payable in Shares of Common Stock</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">If the Corporation pays a dividend or otherwise makes a distribution payable in shares of Common Stock to all or substantially all of the holders of the outstanding shares of any class or series of stock of the Corporation, the Conversion Price shall be adjusted as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">CP<sub>1</sub>&nbsp;= CP<sub>0</sub>&nbsp;x (OS<sub>0</sub>&nbsp;/ OS<sub>1</sub>)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">Where:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">CP<sub>1</sub>&nbsp;= the Conversion Price in effect immediately after the close of business on the record date for such dividend or distribution;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">CP<sub>0</sub>&nbsp;= the Conversion Price in effect immediately before the close of business on the record date for such dividend or distribution;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">OS<sub>0</sub>&nbsp;= the number of shares of Common Stock outstanding immediately before the close of business on the record date for such dividend or distribution; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">OS<sub>1</sub>&nbsp;= the number of shares of Common Stock outstanding immediately after payment of such dividend or distribution.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">If the total number of shares constituting the dividend or distribution does not exceed 1.0% of the number of shares of Common Stock outstanding immediately before the close of business on the record date for such dividend or distribution, then unless adjustment is earlier required pursuant to&nbsp;<u>Section 5(g)(v)</u>, no adjustment shall be made to the Conversion Price, but such shares constituting the dividend or distribution shall be included in the next succeeding dividend or other distribution for purposes of determining whether an adjustment to the Conversion Price shall occur in accordance with this sentence.&nbsp;&nbsp;In case shares of Common Stock are not issued after a record date has been fixed, the Conversion Price shall be readjusted to the Conversion Price that would have been in effect if the record date had not been fixed.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(iii)<u>&nbsp;&nbsp;&nbsp;&nbsp;Common Stock Issuances</u>. (A) If the&nbsp;Corporation shall at any time or from time to time, issue, sell or otherwise dispose of any additional shares of Common Stock (including shares owned or held by or for the account of the Corporation), however designated (other than (t) Common Stock or warrants or options to purchase such additional number of shares of Common Stock, in each case issued in connection with a&nbsp;<i>bona fide</i>&nbsp;acquisition, merger or similar transaction between the Corporation and a non-Affiliated third party; (u) shares of Common Stock issued pursuant to any present or future plan providing for the reinvestment of dividends or interest payable on the Corporation&#8217;s securities or the investment of additional optional amounts in shares of Common Stock under any such plan; (v) the issuance of any shares of Common Stock or options or rights to purchase such shares designated for such issuance as of the date hereof pursuant to any of the Corporation&#8217;s employee, director, trustee, or consultant benefit plans, employment agreements, or similar arrangements or programs; (w) the issuance of any shares of Common Stock pursuant to any option, warrant, right, or exercisable or convertible security outstanding as of the date shares of Series C Preferred Stock were first issued; (x) the issuance of any shares of Common Stock in connection with a conversion of shares of Series A Preferred Stock and Series B Preferred Stock after the date hereof; (y) a change (by merger, reclassification, or otherwise) in the par value of the Common Stock; or (z) the issuance of up to 7,500,000 shares of Common Stock or any securities convertible into or exchangeable or exercisable for up to 7,500,000 shares of Common Stock in one or more public offerings<b> </b>made after the date that shares of Series C Preferred Stock were first issued) then the Conversion Price shall be adjusted as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">CP<sub>1</sub>&nbsp;= CP<sub>0</sub>&nbsp;&#8211; (CP<sub>0</sub>&nbsp;x SI/ OS<sub>1</sub>)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">Where:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">CP<sub>1</sub>&nbsp;= the Conversion Price in effect immediately after the issuance of additional shares of Common Stock;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">CP<sub>0</sub>&nbsp;= the Conversion Price in effect immediately prior to the issuance of additional shares of Common Stock;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">SI = the number of additional shares of Common Stock issued (excluding any shares described in clauses (t) &#8211; (z) above);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">OS<sub>1</sub>&nbsp;= the number of shares of Common Stock outstanding immediately after the issuance of additional shares of Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;<u>Deferral of Issuance of Additional Shares in Connection with Conversions between a Record Date and Occurrence of Triggering Event</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">In any case in which this <u>Section 5(g)</u> requires that an adjustment as a result of any event become effective from and after a record date, the Corporation may elect to defer until after the occurrence of the event&nbsp;(a) issuing to the Holder of any shares of Series C Preferred Stock converted after the record date and before the occurrence of the event the additional shares of Common Stock issuable upon such conversion over and above the shares issuable on the basis of the Conversion Price in effect immediately before adjustment, and (b)&nbsp;paying to such Holder any amount in cash in lieu of a fractional share of Common Stock under <u>Section 5(c)</u> above. In any such case, the Corporation shall issue or cause a transfer agent to issue evidence, in a form reasonably satisfactory to the Holders of such shares of Series C Preferred Stock, of the right to receive the shares as to which the issuance is deferred.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(v)&nbsp;&nbsp;&nbsp;&nbsp;<u>Postponement of Small Adjustments</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">Any adjustment in the Conversion Price otherwise required to be made by this <u>Section</u>&nbsp;<u>5</u> may be postponed until the earlier of (x) the day prior to the Optional Conversion Date or Mandatory Conversion Date, if applicable, or (y) the date of the next adjustment otherwise required to be made up to, but not beyond, one year from the date on which it would otherwise be required to be made, if such adjustment (together with any other adjustments postponed under this <u>Section 5(g)(v)</u> and not theretofore made) would not require an increase or decrease of more than&nbsp;1% in such price and would not, if made, entitle the Holders of all then outstanding shares of Series C Preferred Stock upon conversion to receive additional shares of Common Stock equal in the aggregate to one-tenth of one percent (0.1%) or more of the then issued and outstanding shares of Common Stock. All calculations under this <u>Section 5(g)(v)</u> shall be made to the nearest cent or to the nearest 1/100<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup>&nbsp;of a share, as the case may be.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;<u>Reductions in Conversion Price to Avoid Tax Effects</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">The board of directors of the Corporation may make such reductions in the Conversion Price, in addition to those required by this <u>Section 5(g)</u>, as shall be determined by the board of directors of the Corporation in good faith to be advisable in order to avoid taxation to the recipients so far as practicable of any dividend of stock or stock rights or any event treated as such for federal income tax purposes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(vii)&nbsp;&nbsp;&nbsp;&nbsp;<u>No Adjustment for Participating Transactions</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">The Corporation shall not make any adjustment pursuant to this <u>Section 5(g)</u> if Holders of shares of Series C Preferred Stock are permitted to participate, concurrently with the holders of Common Stock and on an as-converted basis, in any transaction described in this <u>Section 5(g)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(viii)&nbsp;&nbsp;&nbsp;&nbsp;<u>No Adjustment for Other Actions or Transactions</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">No adjustment shall be made to the conversion rights of the Series C Preferred Stock except as specifically set forth in this <u>Section 5(g)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(ix)&nbsp;&nbsp;&nbsp;&nbsp;<u>Successive Adjustments; Multiple Adjustments</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">After an adjustment is made to the Conversion Price under this <u>Section 5</u>, any subsequent event requiring an adjustment under this <u>Section 5</u> shall cause an adjustment to such Conversion Price, as so adjusted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:0pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Voting</u></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 0pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Holders of shares of Series C Preferred Stock shall only have such voting rights as provided for in this <u>Section 6</u> or as otherwise specifically required by law, the Certificate of Incorporation, or the Bylaws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;As to matters upon which Holders of Series C Preferred Stock are entitled to vote separately as a class, the Holders of Series C Preferred Stock will be entitled to one vote per share of Series C Preferred Stock held. The approval of any such matters required to be submitted to such vote will be determined by the Holders holding a majority of the issued and outstanding shares of the Series C Preferred Stock. Each Holder of outstanding shares of Series C Preferred Stock shall be entitled to notice of all stockholder meetings (or requests for written consent), including any meetings where the Holders of shares of Series C Preferred Stock are entitled to vote as a class, in each case, in accordance with the Bylaws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Each Holder of outstanding shares of Series C Preferred Stock shall be entitled to vote together with the holders of outstanding shares of Common Stock, voting together as a single class, with respect to any and all matters presented to the stockholders of the Corporation for their action or consideration (whether at a meeting of stockholders of the Corporation or otherwise), except as otherwise provided by law or this Certificate of Designations. In any such vote, each share of Series C Preferred Stock shall be entitled to a number of votes equal to the largest number of whole shares of Common Stock into which such share would be convertible as of the record date for such vote pursuant to&nbsp;<u>Section 5(a)</u>&nbsp;as though the conditions to conversion set forth in&nbsp;<u>Section 5(a)</u>&nbsp;had been satisfied and treating such record date as the Optional Conversion Date for purposes of such calculation (and in each case irrespective of whether the shares of Series C Preferred Stock are then convertible at the option of the Corporation pursuant to such&nbsp;<u>Section 5(a)</u>).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;In addition to any other vote or consent of stockholders required by law, the Certificate of Incorporation, or the Bylaws, the Corporation will not, directly or indirectly, without the affirmative vote at a meeting (or the written consent with or without a meeting) of the Holders of at least a majority of the number of shares of Series C Preferred Stock then outstanding:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Authorize, create (by reclassification or otherwise) or approve the issuance of any shares of, or of any security convertible into, or convertible or exchangeable for shares of, any Senior Stock (or amend the terms of any existing shares to provide for such ranking);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Authorize, create (by reclassification or otherwise) or approve the issuance of any shares of, or of any security convertible into, or convertible or exchangeable for shares of, Series C Preferred Stock or Parity Stock (or amend the terms of any existing shares to provide for such ranking) except for (i) authorized PIK Shares or shares of Parity Stock paid as dividends in-kind in accordance with the terms of the certificate of designations of such Parity Stock or (ii) Series C Preferred Stock not to exceed an aggregate purchase price of $50,000,000; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;take any other corporate action that adversely affects any of the rights, preferences or privileges of the Series C Preferred Stock; <u>provided</u>, <u>however</u>, that for the avoidance of doubt this <u>Section 6(d)(iii)</u> shall not refer to any commercial or business decision made by the Corporation that may affect the value of the Series C Preferred Stock but does not change its rights, preferences or privileges (such as the incurrence of debt) or the issuance of Parity Stock permitted by <u>Section 6(d)(ii)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;In addition to any other vote or consent of stockholders required by law, the Certificate of Incorporation, or the Bylaws, the Corporation will not, directly or indirectly, without the affirmative vote at a meeting (or the written consent with or without a meeting) of the Holders of at least a majority of the number of shares of Series C Preferred Stock then outstanding: (i) amend, alter or repeal any of the provisions of the Certificate of Incorporation so as to affect adversely the powers, designations, preferences or rights of the Series C Preferred Stock or the Holders thereof; <u>provided</u>, <u>however</u>, that, for the avoidance of doubt, an amendment to the Certificate of Incorporation to authorize or create, or to increase the authorized amount of, any Junior Stock or Parity Stock will not be deemed to affect adversely the powers, designations, preferences or rights of the Series C Preferred Stock or the Holders thereof, or (ii) amend, alter or repeal any of the provisions of this Certificate of Designations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the avoidance of doubt, nothing herein limits the ability of the Corporation to issue Common Stock or incur indebtedness (other than indebtedness convertible or exchangeable for shares of Senior Stock, Series C Preferred Stock or Parity Stock).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:0pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Uncertificated Shares and Certificated Shares; Transfer of Shares; Record Holders</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Restrictive Legends</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(i)<i>&nbsp;&nbsp;&nbsp;&nbsp;Legends</i>. Until such time as the Series C Preferred Stock and Common Stock issued upon the conversion of Series C Preferred Stock, as applicable, have been sold pursuant to an effective registration statement under the Securities Act, or the Series C Preferred Stock or Common Stock issued upon the conversion of Series C Preferred Stock, as applicable, are eligible for resale pursuant to Rule 144 promulgated under the Securities Act without any restriction as to the number of securities as of a particular date that can then be immediately sold, each book-entry account or certificate issued with respect to a share of Series C Preferred Stock or any Common Stock issued upon the conversion of Series C Preferred Stock will, in addition to any legend required in respect of the Series C Purchase Agreement or any other agreement applicable to such shares, contain a legend in substantially the following form:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;"><b>THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE </b>&#8220;<b><u>SECURITIES ACT</u></b>&#8221;<b>), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THE SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OR (2) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE STATE SECURITIES LAWS AND THE APPLICABLE SECURITIES LAWS OF OTHER JURISDICTIONS, IF ANY. IN THE CASE OF A TRANSACTION EXEMPT FROM REGISTRATION, PRIOR TO THE REGISTRATION OF ANY TRANSFER OTHER THAN TO A QUALIFIED INSTITUTIONAL BUYER IN RELIANCE ON RULE 144A PROMULGATED UNDER THE SECURITIES ACT OR A TRANSFER TO THE CORPORATION, THE CORPORATION RESERVES THE RIGHT TO REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT AND SUCH OTHER APPLICABLE SECURITIES LAWS, IF ANY.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;"><b>THESE SECURITIES ARE SUBJECT TO LIMITATIONS ON TRANSFER CONTAINED IN THOSE CERTAIN SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTS BY AND BETWEEN NEXTDECADE CORPORATION, A DELAWARE CORPORATION (THE </b>&#8220;<b><u>CORPORATION</u></b>&#8221;<b>), AND THE PURCHASER (AS DEFINED THEREIN).</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(ii)<i>&nbsp;&nbsp;&nbsp;&nbsp;Removal of Legend</i>. In connection with a sale of the Series C Preferred Stock or Common Stock issued upon the conversion of Series C Preferred Stock, as applicable, in reliance on Rule 144 promulgated under the Securities Act, the applicable holder or its broker shall deliver to the Corporation a broker representation letter providing to the Corporation any information the Corporation reasonably deems necessary to determine that such sale is made in compliance with Rule 144 promulgated under the Securities Act, including, as may be appropriate, a certification that such holder is not an affiliate of the Corporation (as defined in Rule 144 promulgated under the Securities Act) and a certification as to the length of time the applicable equity interests have been held. Upon receipt of such representation letter, the Corporation shall promptly remove the restrictive legend, and the Corporation shall bear all costs associated with the removal of such legend. At such time as the Series C Preferred Stock and Common Stock issued upon the conversion of Series C Preferred Stock, as applicable, (A) have been sold pursuant to an effective registration statement under the Securities Act, (B) have been held by the applicable holder for more than one year where the holder is not, and has not been in the preceding three months, an affiliate of the Corporation (as defined in Rule 144 promulgated under the Securities Act), or (C) no longer require such restrictive legend, as set forth in an opinion of counsel reasonably satisfactory to the Corporation, if the restrictive legend is still in place, the Corporation agrees, upon request of such holder, to take all steps necessary to promptly effect the removal of such legend, and the Corporation shall bear all costs associated with such removal of such legend. The Corporation shall cooperate with the applicable holder to effect the removal of such legend at any time such legend is no longer appropriate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Shares of Series C Preferred Stock</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(i)<i>&nbsp;&nbsp;&nbsp;&nbsp;Form and Dating</i>. Unless otherwise requested in writing by a Holder to the Corporation, the shares of Series C Preferred Stock and any shares of Common Stock issued upon conversion thereof shall be in uncertificated, book-entry form. If certificated shares of Series C Preferred Stock are requested by a Holder, then certificates representing shares of Series C Preferred Stock and the Transfer Agent&#8217;s certificate of authentication will be substantially in the form set forth in <u>Exhibit</u>&nbsp;<u>A</u>, which is hereby incorporated in and expressly made a part of this Certificate of Designations. Each Series C Preferred Stock certificate may have notations, legends or endorsements required by law or stock exchange rules, <u>provided</u> that any such notation, legend or endorsement is in a form acceptable to the Corporation. Each Series C Preferred Stock certificate will be dated the date of its authentication.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(ii)<i>&nbsp;&nbsp;&nbsp;&nbsp;Execution and Authentication</i>. Two officers of the Corporation shall sign each Series C Preferred Stock certificate for the Corporation by manual or facsimile signature.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 72pt;text-indent:36pt;">(A)&nbsp;&nbsp;&nbsp;&nbsp;If an officer of the Corporation whose signature is on a Series C Preferred Stock certificate no longer holds that office at the time the Transfer Agent authenticates the Series C Preferred Stock certificate, the Series C Preferred Stock certificate will be valid nevertheless.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 72pt;text-indent:36pt;">(B)&nbsp;&nbsp;&nbsp;&nbsp;A Series C Preferred Stock certificate will not be valid until an authorized signatory of the Transfer Agent manually signs the certificate of authentication on the Series C Preferred Stock certificate. The signature will be conclusive evidence that the Series C Preferred Stock certificate has been authenticated under this Certificate of Designations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 72pt;text-indent:36pt;">(C)&nbsp;&nbsp;&nbsp;&nbsp;The Transfer Agent shall authenticate and deliver certificates for shares of Series C Preferred Stock for original issue upon a written order of the Corporation signed by two officers of the Corporation. Such order will specify the number of shares of Series C Preferred Stock to be authenticated and the date on which the original issue of the Series C Preferred Stock is to be authenticated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 72pt;text-indent:36pt;">(D)&nbsp;&nbsp;&nbsp;&nbsp;The Transfer Agent may appoint an authenticating agent reasonably acceptable to the Corporation to authenticate the certificates for the Series C Preferred Stock. Unless limited by the terms of such appointment, an authenticating agent may authenticate certificates for the Series C Preferred Stock whenever the Transfer Agent may do so. Each reference in this Certificate of Designations to authentication by the Transfer Agent includes authentication by such agent. An authenticating agent has the same rights as the Transfer Agent or agent for service of notices and demands.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(iii)<i>&nbsp;&nbsp;&nbsp;&nbsp;Transfer</i>. When any certificate representing shares of Series C Preferred Stock is presented to the Transfer Agent with a request to register the transfer of such shares, the Transfer Agent shall register the transfer or make the exchange as requested if its reasonable requirements for such transaction are met; <u>provided</u>, <u>however</u>, that such shares being surrendered for transfer will be duly endorsed or accompanied by a written instrument of transfer in form reasonably satisfactory to the Corporation and the Transfer Agent, duly executed by the Holder thereof or its attorney duly authorized in writing, and accompanied by a certification in substantially the form of <u>Exhibit</u>&nbsp;<u>B</u> hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(iv)<i>&nbsp;&nbsp;&nbsp;&nbsp;Replacement Certificates</i>. If any of the Series C Preferred Stock certificates are mutilated, lost, stolen or destroyed, the Corporation shall issue, in exchange and in substitution for and upon cancellation of the mutilated Series C Preferred Stock certificate, or in lieu of and substitution for the Series C Preferred Stock certificate lost, stolen or destroyed, a new Series C Preferred Stock certificate of like tenor and representing an equivalent amount of shares of Series C Preferred Stock, but only upon receipt of evidence of such loss, theft or destruction of such Series C Preferred Stock certificate and indemnity, if requested, satisfactory to the Corporation and the Transfer Agent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:36pt;">(v)<i>&nbsp;&nbsp;&nbsp;&nbsp;Cancellation</i>. In the event the Corporation purchases or otherwise acquires certificates representing shares of Series C Preferred Stock, the same will thereupon be delivered to the Transfer Agent for cancellation. The Transfer Agent and no one else shall cancel and destroy all Series C Preferred Stock certificates surrendered for transfer, exchange, replacement or cancellation and deliver a certificate of such destruction to the Corporation unless the Corporation directs the Transfer Agent to deliver canceled Series C Preferred Stock certificates to the Corporation. The Corporation may not issue new Series C Preferred Stock certificates to replace Series C Preferred Stock certificates to the extent they evidence Series C Preferred Stock which the Corporation has purchased or otherwise acquired.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Record Holders</u>. Prior to due presentment for registration of transfer of any shares of Series C Preferred Stock, the Transfer Agent and the Corporation may deem and treat the Person in whose name such shares are registered as the absolute owner of such Series C Preferred Stock, and neither the Transfer Agent nor the Corporation shall be affected by notice to the contrary.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>No Obligation of the Transfer Agent</u>. The Transfer Agent will have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this Certificate of Designations or under applicable law with respect to any transfer of any interest in any Series C Preferred Stock other than to require delivery of such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by, the terms of this Certificate of Designations, and to examine the same to determine substantial compliance as to form with the express requirements hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:0pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>No Other Rights</u></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt;">Without limiting the rights and obligations of the Corporation and any Holder of Series C Preferred Stock pursuant to any contract or agreement between the Corporation and any such Holder of Series C Preferred Stock, the shares of Series C Preferred Stock will not have any powers, designations, preferences or relative, participating, optional or other special rights, nor will there be any qualifications, limitations or restrictions or any powers, designations, preferences or rights of such shares, other than as set forth in this Certificate of Designations, the Certificate of Incorporation, the Bylaws or as may be provided by law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>[</i><b><i>Signature page follows</i></b><i>]</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>

<div contenteditable="false" data-auto-pgnum="end">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">IN WITNESS WHEREOF, the Corporation has caused this Certificate of Designations to be signed and attested this day of March 17, 2021.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 52px;">&nbsp;</td>
			<td style="width: 289px;">&nbsp;</td>
			<td colspan="2" style="width: 298px;"><u>THE CORPORATION</u>:</td>
			<td style="width: 693px;">&nbsp;</td>
			<td style="width: 33%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 52px;">&nbsp;</td>
			<td style="width: 289px;">&nbsp;</td>
			<td colspan="2" style="width: 298px;">&nbsp;</td>
			<td style="width: 693px;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 52px;">&nbsp;</td>
			<td style="width: 289px;">&nbsp;</td>
			<td colspan="2" style="width: 298px;"><b>NEXTDECADE CORPORATION</b></td>
			<td style="width: 693px;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 52px;">&nbsp;</td>
			<td style="width: 289px;">&nbsp;</td>
			<td colspan="2" style="width: 298px;">&nbsp;</td>
			<td style="width: 693px;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 52px;">&nbsp;</td>
			<td style="width: 289px;">&nbsp;</td>
			<td style="width: 24px;">By:</td>
			<td style="width: 245px; border-bottom: thin solid rgb(0, 0, 0);">/s/ Matthew Schatzman</td>
			<td style="width: 693px;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 52px;">&nbsp;</td>
			<td style="width: 289px;">&nbsp;</td>
			<td colspan="2" style="width: 298px;">Name:&nbsp; Matthew Schatzman</td>
			<td style="width: 693px;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 52px;">&nbsp;</td>
			<td style="width: 289px;">&nbsp;</td>
			<td colspan="2" style="width: 298px;">Title:&nbsp; Chief Executive Officer</td>
			<td style="width: 693px;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 52px;">&nbsp;</td>
			<td style="width: 289px;">&nbsp;</td>
			<td colspan="2" style="width: 298px;">&nbsp;</td>
			<td style="width: 693px;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 52px;">&nbsp;</td>
			<td style="width: 289px;">&nbsp;</td>
			<td colspan="2" style="width: 298px;">&nbsp;</td>
			<td style="width: 693px;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 52px;">Attest:</td>
			<td style="width: 289px; border-bottom: thin solid rgb(0, 0, 0);">/s/ Krysta De Lima</td>
			<td colspan="2" style="width: 298px;">&nbsp;</td>
			<td style="width: 693px;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 52px;">Name:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
			<td style="width: 289px;">&nbsp;Krysta De Lima&nbsp;&nbsp;</td>
			<td colspan="2" style="width: 298px;">&nbsp;</td>
			<td style="width: 693px;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 52px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
			</td>
			<td style="width: 289px;">&nbsp;General Counsel</td>
			<td colspan="2" style="width: 298px;">&nbsp;</td>
			<td style="width: 693px;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><i>Signature page to Certificate of Designations of&nbsp;</i></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><i>Series C Convertible Preferred Stock of NextDecade Corporation</i></b></p>
</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>EXHIBIT A</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM OF SERIES C CONVERTIBLE PREFERRED STOCK</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FACE OF SECURITY</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;<u>SECURITIES ACT</u>&#8221;), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THE SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OR (2) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE STATE SECURITIES LAWS AND THE APPLICABLE SECURITIES LAWS OF OTHER JURISDICTIONS, IF ANY. IN THE CASE OF A TRANSACTION EXEMPT FROM REGISTRATION, PRIOR TO THE REGISTRATION OF ANY TRANSFER OTHER THAN TO A QUALIFIED INSTITUTIONAL BUYER IN RELIANCE ON RULE 144A PROMULGATED UNDER THE SECURITIES ACT OR A TRANSFER TO THE CORPORATION, THE CORPORATION RESERVES THE RIGHT TO REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT AND SUCH OTHER APPLICABLE SECURITIES LAWS, IF ANY.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">THE SECURITIES EVIDENCED BY THIS CERTIFICATE ARE SUBJECT TO LIMITATIONS ON TRANSFER CONTAINED IN THOSE CERTAIN SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTS BY AND BETWEEN NEXTDECADE CORPORATION, A DELAWARE CORPORATION (THE &#8220;CORPORATION&#8221;), AND THE PURCHASER (AS DEFINED THEREIN).</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">Exhibit A-1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 75.9804%; margin-left: 0pt; margin-right: auto;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Certificate Number</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">[&#9679;] Shares of</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">[&#9679;]</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">Series C Convertible Preferred Stock</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Series C Convertible Preferred Stock</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>of</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NEXTDECADE CORPORATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">NEXTDECADE CORPORATION, a Delaware corporation (the &#8220;<u>Corporation</u>&#8221;), hereby certifies that [&#9679;] (the &#8220;<u>Holder</u>&#8221;) is the registered owner of [&#9679;] fully paid and non-assessable shares of preferred stock, par value $.0001 per share, of the Corporation designated as the Series C Convertible Preferred Stock (the &#8220;<u>Series C Preferred Stock</u>&#8221;). The shares of Series C Preferred Stock are transferable on the books and records of the Transfer Agent, in person or by a duly authorized attorney, upon surrender of this certificate duly endorsed and in proper form for transfer. The designations, rights, privileges, restrictions, preferences and other terms and provisions of the Series C Preferred Stock represented hereby are issued and will in all respects be subject to the provisions of the Certificate of Designations adopted by the Corporation on [&#9679;], as the same may be amended from time to time (the &#8220;<u>Certificate of Designations</u>&#8221;). Capitalized terms used but not otherwise defined herein will have the respective meanings given to such terms in the Certificate of Designations. The Corporation will provide a copy of the Certificate of Designations to a Holder without charge upon written request to the Corporation at its principal place of business.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">The Conversion Price of the shares of Series C Preferred Stock represented hereby is initially $[&#9679;], subject to adjustment in accordance with the Certificate of Designations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">Reference is hereby made to select provisions of the Series C Preferred Stock set forth on the reverse hereof, and to the Certificate of Designations, which provisions and the Certificate of Designations will for all purposes have the same effect as if set forth at this place.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">Upon receipt of this certificate, the Holder is bound by the Certificate of Designations and is entitled to the benefits thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">Unless the Transfer Agent&#8217;s Certificate of Authentication hereon has been properly executed, these shares of Series C Preferred Stock will not be entitled to any benefit under the Certificate of Designations or be valid or obligatory for any purpose.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">IN WITNESS WHEREOF, the Corporation has executed this certificate this [&#9679;] day of [&#9679;].</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 662px; margin-left: 0pt; margin-right: auto;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 237px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="width: 64px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>NEXTDECADE CORPORATION</b></td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 237px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 64px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">By:&nbsp;</td>
			<td style="width: 354px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 237px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 64px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Name:&nbsp;&nbsp;&nbsp;&nbsp;</td>
			<td style="width: 354px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 237px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 64px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Title:</td>
			<td style="width: 354px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 237px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 64px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 354px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 237px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 64px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">By:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
			<td style="width: 354px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 237px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 64px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Name:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
			<td style="width: 354px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 237px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 64px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
			<td style="width: 354px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">Exhibit A-2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TRANSFER AGENT</b>&#8217;<b>S CERTIFICATE OF AUTHENTICATION</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">These are shares of the Series C Preferred Stock referred to in the within-mentioned Certificate of Designations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="text-indent: 9pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 581px;">

		<tr>
			<td style="width: 287px;">Dated: [&#9679;]</td>
			<td style="width: 50px;">&nbsp;</td>
			<td style="width: 239px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 287px;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="width: 50px;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 216pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="width: 287px;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="width: 50px;"><b>[Continental Stock Transfer &amp; Trust Company], as Transfer Agent,</b></td>
		</tr>
		<tr>
			<td style="width: 287px;">&nbsp;</td>
			<td style="width: 50px;">&nbsp;</td>
			<td style="width: 239px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 287px;">&nbsp;</td>
			<td style="width: 50px;">By:&nbsp;&nbsp;&nbsp;</td>
			<td style="width: 239px; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 287px;">&nbsp;</td>
			<td style="width: 50px;">&nbsp;</td>
			<td style="width: 239px;">Authorized Signatory</td>
		</tr>
		<tr>
			<td style="width: 287px;">&nbsp;</td>
			<td style="width: 50px;">&nbsp;</td>
			<td style="width: 239px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 287px;">&nbsp;</td>
			<td style="width: 50px;">&nbsp;</td>
			<td style="width: 239px;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;text-indent:9pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">Exhibit A-3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>REVERSE OF SECURITY</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">The shares of Series C Preferred Stock will be convertible into shares of the Corporation&#8217;s Common Stock at the option of the Holder or the Corporation and redeemable by the Corporation, in each case, upon the satisfaction of the respective conditions and in the respective manner and according to the respective terms set forth in the Certificate of Designations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">The Corporation will furnish without charge to each Holder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock and the qualifications, limitations or restrictions of such preferences or rights.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">Exhibit A-4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><b>ASSIGNMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">FOR VALUE RECEIVED, the undersigned assigns and transfers the shares of Series C Preferred Stock evidenced hereby to:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 1078px;">

		<tr>
			<td style="width: 1072px; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr>
			<td style="border-bottom: thin solid rgb(0, 0, 0); width: 1072px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="border-bottom: thin solid rgb(0, 0, 0); width: 1072px;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(Insert assignee&#8217;s social security or tax identification number)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 1075px;">

		<tr>
			<td style="width: 1069px; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(Insert address and zip code of assignee)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 1077px;">

		<tr>
			<td style="width: 1071px; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">and irrevocably appoints:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 1076px;">

		<tr>
			<td style="width: 1070px; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr>
			<td style="border-bottom: thin solid rgb(0, 0, 0); width: 1070px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="border-bottom: thin solid rgb(0, 0, 0); width: 1070px;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">agent to transfer the shares of Series C Preferred Stock evidenced hereby on the books of the Transfer Agent. The agent may substitute another to act for him or her.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 1041px;">

		<tr>
			<td style="width: 73px;">Date:&nbsp;&nbsp;&nbsp;</td>
			<td style="width: 465px; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="width: 496px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 73px;">&nbsp;</td>
			<td style="width: 465px;">&nbsp;</td>
			<td style="width: 496px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 73px;">Signature:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
			<td style="width: 465px; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="width: 496px;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="2" rowspan="1" style="width: 73px;">(Sign exactly as your name appears on the other side of this Series C Preferred Stock Certificate)</td>
			<td style="width: 496px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 73px;">&nbsp;</td>
			<td style="width: 465px;">&nbsp;</td>
			<td style="width: 496px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="text-align: right; width: 73px;">&nbsp;</td>
			<td style="text-align: right; width: 465px;">Signature Guarantee<sup style="vertical-align:top;line-height:120%;font-size:pt">1</sup>&nbsp;</td>
			<td style="width: 496px; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">1</sup>Signature must be guaranteed by an &#8220;eligible guarantor institution&#8221; that is a bank, stockbroker, savings and loan association or credit union meeting the requirements of the Transfer Agent, which requirements include membership or participation in the Securities Transfer Agents Medallion Program (&#8220;STAMP&#8221;) or such other &#8220;signature guarantee program&#8221; as may be determined by the Transfer Agent in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">Exhibit A-5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>EXHIBIT B</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CERTIFICATE TO BE DELIVERED UPON EXCHANGE OR</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>REGISTRATION OF TRANSFER OF PREFERRED STOCK</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:-36pt;">Re:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Series C Convertible Preferred Stock (the </i>&#8220;<i><u>Series C Preferred Stock</u></i>&#8221;<i>) of NextDecade Corporation, a Delaware corporation (the </i>&#8220;<i><u>Corporation</u></i>&#8221;<i>)</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This Certificate relates to [&#9679;] shares of Series C Preferred Stock held by [&#9679;] (the &#8220;<u>Transferor</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Transferor has requested the Transfer Agent by written order to exchange or register the transfer of Series C Preferred Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In connection with such request and in respect of such Series C Preferred Stock, the Transferor does hereby certify that the Transferor is familiar with the Certificate of Designations relating to the above-captioned Series C Preferred Stock and that the transfer of this Series C Preferred Stock does not require registration under the Securities Act of 1933, as amended (the &#8220;<u>Securities Act</u>&#8221;), because (please check the applicable box):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:-36pt;">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such shares of Series C Preferred Stock are being acquired for the Transferor&#8217;s own account without transfer;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:-36pt;">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such shares of Series C Preferred Stock are being transferred to the Corporation;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:-36pt;">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such shares of Series C Preferred Stock are being transferred to a qualified institutional buyer (as defined in Rule 144A under the Securities Act), in reliance on Rule 144A; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:-36pt;">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such shares of Series C Preferred Stock are being transferred in reliance on, and in compliance with, another exemption from the registration requirements of the Securities Act (and based on an opinion of counsel if the Corporation so requests).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 484px;">

		<tr>
			<td style="width: 36px;">&nbsp;</td>
			<td style="width: 225px;">&nbsp;</td>
			<td style="width: 9px;">&nbsp;</td>
			<td style="width: 28px;">[&#9679;]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
			<td style="width: 293px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 36px;">&nbsp;</td>
			<td style="width: 225px;">&nbsp;</td>
			<td style="width: 9px;">&nbsp;</td>
			<td style="width: 28px;">By:&nbsp;&nbsp;</td>
			<td style="width: 293px; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 36px;">Date:</td>
			<td style="width: 225px; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="width: 9px;">&nbsp;</td>
			<td style="width: 28px;">&nbsp;</td>
			<td style="width: 293px;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">Exhibit B-1</div>
</div>
</div>

<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ex_234759.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<html><head><meta charset="utf-8"><meta name="format-detection" content="telephone=no"><!--Created on 3/17/2021 9:03:07 AM --><meta name="generator" content="RDG HTML Converter 3.4.3.0">
	<title>ex_234759.htm</title>

</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>Exhibit 4.1</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1167px; margin-left: 0pt; margin-right: auto;">

		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="vertical-align: top; width: 611px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="vertical-align: top; width: 611px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Warrant No. [&#9679;]</p>
			</td>
			<td style="vertical-align: top; width: 491px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">Void After [&#9679;]</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NEXTDECADE CORPORATION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>WARRANT TO PURCHASE SHARES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This Warrant is issued to [________________] (&#8220;<u>Investor</u>&#8221;) by NextDecade Corporation, a Delaware corporation (the &#8220;<u>Company</u>&#8221;), in connection with a private offering of Series C Convertible Preferred Stock of the Company (the &#8220;<u>Series C Preferred Stock</u>&#8221;) pursuant to which certain accredited investors are purchasing shares of Series C Preferred Stock, which include this Warrant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">1.&nbsp;&nbsp;&nbsp;&nbsp;<u>Purchase of Shares</u>. Subject to the terms and conditions hereinafter set forth, the Investor or other holder of this Warrant pursuant to a valid transfer made in accordance with the terms hereof (&#8220;<u>Holder</u>&#8221;) is entitled, upon surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify the holder in writing), to purchase from the Company up to an aggregate number of fully paid and nonassessable shares (each a &#8220;<u>Share</u>&#8221; and collectively the &#8220;<u>Shares</u>&#8221;) of Company common stock, par value $0.0001 per share (the &#8220;<u>Common Stock</u>&#8221;), equal to [&#9679;]% of the Common Stock on a Fully Diluted Basis (defined below) on the Exercise Date (defined below) at an exercise price of $0.01 per Share (such price, as adjusted from time to time, is herein referred to as the &#8220;<u>Exercise Price</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For purposes of this Warrant, &#8220;<u>Fully Diluted Basis</u>&#8221; shall mean, at any time, without duplication, the number of outstanding shares of Common Stock, after giving effect to (i)&nbsp;all shares of Common Stock actually outstanding at the time of determination, (ii)&nbsp;all shares of Common Stock issuable upon the exercise of any option, warrant (other than this Warrant) or similar right outstanding at the time of determination, and (iii)&nbsp;all shares of Common Stock issuable upon the exercise of any conversion or exchange right contained in any security outstanding at the time of determination and convertible into or exchangeable for shares of Common Stock; <u>provided</u>, <u>however</u>, (i) Fully Diluted Basis shall not include any Common Stock issued pursuant to, but not yet vested pursuant to, any Company equity incentive plan and (ii) any warrants issued by Harmony Merger Corporation (12,081,895 as of the date hereof) shall be reduced by dividing the outstanding number by 2.9167, which shall be proportionately adjusted pursuant to any appropriate adjustments contained in <u>Section 6</u> of this Warrant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Exercise Date</u>. This Warrant may be exercisable by Holder before 5 p.m. Central Standard Time on the third anniversary date of the issuance date of this Warrant, or 5 p.m. Central Standard Time on [&#9679;] (the &#8220;<u>Exercise Date</u>&#8221;); <u>provided</u>, the Company can force a mandatory exercise of the Warrants prior to the Exercise Date if (a) the volume weighted average trading price of shares of Common Stock for each trading day during any sixty (60) of the prior ninety (90) trading days is equal to or greater than 175% of the conversion price of the Company&#8217;s Series A Convertible Preferred Stock and Series B Convertible Preferred Stock&nbsp;and (b) the Company simultaneously elects to force a mandatory exercise of all other warrants then-outstanding and unexercised and held by any holder of Parity Stock; <u>provided</u>, <u>further</u>, that such trigger price shall be appropriately adjusted consistent with <u>Section 6</u> of this Warrant for any of the events described therein. All rights of Holder under this Warrant shall cease after 5:00&nbsp;p.m. Central time on the Exercise Date. For purposes of this <u>Section 2</u>, &#8220;<u>Parity Stock</u>&#8221; has the meaning ascribed to such term in that certain Certificate of Designations of Series C Convertible Preferred Stock of NextDecade Corporation, dated as of March 17, 2021 (the &#8220;<u>Series C Certificate of Designations</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.&nbsp;&nbsp;&nbsp;&nbsp;<u>Method of Exercise</u>. While this Warrant remains outstanding and exercisable in accordance with <u>Section 2</u> above, the Holder may exercise from time to time, in whole or in part, the purchase rights evidenced hereby. Such exercise shall be effected by:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;the surrender of the Warrant, together with a notice of exercise to the Secretary of the Company at its principal offices; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the payment to the Company of an amount equal to the aggregate Exercise Price for the number of Shares being purchased.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">4.&nbsp;&nbsp;&nbsp;&nbsp;<u>Certificates for Shares</u>. Upon the exercise of the purchase rights evidenced by this Warrant, one or more certificates for the number of Shares so purchased shall be issued as soon as practicable thereafter, and in any event, within thirty (30) days of the delivery of the subscription notice.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.&nbsp;&nbsp;&nbsp;&nbsp;<u>Issuance of Shares</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company covenants that (i)&nbsp;the Shares, when issued pursuant to the exercise of this Warrant, will be duly and validly issued, fully paid and nonassessable and free from all taxes, liens, and charges with respect to the issuance thereof, (ii) the Company will reserve from its authorized and unissued Common Stock sufficient Shares in order to perform its obligations under this Warrant, and (iii) such Shares will be eligible to be registered under the Securities Act in accordance with the terms of the Registration Rights Agreement, dated as of the date hereof, by and between the Company and the Investor.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained in this Warrant, prior to the Company&#8217;s receipt of the Required Approval (as defined in the Series C Certificate of Designations), the number of shares of Common Stock that may be issued (1) under the Series C Certificate of Designations, including Common Stock issued upon conversion of PIK Shares (as defined in the Series C Certificate of Designations), and/or (2) upon the exercise of all warrants issued in connection with the Series C Preferred Stock, in the aggregate, may not exceed 19.99% of the total shares of Common Stock issued and outstanding as of the effective date of the purchase agreement pursuant to which this Warrant was issued. If, prior to the Company&#8217;s receipt of the Required Approval, the exercise of this Warrant, individually, or in the aggregate with shares of Common Stock theretofore issued (x) under the Series C Certificate of Designations and (y) upon the exercise of warrants issued in connection with the Series C Preferred Stock, would result in the issuance of a number of shares of Common Stock greater than 19.99% of the total shares of Common Stock issued and outstanding as of the effective date of the purchase agreement pursuant to which this Warrant was issued (the &#8220;<u>Maximum Amount</u>&#8221;), then, upon such exercise, the Company shall pay to the Holder cash in lieu of such number of shares of Common Stock in excess of the Maximum Amount in an amount equal to (i) the number of shares of Common Stock in excess of the Maximum Amount which would otherwise be issuable to the Holder, multiplied by (ii) the VWAP (as defined below) of the Common Stock based on a trailing ten (10) trading day period beginning at 9:30 a.m. Eastern time on the tenth trading day prior to the date of such exercise and ending at 4:00 p.m. Eastern time on the trading day immediately prior to the date of such exercise, net of the aggregate Exercise Price due upon such exercise, determined on a pro rata basis in respect of all converting and/or exercising holders of Series C Preferred Stock and associated warrants in the event of the concurrent conversions of Series C Preferred Stock and/or exercises of warrants by multiple holders. For purposes of this paragraph, &#8220;<u>VWAP</u>&#8221; shall mean the per share volume-weighted average price as displayed under the heading Bloomberg VWAP on Bloomberg page&nbsp;&#8220;NEXT:US &lt;equity&gt;&#8221; (or its equivalent successor if such page&nbsp;is not available) in respect of the period from the open of trading on the relevant trading day until the close of trading on such trading day.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">6.&nbsp;&nbsp;&nbsp;&nbsp;<u>Adjustment of Exercise Price and Number of Shares</u>. The number of and kind of securities purchasable upon exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Subdivisions, Combinations, Dividends and Other Issuances</u>. If at any time before the expiration of this Warrant (x) the outstanding Shares are subdivided, by split-up or otherwise, or any additional Shares are issued as a dividend or otherwise (including any deemed dividend or distribution pursuant to <u>Section 6(b)</u>), then on the effective date of such subdivision or issuance, the number of Shares issuable on the exercise of this Warrant shall forthwith be increased in proportion to such increase in outstanding Shares or (y) the number of outstanding Shares is decreased by a consolidation, combination, reverse share split or reclassification of the Shares or other similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number of Shares issuable on exercise of each Warrant shall forthwith be decreased in proportion to such decrease in outstanding Shares. Whenever the number of Shares purchasable upon the exercise of this Warrant is adjusted as provided herein, the Exercise Price shall be adjusted by multiplying such Exercise Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of Shares purchasable upon the exercise of this Warrant immediately prior to such adjustment, and (y) the denominator of which shall be the number of Shares or other securities so purchasable immediately thereafter, such that the aggregate purchase price payable for the total number of Shares purchasable under this Warrant (as adjusted) shall remain the same. Any adjustment under this <u>Section</u>&nbsp;<u>6(a)</u> shall become effective at the close of business on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that no record date is fixed, upon the making of such dividend.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Rights Offerings</u>. An offering of rights, options, securities or other instruments convertible into Shares, or other similar offering to holders of Shares entitling holders to purchase Shares at a price less than the &#8220;Fair Market Value&#8221; (as defined below) shall be deemed a stock dividend of a number of Shares equal to the product of (i) the number of Shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Shares) multiplied by (ii) one (1) minus the quotient of (x) the aggregate price per Share payable for such offering divided by (y) the Fair Market Value. For purposes of this <u>Section 6(b)</u>, (i) if the rights offering is for securities convertible into or exercisable for the Shares, in determining the price payable for the Shares, there shall be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) &#8220;Fair Market Value&#8221; means the volume weighted average price of the Shares as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the Shares trade on the applicable exchange or in the applicable market, regular way, with the right to receive such rights.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Reclassification, Reorganization and Consolidation</u>. In case of any reclassification, capital reorganization, or change in the capital stock of the Company (other than as a result of a subdivision, combination, or stock dividend provided for in <u>Section</u>&nbsp;<u>6(a)</u> above), or in the case of any merger, consolidation or other business combination of the Company with or into another Person (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding Shares), or in the case of any sale or conveyance to another Person of the assets or other property of the Company as an entirety or substantially as an entirety, the Holder of this Warrant shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the Shares of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the Holder of this Warrant would have received if such Holder had exercised this Warrant immediately prior to such event (the &#8220;<u>Alternative Issuance</u>&#8221; ); <u>provided</u>, <u>however</u>, that (i) if the holders of the Shares were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets constituting the Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Shares in such consolidation or merger that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Shares under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (the &#8220;<u>Exchange Act</u>&#8221;)) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than 50% of the outstanding shares of Common Stock, the Holder of this Warrant shall be entitled to receive as the Alternative Issuance, the highest amount of cash, securities or other property to which such Holder would actually have been entitled as a stockholder if the Holder of this Warrant had exercised the Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Shares held by such Holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this <u>Section 6</u>. For purposes of this <u>Section 6(c)</u>, &#8220;Person&#8221; means any corporation, limited liability company, partnership, joint venture, trust, or any other entity or organization of any kind.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Special Distributions</u>. In case the Company shall declare a dividend or make any other distribution (excluding dividends payable in Shares and other dividends or distributions referred to in <u>Section 6(a)</u>, including, without limitation, in cash, property or assets, to holders of Shares (a &#8220;<u>Special Distribution</u>&#8221;), then the board of directors of the Company shall make provision so that upon the exercise of this Warrant, the Holder of this Warrant shall be entitled to receive such dividend or distribution that the Holder would have received had this Warrant been exercised immediately prior to the record date for such dividend or distribution. When a Special Distribution is authorized by the board of directors of the Company to be made, the Company shall promptly notify the Holder of this Warrant of such event in writing and the dividend or other distribution that the Holder of this Warrant are entitled to receive.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Other Events</u>. In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections of this <u>Section 6</u> are strictly applicable, but which would require an adjustment to the terms of this Warrant in order to (i) avoid an adverse impact on this Warrant and (ii) effectuate the intent and purpose of this <u>Section 6</u>, then, in each such case, the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate the intent and purpose of this <u>Section 6</u> and, if such firm determines that an adjustment is necessary, the terms of such adjustment. The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended in such opinion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;<u>Notice of Adjustment</u>. When any adjustment is required to be made in the number or kind of shares purchasable upon exercise of the Warrant, or in the Exercise Price, the Company shall promptly notify the Holder in writing of the adjustment and of the number of Shares or other securities or property thereafter purchasable upon exercise of this Warrant and provide the Holder with a certificate of its Chief Financial Officer setting forth the adjustment and the facts upon which the adjustment is based. The Company shall, upon written request, furnish the Holder a certificate setting forth the Exercise Price in effect upon the date thereof and the series of adjustments leading to such Exercise Price.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">7.&nbsp;&nbsp;&nbsp;&nbsp;<u>No Fractional Shares or Script</u>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the Exercise Price then in effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">8.&nbsp;&nbsp;&nbsp;&nbsp;<u>Representations of the Company</u>. The Company represents and warrants to the Holder as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company has been duly formed, and is validly existing in good standing, under the laws of the State of Delaware. The Company has the requisite corporate power and authority to enter into and perform this Warrant, to own and operate its properties and assets and to carry on its business as currently conducted and as presently proposed to be conducted. The Company is duly qualified to do business as a foreign company and is in good standing in all jurisdictions in which it is required to be qualified to do business as the Company&#8217;s business is currently conducted and as presently proposed to be conducted by the Company, except for jurisdictions in which failure to so qualify would not have a material adverse effect on the business and operations of the Company taken as a whole.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;All corporate actions on the part of the Company, its officers, directors and stockholders necessary for (i) the authorization, execution, delivery of, and the performance of all obligations of the Company under this Warrant and (ii) the authorization, issuance, reservation for issuance and delivery of this Warrant and all of the Common Stock to allow for the exercise of this Warrant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;This Warrant is, and any Warrant issued in substitution for or replacement of this Warrant shall be, upon issuance, duly authorized and validly issued. All Shares which may be issued upon the exercise of the purchase right represented by this Warrant, shall, upon issuance, be duly authorized, validly issued, fully paid and nonassessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein, the Company&#8217;s governing documents and in any documents relating to the Shares, each as may be amended from time to time, and all such securities will be issued in compliance with all applicable federal and state securities laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company is not in violation or default in any material respect of any provisions of the Company&#8217;s Second Amended and Restated Certificate of Incorporation (the &#8220;<u>Certificate of Incorporation</u>&#8221;) or Amended and Restated Bylaws of the Corporation, both as amended to date, and the Company is in compliance in all material respects with all applicable statutes, laws, regulations and executive orders of the United States of America and all states, foreign countries or other governmental bodies and agencies having jurisdiction over the Company&#8217;s business or properties. The Company has not received any notice of any violation of any such statute, law, regulation or order which has not been remedied prior to the date hereof. The execution, delivery and performance of this Warrant will not result in any such violation or default, or be in conflict with or result in a violation or breach of, with or without the passage of time or the giving of notice or both, the Certificate of Incorporation, any judgment, order or decree of any court or arbitrator to which the Company is a party or is subject, any material agreement or instrument by which it is bound or to which its properties or assets are subject or a violation of any statute, law, regulation or order, or an event which results in the creation of any lien, charge or encumbrance upon any asset of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">9.&nbsp;&nbsp;&nbsp;&nbsp;<u>Representations and Warranties by the Holder</u>. The Holder represents and warrants to the Company as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;This Warrant and the Shares issuable upon exercise thereof are being acquired for its own account, for investment and not with a view to, or for resale in connection with, any distribution or public offering thereof within the meaning of the Securities Act of&nbsp;1933, as amended (the &#8220;<u>Act</u>&#8221;). Upon exercise of this Warrant, the Holder shall, if so requested by the Company, confirm in writing, in a form satisfactory to the Company, that the securities issuable upon exercise of this Warrant are being acquired for investment and not with a view toward distribution or resale.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Holder understands that the Warrant and the Shares have not been registered under the Act by reason of their issuance in a transaction exempt from the registration and prospectus delivery requirements of the Act pursuant to Regulation D thereof, and that they must be held by the Holder indefinitely, and that the Holder must therefore bear the economic risk of such investment indefinitely, unless a subsequent disposition thereof is registered under the Act or is exempted from such registration.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Holder has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of the purchase of this Warrant and the Shares purchasable pursuant to the terms of this Warrant and of protecting its interests in connection therewith.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Holder is able to bear the economic risk of the purchase of the Shares pursuant to the terms of this Warrant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Holder is an &#8220;accredited investor&#8221; as such term is defined in Rule 501 of Regulation D promulgated under the Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">10.&nbsp;&nbsp;&nbsp;&nbsp;<u>Restrictive Legend</u>. Until such time as the Shares issued upon the conversion of this Warrant have been sold pursuant to an effective registration statement under the Act, or Shares issued upon the exercise of this Warrant are eligible for resale pursuant to Rule 144 promulgated under the Act without any restriction as to the number of securities as of a particular date that can then be immediately sold, each certificate issued with respect to Shares issued upon the exercise of this Warrant will bear a legend in substantially the following form:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">THE SECURITIES EVIDENCED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THE SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OR (2) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE STATE SECURITIES LAWS AND THE SECURITIES LAWS OF OTHER JURISDICTIONS, AND IN THE CASE OF A TRANSACTION EXEMPT FROM REGISTRATION, UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT OR SUCH OTHER APPLICABLE LAWS.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In connection with a transfer of Shares issued upon the exercise of this Warrant in reliance on Rule 144 promulgated under the Act, the Holder or its broker shall deliver to the Company a broker representation letter providing to the Company any information the Company reasonably deems necessary to determine that such sale is made in compliance with Rule 144 promulgated under the Act, including, as may be appropriate, a certification that such Holder is not an affiliate of the Company (as defined in Rule 144 promulgated under the Act) and a certification as to the length of time the applicable equity interests have been held. Upon receipt of such representation letter, the Company shall promptly remove the restrictive legend on Shares, and the Company shall bear all costs associated with the removal of such legend from Shares. At such time as Shares issued upon the conversion of this Warrant (A) have been sold pursuant to an effective registration statement under the Act, (B) have been held by the Holder for more than one year where the Holder is not, and has not been in the preceding three months, an affiliate of the Company (as defined in Rule 144 promulgated under the Securities Act), or (C) no longer require such restrictive legend on Shares, as set forth in an opinion of counsel reasonably satisfactory to the Company, if the restrictive legend is still in place, the Company agrees, upon request of such Holder, to take all steps necessary to promptly effect the removal of such legend, and the Company shall bear all costs associated with such removal of such legend. The Company shall cooperate with the Holder to effect the removal of such legend from Shares at any time such legend is no longer appropriate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">11.&nbsp;&nbsp;&nbsp;&nbsp;<u>Limitation on Transferability of this Warrant</u>. THIS WARRANT IS NOT TRANSFERRABLE WITHOUT THE CONSENT OF THE COMPANY, EXCEPT THAT, WITHOUT THE CONSENT OF THE COMPANY, THE INVESTOR SHALL BE ENTITLED TO TRANSFER THIS WARRANT TO AN AFFILIATE OF THE INVESTOR. FOR PURPOSES OF THIS <u>SECTION 11</u>, THE TERM &#8220;<u>AFFILIATE</u>&#8221; HAS THE MEANING ASCRIBED TO SUCH TERM IN THE SERIES C CERTIFICATE OF DESIGNATIONS.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">12.&nbsp;&nbsp;&nbsp;&nbsp;<u>Lost, Stolen or Mutilated Warrant</u>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary form or the provision of reasonable security by the Holder to the Company and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder a new Warrant (in accordance with <u>Section 6(f)</u>) representing the right to purchase the Shares then underlying this Warrant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">13.&nbsp;&nbsp;&nbsp;&nbsp;<u>Exchangeable for Multiple Warrants</u>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company together with all applicable transfer taxes, for a new Warrant or Warrants (in accordance with <u>Section 14</u>) representing in the aggregate the right to purchase the number of Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Shares as is designated by the Holder at the time of such surrender; <u>provided</u>, <u>however</u>, that the Company shall not be required to issue Warrants for fractional shares of Common Stock hereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">14.&nbsp;&nbsp;&nbsp;&nbsp;<u>Issuance of New Warrants</u>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant shall (i) be of like tenor with this Warrant, (ii) represent, as indicated on the face of such new Warrant, the right to purchase the Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to <u>Section 12</u>, the Shares designated by the Holder which, when added to the number of Shares underlying the other new Warrants issued in connection with such issuance, does not exceed the number of Shares then underlying this Warrant), (iii) have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date and (iv) have the same rights and conditions as this Warrant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">15.&nbsp;&nbsp;&nbsp;&nbsp;<u>Rights of Stockholders</u>. Except as expressly provided herein, no Holder of this Warrant shall be entitled, by virtue of being a Holder, to vote or receive dividends or be deemed a Holder of Shares or any other securities of the Company which may at any time be issuable on the exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon a Holder of this Warrant, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any recapitalization, issuance of stock, reclassification of stock, change of par value, consolidation, merger, conveyance, or otherwise) or to receive notice of meetings, or to receive dividends or subscription rights or otherwise until the Warrant shall have been exercised and the Shares purchasable upon the exercise hereof shall have become deliverable, as provided herein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">16.&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices</u>. All notices and other communications required or permitted hereunder shall be in writing, shall be effective when given, and shall in any event be deemed to be given upon receipt or, if earlier, (a)&nbsp;five (5)&nbsp;days after deposit with the U.S. Postal Service or other applicable postal service, if delivered by first class mail, postage prepaid, (b)&nbsp;upon delivery, if delivered by hand, or (c)&nbsp;one business day after the business day of deposit with Federal Express or similar overnight courier, freight prepaid, and shall be addressed (i)&nbsp;if to the Holder, at the Holder&#8217;s address as set forth on the Schedule of Holders attached hereto as <u>Exhibit B</u>, and (ii)&nbsp;if to the Company, at the address of its principal corporate offices (attention: Krysta De Lima), with a copy to Sean Jones, K&amp;L Gates LLP, 300 South Tryon Street, Suite 1000, Charlotte, North Carolina 28202 (which copy shall not be deemed to constitute notice to the Company) or at such other address as a party may designate by ten days advance written notice to the other party pursuant to the provisions above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">17.&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law</u>. This Warrant and all actions arising out of or in connection with this Warrant shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflicts of law provisions of the State of Delaware.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">18.&nbsp;&nbsp;&nbsp;&nbsp;<u>Rights and Obligations Survive Exercise of Warrant</u>. Unless otherwise provided herein, the rights and obligations of the Company, of the holder of this Warrant and of the holder of the Shares issued upon exercise of this Warrant, shall survive the exercise of this Warrant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">19.&nbsp;&nbsp;&nbsp;&nbsp;<u>Counterparts</u>. This Warrant may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">20.&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendment</u>. No amendment, waiver, consent, modification or termination of any provision of this Agreement shall be effective unless signed in writing by each of the parties hereto and each other Holder, if any, to which this Warrant may have been validly transferred pursuant to the terms set forth herein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">21.&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability</u>. This Warrant shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Warrant or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Warrant a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[<i>Signature Page Follows</i>]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">&nbsp;</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; width: 1251px;">

		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="width: 439px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>NEXTDECADE CORPORATION</b></td>
			<td style="width: 596px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 24px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">By:</td>
			<td style="width: 604px; border-bottom: thin solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 596px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 24px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 604px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Matthew Schatzman</td>
			<td style="width: 596px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 24px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 604px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Chief Executive Officer</td>
			<td style="width: 596px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 312px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="width: 439px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 596px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;"><br>
<br>
<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;"><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">[<i>Signature Page to Warrant Agreement</i>]</p>
</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>EXHIBIT A</u></b></p>

<p style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0"><b>NOTICE OF EXERCISE</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>To:</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>NextDecade Corporation</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;"><b>1000 Louisiana Street, Suite 3900</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;"><b>Houston, Texas 77002</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;"><b>Attention: [</b>&#9679;<b>]</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">1.&nbsp;&nbsp;&nbsp;&nbsp;The undersigned hereby elects to purchase shares of Common Stock of NextDecade Corporation (the &#8220;<u>Shares</u>&#8221;) pursuant to the terms of the attached Warrant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">2.&nbsp;&nbsp;&nbsp;&nbsp;The undersigned elects to exercise the attached Warrant by means of a cash payment, and tenders herewith payment in full for the purchase price of the shares being purchased, together with all applicable transfer taxes, if any.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.&nbsp;&nbsp;&nbsp;&nbsp;Please issue a certificate or certificates representing said Shares in the name of the undersigned or in such other name as is specified below:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">Exhibit A-1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>EXHIBIT B</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SCHEDULE OF HOLDERS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">[___________________]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">[___________________]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">[___________________]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 72pt;">with a copy to (which shall not be deemed to constitute notice to the Holder) to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">[___________________]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">[___________________]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">[___________________]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">Exhibit B-1</div>
</div>
</div>
</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ex_234853.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head><meta charset="utf-8"><meta name="format-detection" content="telephone=no"><!--Created on 3/17/2021 11:37:57 AM --><meta name="generator" content="RDG HTML Converter 3.4.3.0">
	<title>ex_234853.htm</title>


</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>Exhibit 10.1</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this &#8220;<u>Agreement</u>&#8221;), dated as of March 17, 2021 (the &#8220;<u>Effective Date</u>&#8221;), is entered into by and between NextDecade Corporation, a Delaware corporation (&#8220;<u>NextDecade</u>&#8221; or the &#8220;<u>Company</u>&#8221;), and [________________], a [__________] (the &#8220;<u>Purchaser</u>&#8221;). NextDecade and the Purchaser are referred to herein individually as a &#8220;<u>Party</u>&#8221; and collectively as the &#8220;<u>Parties</u>.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>RECITALS:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">WHEREAS, the Company has commenced a convertible preferred equity and warrant offering (the &#8220;<u>Series C Preferred Equity Offering</u>&#8221;), pursuant to which the Company has offered the Purchaser an opportunity to purchase shares of Series C Preferred Stock (as defined herein), together with certain associated Warrants (as defined herein), substantially on the terms and conditions set forth in the Certificate of Designations of Series C Convertible Preferred Stock of NextDecade Corporation attached to this Agreement as <u>Exhibit C</u> (the &#8220;<u>Certificate of Designations</u>&#8221;); and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">WHEREAS, the Company desires to sell to the Purchaser, and the Purchaser desires to purchase from the Company, Series C Preferred Stock, together with associated Warrants, as more fully set forth herein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NOW, THEREFORE, in consideration of the premises and the mutual agreements contained herein, and for other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Section 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>DEFINITIONS</u></b>. As used in this Agreement, the following terms shall have the following meanings:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Addendum</u>&#8221; has the meaning assigned to it in <u>Section 10.9</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Affiliate</u>&#8221; means, with respect to any specified Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such specified Person.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Agreement</u>&#8221; has the meaning assigned to it in the preamble hereto; it includes the Exhibits and Schedules hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Assumption Agreement</u>&#8221; has the meaning assigned to it in <u>Section</u>&nbsp;<u>10.9</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Board</u>&#8221; means the board of directors of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Business Day</u>&#8221; means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by Law to be closed in the City of New York.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Certificate of Designations</u>&#8221; has the meaning assigned to it in the Recitals hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Charter Documents</u>&#8221; means, collectively, the certificate of incorporation, articles of incorporation, bylaws, certificate of designations or Board resolutions establishing the terms of any security, certificate of formation, operating agreement, limited liability company agreement and similar formation or organizational documents of any entity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Closing</u>&#8221; has the meaning assigned to it in <u>Section 2.4</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Closing Actions</u>&#8221; has the meaning assigned to it in <u>Section 2.6</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Closing Date</u>&#8221; has the meaning assigned to it in <u>Section 2.4</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Code</u>&#8221; means the Internal Revenue Code of 1986.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Common Stock</u>&#8221; means the common stock of the Company, $0.0001 par value.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Company</u>&#8221; has the meaning assigned to it in the preamble hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Company Benefit Plan</u>&#8221; means each (i) &#8220;employee benefit plan&#8221; within the meaning of Section 3(3) of ERISA, (ii) other benefit and compensation plan, contract, policy, program, practice, arrangement or agreement, including, but not limited to, pension, profit-sharing, savings, termination, executive compensation, phantom stock, change-in-control, retention, salary continuation, vacation, sick leave, disability, death benefit, insurance, hospitalization, medical, dental, life (including all individual life insurance policies as to which the Company or its Subsidiaries are the owners, the beneficiaries, or both), employee loan, educational assistance, fringe benefit, deferred compensation, retirement or post-retirement, severance, equity or equity-based, incentive and bonus plan, contract, policy, program, practice, arrangement or agreement, and (iii) other employment, consulting or other individual agreement, plan, practice, policy, contract, program, and arrangement, in each case, (x) which is sponsored or maintained by the Company or any of its ERISA Affiliates in respect of any current or former employees, directors, independent contractors, consultants or leased employees of the Company or any of its Subsidiaries or (y) with respect to which the Company or any of its Subsidiaries has any actual or potential liability.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Control</u>&#8221; (including the terms &#8220;<u>control</u>&#8221; &#8220;<u>controlled by</u>&#8221; and &#8220;<u>under common control with</u>&#8221;), with respect to the relationship between or among two or more Persons, means the possession, directly or indirectly or as trustee, personal representative or executor, of the power to direct or cause the direction of the affairs, policies or management of a Person, whether through the ownership of voting securities, as trustee, personal representative or executor, by contract, credit arrangement or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Conversion Price</u>&#8221; means $2.9632.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Effective Date</u>&#8221; has the meaning assigned to it in the preamble hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Encumbrance</u>&#8221; means any security interest, pledge, mortgage, lien, claim, option, charge, restriction or encumbrance.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Environmental Claim</u>&#8221; means any claim, action, cause of action, suit, proceeding, investigation, Order, demand or notice by any Person alleging liability (including liability for investigatory costs, cleanup costs, governmental response costs, natural resources damages, property damages, personal injuries, attorneys&#8217; fees, fines or penalties) arising out of, based on, resulting from or relating to (a) the presence or Release of, or exposure to, any Hazardous Materials; (b) circumstances forming the basis of any violation, or alleged violation, of any Environmental Law; or (c) any other matters covered or regulated by, or for which liability is imposed under, Environmental Laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Environmental Laws</u>&#8221; means all applicable Laws relating to pollution, the protection, restoration or remediation of or prevention of harm to the environment or natural resources (including plant and animal species), or the protection of human health and safety, including Laws relating to: (i) the exposure to, or Releases or threatened Releases of, Hazardous Materials; (ii) the generation, manufacture, processing, distribution, use, treatment, containment, disposal, storage, transport or handling of Hazardous Materials; or (iii) recordkeeping, notification, disclosure and reporting requirements respecting Hazardous Materials</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>ERISA</u>&#8221; means the Employee Retirement Income Security Act of 1974, as amended.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>ERISA Affiliate</u>&#8221; means any Person (whether or not incorporated) that together with the Company or any of its Subsidiaries is treated as a single employer within the meaning of Section 414 of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Exchange Act</u>&#8221; means the Securities Exchange Act of 1934, as amended from time to time, and the rules and regulations promulgated thereunder, or any successor statute.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Final Order</u>&#8221; means a final, nonappealable Order of a court of competent jurisdiction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Fundamental Representations</u>&#8221; means (i) with respect to the Company, those representations and warranties of the Company set forth in <u>Sections 3.1</u> (<i>Organization and Qualification; Subsidiaries</i>), <u>3.2</u> (<i>Authorization; Enforcement; Validity</i>), <u>3.3</u> (<i>No Conflicts</i>), <u>3.4</u> (<i>Consents and Approvals</i>), <u>3.5</u> (<i>Capitalization</i>) and <u>3.6</u> (<i>Valid Issuance</i>), and (ii) with respect to the Purchaser, those representations and warranties of the Purchaser set forth in <u>Sections 4.1</u> (<i>Organization and Qualification</i>), <u>4.2</u> (<i>Authorization; Enforcement; Validity</i>), <u>4.3</u> (<i>No Conflicts</i>) and <u>4.4</u> (<i>Consents and Approvals</i>).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Governmental Authority</u>&#8221; means any federal, national, supranational, foreign, state, provincial, local, county, municipal or other government, any governmental, regulatory or administrative authority, agency, department, bureau, board, commission or official or any quasi-governmental or private body exercising any regulatory, taxing, importing or other governmental or quasi-governmental authority, or any court, tribunal, judicial or arbitral body, or any Self-Regulatory Organization.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Hazardous Materials</u>&#8221; means: (a) any hazardous materials, hazardous wastes, hazardous substances, toxic wastes, solid wastes, and toxic substances as those or similar terms are defined under any Environmental Laws; (b) any asbestos or asbestos containing material; (c) polychlorinated biphenyls (&#8220;<u>PCBs</u>&#8221;), or PCB containing materials or fluids; (d) radon; (e) any petroleum, petroleum hydrocarbons, petroleum products, crude oil and any fractions or derivatives thereof; and (f) any other substance, material, chemical, waste, pollutant, or contaminant that, whether by its nature or its use, or exposure to is subject to regulation or could give rise to liability under any Laws relating to pollution, waste, human health and safety, or the environment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Indemnified Party</u>&#8221; means the Purchaser, its Affiliates, and each of their respective directors, managers, officers, principals, partners, members, equity holders (regardless of whether such interests are held directly or indirectly), trustees, controlling persons, predecessors, successors and assigns, Subsidiaries, employees, agents, advisors, attorneys and representatives.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Insolvency Event</u>&#8221; means, with respect to any Person, the occurrence of any of the following:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">(a) such Person shall (A) (i) voluntarily commence any proceeding or file any petition seeking relief under Title 11 of the United States Code, Sections 101 et. seq. (the &#8220;<u>Bankruptcy Code</u>&#8221;) or any other federal, state or foreign bankruptcy, insolvency, liquidation or similar Law, (ii) consent to the institution of, or fail to contravene in a timely and appropriate manner, any such proceeding or the filing of any such petition, (iii) apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator or similar official for such Person or for a substantial part of its property or assets, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors or (vi) take any action for the purpose of effecting any of the foregoing or (B) such Person shall become unable, admit in writing its inability or fail generally to pay its debts as they become due; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">(b) an involuntary proceeding shall be commenced or an involuntary petition shall be filed seeking (A) relief in respect of such Person or of a substantial part of the property or assets of such Person, under the Bankruptcy Code or any other federal, state or foreign bankruptcy, insolvency, receivership or similar Law, (B) the appointment of a receiver, trustee, custodian, sequestrator or similar official for such Person or for a substantial part of the property of such Person or (C) the winding-up or liquidation of such Person; and such proceeding or petition shall continue undismissed for sixty (60) days or an order or decree approving or ordering any of the foregoing shall have been entered.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Intellectual Property</u>&#8221; means the following intellectual property rights, both statutory and common law rights, if applicable: (a) copyrights and registrations and applications for registration thereof, (b) trademarks, service marks, trade names, slogans, domain names, logos, trade dress, and registrations and applications for registrations thereof, (c) patents, as well as any reissued and reexamined patents and extensions thereto, and any patent applications, continuations, continuations in part and divisional applications and patents issuing therefrom, and (d) trade secrets and confidential information, including ideas, designs, concepts, compilations of information, methods, techniques, procedures, processes and other know-how, whether or not patentable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Knowledge</u>&#8221; means with respect to the Company, the actual knowledge after due inquiry of the persons set forth on <u>Schedule 1.1(a)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Law</u>&#8221; means any federal, national, supranational, foreign, state, provincial, local, county, municipal or similar statute, law, common law, guideline, policy, ordinance, regulation, rule, code, constitution, treaty, requirement, judgment or judicial or administrative doctrines enacted, promulgated, issued, enforced or entered by any Governmental Authority.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Material Adverse Effect</u>&#8221; means any effect, change, event, occurrence, development, or state of facts that, individually or in the aggregate with all other such effects, changes, events, occurrences, developments, or states of fact, (A) has had, or would reasonably be expected to have, a material adverse effect on the business, assets, liabilities, condition (financial or otherwise), or results of operations of the Company and its Subsidiaries, taken as a whole or (B) would, or would reasonably be expected to, prevent or materially impair the ability of the Company to consummate the transactions contemplated by this Agreement, <i>but expressly excluding </i>in the case of the foregoing clause (A) any such effect, change, event, occurrence, development, or state of facts, either alone or in combination, to the extent arising out of or resulting from:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 23pt;text-indent:72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the execution or delivery of this Agreement, the consummation of the transactions contemplated by this Agreement or the public announcement or other publicity with respect to any of the foregoing; <i>provided, however</i>, that the exception set forth in this clause (a) shall not apply to the representations and warranties set forth in clauses (b) and (c) of <u>Section 3.3</u> or to the representations and warranties set forth in <u>Section 3.4</u>;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;general economic conditions (or changes in such conditions) in the United States or conditions in the global economy generally that do not affect the Company and its Subsidiaries, taken as a whole, disproportionately as compared to other similarly situated participants in the liquefied natural gas export industry (in which case only such disproportionate impact shall be considered);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;changes in the trading price or trading volume of the Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;conditions (or changes in such conditions) generally affecting the liquefied natural gas export industry that do not affect the Company and its Subsidiaries, taken as a whole, disproportionately as compared to other similarly situated participants in the liquefied natural gas export industry (in which case only such disproportionate impact shall be considered);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;conditions (or changes in such conditions) in the financial markets, credit markets or capital markets in the United States or any other country or region, including (i) changes in interest rates in the United States or any other country and changes in exchange rates for the currencies of any countries or (ii) any suspension of trading in securities (whether equity, debt, derivative or hybrid securities) generally (other than a suspension of the trading of the Company&#8217;s Common Stock, which constitutes a Material Adverse Effect, provided such suspension is not part of a broader suspension of securities) on any securities exchange or over-the-counter market operating in the United States or any other country or region in each case, that do not affect the Company as a whole disproportionately as compared to other similarly situated participants in the liquefied natural gas export industry (in which case only such disproportionate impact shall be considered);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any actions taken or omitted to be taken at the written request or with the written consent of the Purchaser; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any changes in any Laws or any accounting regulations or principles that do not affect the Company, taken as a whole, disproportionately as compared to other similarly situated participants in the liquefied natural gas export industry (in which case only such disproportionate impact shall be considered).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Notwithstanding any provision of the preceding sentence to the contrary, the occurrence of an Insolvency Event in respect of the Company or any Subsidiary of the Company shall be deemed to constitute a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Material Contracts</u>&#8221; means all &#8220;material contracts&#8221; of the Company within the meaning of Item 601 of Regulation S-K of the SEC.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>NextDecade</u>&#8221; has the meaning assigned to it in the preamble hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>OFAC</u>&#8221; means the Office of Foreign Assets Control of the U.S. Department of the Treasury.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Offering Documents</u>&#8221; means, collectively, all agreements, documents, or instruments related to or in connection with the Series C Preferred Equity Offering, including this Agreement and any other documents or exhibits related to or contemplated in the foregoing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Order</u>&#8221; means any order, writ, judgment, injunction, decree, ruling, directive, stipulation, determination or award made, issued or entered by or with any Governmental Authority, whether preliminary, interlocutory or final.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Party</u>&#8221; or &#8220;<u>Parties</u>&#8221; has the meaning assigned to it in the preamble hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Person</u>&#8221; means any individual, partnership, firm, corporation, limited liability company, association, joint venture, trust, Governmental Authority, unincorporated organization or other entity, as well as any syndicate or group that would be deemed to be a person under Section&nbsp;13(d)(3) of the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Permits</u>&#8221; means all permits, consents, approvals, registrations, licenses, authorizations, qualifications and filings with and under all federal, state, local or foreign Laws and Governmental Authorities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Purchase Price</u>&#8221; has the meaning assigned to it in <u>Section 2.2</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Purchaser</u>&#8221; has the meaning assigned to it in the preamble hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Purchaser Default</u>&#8221; means the failure by the Purchaser to&nbsp;deliver and pay&nbsp;the Purchase Price to be paid pursuant to this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Purchaser Material Adverse Effect</u>&#8221; means any event, circumstance, development, change or effect that, individually or in the aggregate with all other events, circumstances, developments, changes or effects, has or would reasonably be expected to prevent, materially delay or materially impair the ability of the Purchaser to consummate the transactions contemplated hereby.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Purchaser Termination</u>&#8221; means the termination of this Agreement by the Purchaser.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Purchaser Termination Event</u>&#8221; has the meaning assigned to it in <u>Section 8(a)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Registration Rights Agreement</u>&#8221; means the Registration Rights Agreement, in substantially the form attached hereto as <u>Exhibit F</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Release</u>&#8221; means any release, spill, emission, discharge, leaking, pouring, dumping or emptying, pumping, injection, deposit, disposal, dispersal, leaching or migration into the indoor or outdoor environment (including, without limitation, soil, ambient air, surface water, groundwater and surface or subsurface strata) or into or out of any property, including the movement of Hazardous Materials through or in the air, soil, surface water, groundwater or property.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Sanctioned Person</u>&#8221; means any Person that is the target of Sanctions, including, (a) any Person listed in any Sanctions related list of designated Persons maintained by OFAC or the U.S. Department of State, by the United Nations Security Council, the European Union or Her Majesty&#8217;s Treasury of the United Kingdom, (b) any Person located, organized or resident in a Sanctioned Territory, or (c) any Person directly or indirectly owned or controlled by any such Person or Persons described in the foregoing clauses (a) and (b).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Sanctions</u>&#8221; means economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by relevant Governmental Authorities, including, but not limited those administered by the U.S. government through OFAC or the U.S. Department of State, the United Nations Security Council, the European Union or Her Majesty&#8217;s Treasury of the United Kingdom.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>SEC</u>&#8221; has the meaning assigned to it in <u>Section 3.7(a)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>SEC Reports</u>&#8221; has the meaning assigned to it in <u>Section 3.7(a)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933, as amended from time to time, and the rules and regulations promulgated thereunder, or any successor statute.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Self-Regulatory Organization</u>&#8221; means any securities exchange, futures exchange, contract market, any other exchange or corporation or similar self-regulatory body or organization applicable to a Party to this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Series C Preferred Equity Offering</u>&#8221; has the meaning assigned to it in the Recitals hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Series C Preferred Stock</u>&#8221; means the Series C Convertible Preferred Stock of the Company (including any Series C Preferred Stock issued in respect of dividend payments thereon).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Subsidiary</u>&#8221; means, with respect to any Person, any other Person of which the first Person owns, directly or indirectly, securities or other ownership interests having voting power to elect a majority of the board of directors or other Persons performing similar functions for such Person (or, if there are no such voting interests, more than 50% of the equity interests allowing for effective control of the second Person).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Survival Period</u>&#8221; has the meaning assigned to it in <u>Section 10.3</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Tax</u>&#8221; (and, with correlative meaning, &#8220;Taxes&#8221; and &#8220;Taxable&#8221;) means: (a) any taxes, customs, duties, charges, fees, levies, penalties or other assessments, fees and other governmental charges imposed by any Governmental Authority, including, but not limited to, income, profits, gross receipts, net proceeds, windfall profit, severance, property, personal property (tangible and intangible), production, sales, use, leasing or lease, license, excise, duty, franchise, capital stock, net worth, employment, occupation, payroll, withholding, social security (or similar), unemployment, disability, payroll, fuel, excess profits, occupational, premium, severance, estimated, alternative or add-on minimum, ad valorem, value added, turnover, transfer, stamp or environmental tax, or any other tax, custom, duty, fee, levy or other like assessment or charge of any kind whatsoever, together with any interest, penalty, addition to tax, or additional amount attributable thereto; and (b) any liability for the payment of amounts with respect to payment of a type described in clause (a), including (i) as a result of being a member of an affiliated, consolidated, combined or unitary group, (ii) as a result of succeeding to such liability as a result of merger, conversion or asset transfer or (iii) as a result of any obligation under any Tax sharing, Tax allocation, Tax indemnity, or similar agreement or arrangement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Tax Representations</u>&#8221; means those representations and warranties of the Company set forth in <u>Section 3.19</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Tax Returns</u>&#8221; means any return, report, statement, information return or other document (including any amendments thereto and any related or supporting information) filed or required to be filed with any Governmental Authority in connection with the determination, assessment, collection or administration of any Taxes or the administration of any laws, regulations or administrative requirements relating to any Taxes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Treasury Regulations</u>&#8221; means the regulations promulgated under the Code, by the United States Department of the Treasury, as such regulations may be amended from time to time. All references herein to specific sections of the regulations shall be deemed also to refer to any corresponding provisions of succeeding regulations, and any reference to temporary regulations shall be deemed also to refer to any corresponding provisions of final regulations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Warrants</u>&#8221; means detached warrants in the form attached hereto as <u>Exhibit D</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Section 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>AGREEMENT TO SELL AND PURCHASE</u></b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Sale and Purchase of Shares</u>. Subject to the terms of this Agreement, at the Closing, the Company hereby agrees to issue and sell to the Purchaser, and the Purchaser hereby agrees, to purchase from the Company, [&#9679;] shares of Series C Preferred Stock, together with the associated Warrants, free and clear of all Encumbrances.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Purchase Price</u>. The purchase price for the Series C Preferred Stock to be purchased by the Purchaser hereby shall be $1,000 per share such that the aggregate purchase price to be paid by the Purchaser shall be $[&#9679;] (the &#8220;<u>Purchase Price</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Origination Fee</u>. Subject to the terms of this Agreement, at the Closing, the Company hereby agrees to issue to the Purchaser [&#9679;] additional shares of Series C Preferred Stock (but excluding the associated Warrants), representing an origination fee in an aggregate amount equal to $[&#9679;] or approximately two percent (2%) of the Purchase Price, free and clear of all Encumbrances.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">2.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Closing</u>. Subject to the terms of this Agreement, the closing of the transactions contemplated hereby (the &#8220;<u>Closing</u>&#8221;) will occur on as soon as practicable and in no event later than the date three (3) Business Days after the date hereof (the &#8220;<u>Closing Date</u>&#8221;), unless otherwise agreed by the mutual consent of the Parties. The Closing&nbsp;shall take place at the offices of NextDecade Corporation, 1000 Louisiana Street, Suite 3900, Houston, Texas 77002 or such other place as the Parties mutually agree. The Parties agree that the Closing may occur via delivery of facsimiles or photocopies of the applicable Offering Documents. Unless otherwise provided herein, all proceedings to be taken and all documents to be executed and delivered by all Parties at the Closing will be deemed to have been taken and executed simultaneously, and no proceedings will be deemed to have been taken nor documents executed or delivered until all have been taken, executed and delivered.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">2.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Rounding of Shares</u>. The number of shares of Series C Preferred Stock issued to the Purchaser pursuant to the terms of this Agreement shall be rounded in accordance with the terms of the Certificate of Designations to avoid fractional shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">2.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Actions at the Closing</u>. At the Closing, the Purchaser and the Company (as applicable) shall take or cause to be taken the following actions (&#8220;<u>Closing Actions</u>&#8221;):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Payment of the Purchase Price</u>. The Purchaser shall pay the Purchase Price in respect of the shares purchased by the Purchaser pursuant to <u>Section 2.1</u> to the Company by wire transfer of immediately available funds to the account specified by the Company to the Purchaser in writing not less than two (2) Business Days prior to the Closing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Issuance of Series C Preferred Stock</u>. The Company shall deliver to the Purchaser a true, correct and complete certificate, or other applicable evidence of ownership acceptable to the Purchaser, representing the shares of Series C Preferred Stock purchased by the Purchaser pursuant to this <u>Section 2</u>, duly authorized by all requisite corporate action on the part of the Company, together with all instruments of transfer in respect of the Purchaser&#8217;s interests in such shares, and in the form required by the Certificate of Designations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Warrants</u>. The Company shall deliver to the Purchaser the Warrants, duly authorized by all requisite corporate action on the part of the Company, together with all instruments of transfer in respect of the Purchaser&#8217;s interests in such Warrants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Registration Rights Agreement</u>. The Purchaser and the Company shall execute and deliver the Registration Rights Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">2.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Transfer Taxes</u>. All of the Series C Preferred Stock issued to the Purchaser pursuant to this Agreement will be delivered with any and all issue, stamp, transfer or similar taxes or duties payable in connection with such delivery duly paid by the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Section 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</u></b>. The Company hereby represents and warrants to the Purchaser as of the date hereof and, with respect to the Fundamental Representations, as of the date hereof and as of the Closing Date (except for representations and warranties that are made as of a specific date, which are made only as of such date), on behalf of itself and not any other Party, as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Organization and Qualification; Subsidiaries</u>. The Company and each of its Subsidiaries has been duly organized and is validly existing and, except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, is in good standing under the laws of its jurisdictions of organization, with the requisite power and authority to own its properties and conduct its business as currently conducted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Authorization; Enforcement; Validity</u>. The Company has all necessary corporate power and authority to enter into this Agreement and to carry out its obligations hereunder, including the issuance to the Purchaser of the Series C Preferred Stock and Warrants (and the Common Stock issuable upon the conversion or exercise of such Series C Preferred Stock and Warrants, as applicable) pursuant to <u>Sections 2.1</u> and <u>2.3</u> of this Agreement. The execution and delivery by the Company of this Agreement and the performance by the Company of its obligations hereunder, have been duly authorized by all requisite action on the part of the Company, and no other action on the part of the Company or any of its Subsidiaries is necessary to authorize the execution and delivery by the Company of this Agreement or the consummation of the transactions contemplated by this Agreement. This Agreement has been duly executed and delivered by the Company, and assuming due authorization, execution and delivery by the Purchaser, this Agreement constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to bankruptcy, insolvency, reorganization, moratorium or similar Laws now or hereafter in effect relating to creditors&#8217; rights generally and subject to general principles of equity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>No Conflicts</u>. Assuming that all consents, approvals, authorizations and other actions described in <u>Section</u>&nbsp;<u>3.4</u> have been obtained, and except as may result from any facts or circumstances relating solely to the Purchaser, the execution, delivery and performance by the Company of this Agreement and the consummation of the transactions contemplated hereby do not and will not: (a)&nbsp;violate, conflict with or result in the breach of the Charter Documents of the Company or any of its Subsidiaries; (b)&nbsp;conflict with or violate any Law or Order applicable to the Company or any of its Subsidiaries, or any of its or their respective assets or properties; or (c)&nbsp;violate, conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under, require any consent under, or give to others any rights of termination, amendment, acceleration, suspension, revocation or cancellation of, any note, bond, mortgage or indenture, contract, agreement, lease, sublease, license, permit, franchise or other instrument or arrangement to which the Company or any of its Subsidiaries is a party or to which any of their respective assets or properties are subject, or result in the creation of any Encumbrance on any of their respective assets or properties, except, in the case of clauses (b)&nbsp;and (c), for any such conflict, violation, breach or default that would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Consents and Approvals</u>. The execution, delivery and performance by the Company of this Agreement do not require any consent, approval, authorization or other Order of, action by, filing with or notification to, any Governmental Authority or any other Person under any of the terms, conditions or provisions of any Law or Order applicable to the Company or any of its Subsidiaries or by which any of its or their assets or properties may be bound, any contract or agreement to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries may be bound, except for any consent, approval, authorization or other Order of, action by, filing with or notification to, any Governmental Authority or any other Person under any of the terms, conditions or provisions of any Law or Order applicable to the Company or any of its Subsidiaries that, if not made or obtained, would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Capitalization</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of the date of this Agreement, and immediately prior to the issuance and sale of the Series C Preferred Stock (including the associated Warrants), the capitalization of the Company and each of its Subsidiaries is set forth in <u>Schedule 3.5(a)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <u>Schedule 3.5(b)</u>, there are no outstanding options, warrants, &#8220;phantom&#8221; stock rights, claims, calls, puts, convertible or exchangeable securities or other contracts or rights of any nature obligating the Company or any of its Subsidiaries to issue, return, redeem, repurchase, transfer, deliver or sell equity interests or other securities or ownership interests in the Company or any of its Subsidiaries, and no Person is entitled to any preemptive or similar right with respect to the issuance of securities or other equity interests in the Company or any of its Subsidiaries.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <u>Schedule 3.5(c)</u>, (x) to the Knowledge of the Company, there are no voting agreements, voting trusts, shareholder agreements, proxies or other similar agreements or understandings with respect to the equity interests of the Company or any of its Subsidiaries or that restrict or grant any right, preference or privilege with respect to the transfer of such equity interests, and (y) there are no contracts to declare, make or pay any dividends or distributions, whether current or accumulated, or due or payable, on the equity interests of the Company or any of its Subsidiaries.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <u>Schedule 3.5(d)</u> and as contemplated by <u>Section 5.5(c)</u>, the Company has no authorized or outstanding class of equity securities ranking as to dividends, redemption or distribution of assets upon a liquidation senior to or pari passu with the Series C Preferred Stock or that would otherwise constitute &#8220;Senior Stock&#8221; (as defined in the Certificate of Designations) or &#8220;Parity Stock&#8221; (as defined in the Certificate of Designations).<sup style="vertical-align:top;line-height:120%;font-size:pt"> </sup></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Valid Issuance</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon payment of the Purchase Price and the occurrence of the Closing, the Purchaser will be the owner, of record and beneficially, of [&#9679;] duly and validly issued, fully paid, and non-assessable shares of Series C Preferred Stock. The Purchaser shall have good and valid title to such Series C Preferred Stock, free and clear of any Encumbrances.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assuming the accuracy of the Purchaser&#8217;s representations and warranties set forth herein, the offer, sale and issuance of such Series C Preferred Stock as contemplated hereby are exempt from the registration and qualification of the Securities Act and will be issued in compliance with all applicable federal and state securities and blue sky laws. Neither the Company nor any Person acting on behalf of the Company has taken any action that would cause the loss of such exemption.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>SEC Reports; Financial Statements</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has filed or furnished with the Securities and Exchange Commission (&#8220;<u>SEC</u>&#8221;) all forms, reports, schedules, proxy statements (collectively, and in each case including all exhibits and schedules thereto and documents incorporated by reference therein and including all registration statements and prospectuses filed with the SEC, the &#8220;<u>SEC Reports</u>&#8221;) required to be filed or furnished by the Company with the SEC since July 25, 2017. As of its date of filing or furnishing, each SEC Report complied in all material respects with the requirements of the Exchange Act or the Securities Act, and none of such SEC Reports (including any and all financial statements included therein) contained when filed or furnished (except to the extent revised or superseded by a subsequent filing with the SEC that is publicly available prior to the date hereof) any untrue statement of a material fact or omitted or omits to state a material fact required to be stated therein or necessary to make the statements made therein, in light of the circumstances under which they were made, not misleading.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the consolidated financial statements (including the notes thereto) included in the SEC Reports (i) complied as to form required by published rules and regulations of the SEC related thereto as of its date of filing with the SEC, (ii) complied in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, (iii) has been prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto or otherwise permitted by the SEC on Form 10-Q or any successor form under the Exchange Act) and (iv) presents fairly in all material respects the consolidated financial position of Company and its consolidated Subsidiaries as of the dates thereof and the consolidated results of their operations and cash flows for the periods then ended, subject (in the case of unaudited financial statements) to normal year-end adjustments and any other adjustments described therein or in the notes or schedules thereto or the absence of footnotes (none of which are material).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The unaudited balance sheet and the related unaudited statement of operations and unaudited statement of cash flows for the Company&#8217;s most recently filed Quarterly Report on Form 10-Q as of the date of this Agreement (i) present fairly in all material respects the financial condition of the Company as of such date and the results of operations for the nine (9) month period then ended and (ii) were prepared on a basis consistent with the Company&#8217;s past practice, subject to normal year-end adjustments and the absence of footnotes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Undisclosed Liabilities</u>. Except as set forth in <u>Schedule 3.8</u>, and except for liabilities included or reserved for in the unaudited consolidated balance sheet of the Company or disclosed in the notes thereto included in the Company&#8217;s most recently filed Quarterly Report on Form 10-Q as of the date of this Agreement, neither the Company nor any of its Subsidiaries has incurred liabilities, including contingent liabilities, or any other obligations of a nature required to be disclosed on a consolidated balance sheet or in the notes thereto, except liabilities that are not material and were incurred in the ordinary course of business subsequent to the date of the consolidated balance sheet contained in the Company&#8217;s most recently filed Quarterly Report on Form 10-Q as of the date of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Contracts</u>. Except as set forth in <u>Schedule 3.9</u>, neither the Company nor any of its Subsidiaries is, or to the Knowledge of the Company, is alleged to be (nor, to the Company&#8217;s Knowledge, is any other party to any Material Contract) in material default under, or in material breach or material violation of, any Material Contract, and no event has occurred which, with the giving of notice or passage of time or both, would constitute a material default by the Company or any other party under any Material Contract. Other than Material Contracts which have terminated or expired in accordance with their terms, each of the Material Contracts is in full force and effect and is a legal, valid and binding obligation of the Company and, to the Knowledge of the Company, the other parties thereto enforceable against the Company and, to the Knowledge of the Company, such other parties in accordance with its terms (subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors&#8217; rights generally and general equitable principles (whether considered in a proceeding in equity or at law).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Affiliate Transactions</u>. Except as set forth in <u>Schedule 3.10</u>, there are no transactions between the Company, on the one hand, and any (A) officer or director of the Company or any of its Subsidiaries, (B) to the Knowledge of the Company, record or beneficial owner of five (5) percent or more of the voting securities of the Company or (C) Affiliate or family member of any such officer or director or, to the Knowledge of the Company, record or beneficial owner, on the other hand, except employee benefit plans, executive compensation or director compensation, employment agreements, consulting agreements, indemnification agreements and similar transactions. Neither the Company nor any of its Subsidiaries is a guarantor or indemnitor of any indebtedness of any of the persons set forth in the foregoing clause (A) or, to the Knowledge of the Company, clauses (B) through (C).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Title</u>. The Company and each of its Subsidiaries has good and marketable title to their respective owned properties and assets, and good leasehold title to their respective leasehold estates in leased properties and assets, in each case, subject to no Encumbrances, other than Encumbrances that would not reasonably be expected to result in, individually or in the aggregate, a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Compliance with Law; Permits</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries (i) is in material violation or default of the Charter Documents of the Company or any of its Subsidiaries, (ii) is in violation or default of any Order or any Law, except for such violations and defaults that would not reasonably be expected to result in, individually or in the aggregate, a Material Adverse Effect or (iii) has received, since October 28, 2019, any written notice of, and to the Knowledge of the Company, no investigation or review is in process or threatened by any Governmental Authority with respect to, any material violation or alleged violation of any Order or Law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <u>Schedule 3.12(b)</u> or as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect, (i) the Company and its Subsidiaries hold all Permits necessary for the lawful conduct of their respective businesses as they are presently being conducted, (ii) all Permits are in full force and effect, (iii) the Company and its Subsidiaries are in compliance with the terms of the Permits, (iv) there are no pending or, to the Knowledge of the Company, threatened, modifications, amendments, cancellations, suspensions, limitations, nonrenewals or revocations of any Permit, and (v) there has occurred no event which (whether with notice or lapse of time or both) could reasonably be expected to result in or constitute the basis for such a modification, amendment, cancellation, suspension, limitation, nonrenewal or revocation thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Litigation</u>. Except as set forth in <u>Schedule 3.13</u>, no action, suit, claim, demand, hearing, investigation or other proceeding is pending against the Company or any of its Subsidiaries, or, to the Knowledge of the Company, any officer, director, manager, member, shareholder or employee of any such Person, and none of the Company or any of its Subsidiaries, or, to the Knowledge of the Company, any officer, director, manager, member, shareholder or employee of any such Person, is subject to any outstanding injunction, judgment, order, decree, ruling or charge or, to the Knowledge of the Company, is threatened with being made a party to any action, suit, proceeding, hearing or investigation of, in, or before any Governmental Authority or before any arbitrator, all cases, that are required to be described in the SEC Reports but are not described as required in the SEC Reports, or that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Intellectual Property</u>. The Company and its Subsidiaries own or have obtained valid and enforceable licenses for, or other legal and valid rights to use, the Intellectual Property necessary for the conduct of the business of the Company and its Subsidiaries as currently conducted, except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Neither the Company nor any of its Subsidiaries has received from any third party a claim in writing that the Company or any of its Subsidiaries is infringing in any material respect the Intellectual Property rights of any third party.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Insurance</u>. <u>Schedule 3.15</u> sets forth a true, correct and complete list of all of the insurance maintained for or on behalf of the Company or any of its Subsidiaries and claims made to date. All premiums with respect to such policies have been paid to the extent due and payable. No written notice of cancellation or termination has been received by the Company or any of its Subsidiaries with respect to any such policies that have not been replaced on substantially similar terms prior to the date of such cancellation or termination.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Environmental Matters</u>. The Company and its Subsidiaries have at all times been in compliance in all material respects with all Environmental Laws. To the Knowledge of the Company, there are no locations or premises where Hazardous Materials have been Released such that (A) the Company or any of its Subsidiaries would reasonably be expected to be obligated to remove, remediate or otherwise respond to pursuant to any Environmental Laws or (B) would reasonably be expected to result in a liability of the Company or any of its Subsidiaries to any Person under any Environmental Laws. There are no Environmental Claims pending, or to the Knowledge of the Company threatened against the Company or any of its Subsidiaries, and there no actions, activities, circumstances, facts, conditions, events or incidents, including the presence of any Hazardous Material, which would be reasonably likely to form the basis of any such Environmental Claim.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Company Benefits Plans</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.17</u> lists each material Company Benefit Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its ERISA Affiliates has ever maintained, sponsored, contributed to, or had an obligation to maintain, sponsor or contribute to, or has any liability under or with respect to (i) a &#8220;defined benefit plan,&#8221; as defined in Section 3(35) of ERISA, (ii) a pension plan subject to the minimum funding standards of Section 302 of ERISA or Section 412 of the Code, (iii) a &#8220;multiemployer plan,&#8221; as defined in Section 3(37) of ERISA, (iv) a &#8220;multiple employer plan&#8221; (within the meaning of Section 413 of the Code), (v) a &#8220;voluntary employees&#8217; beneficiary association&#8221; (within the meaning of Section 501(c)(9) of the Code), (vi) an organization or trust described in Sections 501(c)(17) or 501(c)(20) of the Code or (vii) a &#8220;welfare benefits fund&#8221; described in Section 419(e) of the Code. No current or former employee, officer, director, consultant or other service provider of the Company or any of its Subsidiaries is or may become entitled under any Company Benefit Plan to receive health, life insurance or other welfare benefits (whether or not insured), beyond their retirement or other termination of service, other than health continuation coverage as required by Section 4980B of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Company Benefit Plan has been administered in all material respects in accordance with its terms and applicable Law. Each Company Benefit Plan intended to be qualified under Section 401(a) of the Code has either received a favorable determination letter from the IRS or may rely on a favorable opinion letter issued by the IRS, and, to the Knowledge of the Company, nothing has occurred since the date of such determination or opinion letter that would reasonably be expected to adversely affect such qualification.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as would not be reasonably likely to result in a Material Adverse Effect, there are no actions, suits, audits or investigations by any Governmental Authority or other claims (except for routine claims for benefits) pending or, to the Knowledge of the Company, threatened, against or involving any Company Benefit Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the execution and delivery of this Agreement, nor the consummation of the transactions contemplated hereby will (whether alone or upon the occurrence of any additional or further acts or events) (i) result in any payment becoming due to any current or former employee, officer, director or independent contractor of the Company or any Subsidiary thereof or satisfy any prerequisite (whether exclusive or non-exclusive) to any payment or benefit to any current or former employee, director or independent contractor of the Company or any Subsidiary thereof, (ii) increase any benefits under any Company Benefit Plan, (iii) result in the acceleration of the time of payment, vesting or funding of any such benefits under any Company Benefit Plan, or (iv) result in the forgiveness of any indebtedness of any current or former employee, officer, director or independent contractor of the Company or any Subsidiary thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Labor</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is a party to any labor or collective bargaining agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There are no (i) strikes, work stoppages, work slowdowns or lockouts pending or, to the Knowledge of the Company, threatened against or involving the Company or any of its Subsidiaries, or (ii) unfair labor practice charges, grievances or complaints pending or, to the Knowledge of the Company, threatened by or on behalf of any employee or group of employees of the Company or any of its Subsidiaries, except in each case as would not have a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Matters</u>. Except as set forth in <u>Schedule 3.19</u>:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of the date of this Agreement, the Company has timely filed all material Tax Returns required to be filed (after giving effect to any extensions that have been requested by and granted to such party by the applicable Governmental Authority) and has paid or caused to be paid on its behalf all Taxes due and owing, other than those (i) that are being contested in good faith and for which adequate reserves have been established in accordance with GAAP or (ii) that, if not paid, would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. All such Tax Returns are true, correct and complete in all material respects. There are no past, current, pending or, to the Knowledge of the Company, threatened audits, claims or proceedings by any Governmental Authority relating to Taxes. The Company has not waived any statutes of limitation or agreed to any extension of time with respect to any Tax assessment or deficiency. The Company has not received written notice from any Governmental Authority in a jurisdiction where it does not file Tax Returns claiming that it is subject to Tax in that jurisdiction. There are no liens for Taxes against the property of the Company or the Project except for Taxes not yet due and payable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has complied with all Laws relating to the withholding and collection of Taxes relating to the Company. The Company has not engaged in any reportable transaction within the meaning of Treasury Regulations Section 1.6011-4(b).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has made an election under Section 965(h) of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company (A) has not entered into any agreement with any Governmental Authority that would impact the amount of Taxes due by it, (B) has never been a member of an affiliated, combined, consolidated or unitary group for purposes of filing any Tax Return or has any liability for the Taxes of any other Person (1) under Treasury Regulations Section 1.1502-6 (or any similar provision of state, local or foreign law), or (2) as a transferee or successor, by Contract, or otherwise, or (C) is not a party to, or has any liability under, any Tax sharing, Tax allocation, Tax indemnity, or similar agreement or arrangement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Investment Company Act</u>. The Company is not and, after giving effect to the transactions contemplated by this Agreement will not be, an &#8220;investment company&#8221; as that term is defined in, nor is the Company otherwise subject to registration or regulation under, the Investment Company Act of 1940.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>OFAC and Related Matters</u>. None of the transactions contemplated hereby will violate (i) any Sanctions, or (ii) the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT ACT) Act of 2001, Public Law 107-56 (October 26, 2001). The Company is in compliance with Sanctions in all material respects. There are no pending or threatened claims or legal actions, or investigations by any Governmental Authority, of or against the Company, nor are there any judgments imposed (or threatened to be imposed) upon the Company by or before any Governmental Authority, in each case, in connection with any alleged violation of Sanctions. Neither the Purchase Price nor any other proceeds received by the Company hereunder will be used in any dealings or transactions with any Sanctioned Person or in any manner that will result in a violation of Sanctions. The Company has not violated any provision of the U.S. Foreign Corrupt Practices Act of 1977 or the U.K. Bribery Act 2010.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">3.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Broker; Fees</u>. Neither the Company nor any of its Subsidiaries has employed any broker or finder, or incurred any liability for any brokerage or finders&#8217; fees or any similar fees or commissions in connection with the transactions contemplated by this Agreement for which the Purchaser is liable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Section 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>REPRESENTATIONS AND WARRANTIES OF THE PURCHASER</u></b>. The Purchaser represents and warrants to the Company as of the date hereof and, with respect to the Fundamental Representations, as of the date hereof and as of the Closing Date (except for representations and warranties that are made as of a specific date, which are made only as of such date), as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Organization and Qualification</u>. The Purchaser has been duly organized and is validly existing and, except as would not reasonably be expected to have, individually or in the aggregate, a Purchaser Material Adverse Effect, is in good standing under the laws of its jurisdiction of organization, with the requisite power and authority to own its properties and conduct its business as currently conducted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Authorization; Enforcement; Validity</u>. The Purchaser has all necessary corporate, limited liability company or equivalent power and authority to enter into this Agreement and to carry out, or cause to be carried out, its obligations hereunder in accordance with the terms hereof. The execution and delivery by the Purchaser of this Agreement and the performance by the Purchaser of its obligations hereunder have been duly authorized by all requisite action on the part of the Purchaser, and no other action on the part of the Purchaser is necessary to authorize the execution and delivery by the Purchaser of this Agreement or the consummation of the transactions contemplated by this Agreement. This Agreement has been duly executed and delivered by the Purchaser, and assuming due authorization, execution and delivery by the Company, this Agreement constitutes the legal, valid and binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, subject to bankruptcy, insolvency, reorganization, moratorium or similar Laws now or hereafter in effect relating to creditors&#8217; rights generally and subject to general principles of equity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>No Conflicts</u>. The execution, delivery, and performance by the Purchaser of this Agreement do not and will not (a)&nbsp;violate any provision of the organizational documents of the Purchaser; (b)&nbsp;conflict with or violate any Law or Order applicable to the Purchaser or any of its respective assets or properties; or (c)&nbsp;violate, conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under, require any consent under, or give to others any rights of termination, amendment, acceleration, suspension, revocation or cancellation of, any note, bond, mortgage or indenture, contract, agreement, lease, sublease, license, permit, franchise or other instrument or arrangement to which the Purchaser is a party or to which any of its assets or properties are subject, or result in the creation of any Encumbrance on any of its assets or properties, except, in the case of clauses (b)&nbsp;and (c), for any such conflict, violation, breach or default that would not reasonably be expected to have, individually or in the aggregate, a Purchaser Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Consents and Approvals</u>. The execution, delivery and performance by the Purchaser of this Agreement do not require the Purchaser to obtain any consent, approval, authorization or other Order of, action by, filing with or notification to, any Governmental Authority or any other Person under any of the terms, conditions or provisions of any Law or Order applicable to the Purchaser or by which any of its assets or properties may be bound, any contract to which the Purchaser is a party or by which the Purchaser may be bound, except for any consent, approval, authorization or other Order of, action by, filing with or notification to, any Governmental Authority or any other Person under any of the terms, conditions or provisions of any Law or Order applicable to the Purchaser that, if not made or obtained, would not reasonably be expected to have, individually or in the aggregate, a Purchaser Material Adverse Effect with respect to the Purchaser.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Purchaser Representation</u>. (i) The Purchaser is either (A) a qualified institutional buyer as defined in Rule 144A of the Securities Act, (B)&nbsp;an accredited investor as defined in Rule 501(a)(1), (2), (3), (7) or (8) under the Securities Act, (C) a non&#8209;U.S. person under Regulation&nbsp;S under the Securities Act, or (D) the foreign equivalent of (A) or (B) above, and (ii)&nbsp;any securities of the Company acquired by the Purchaser under this Agreement will have been acquired for investment and not with a view to distribution or resale in violation of the Securities Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Sufficient Funds</u>. The Purchaser has sufficient assets (or the ability to call sufficient capital from its equityholders) and the financial capacity to perform all of its obligations under this Agreement, including the ability to fully fund the Purchase Price at the Closing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Section 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>ADDITIONAL COVENANTS</u></b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Commercially Reasonable Efforts</u>. Each of the Company and the Purchaser hereby agrees to use its commercially reasonable efforts to timely satisfy (if applicable) each of the conditions applicable to such Party under <u>Sections 6</u> and <u>7</u>, respectively, of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Further Assurances</u>. Each Party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other Party may reasonably request to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Use of Proceeds</u>. The Company shall use the proceeds from the transactions contemplated hereby solely as provided for in <u>Exhibit E</u> to this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Expenses</u>. The Company shall bear all of its own expenses in connection with the execution, delivery and performance of this Agreement and the transactions contemplated hereby, including without limitation all fees and expenses of its agents, representatives, counsel and accountants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">5.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Conduct of the Business of Company</u>. From the date hereof until the Closing Date, except (a) as expressly permitted by this Agreement, (b) as required by Law, or (c) with the written consent of the Purchaser (such consent not to be unreasonably withheld, conditioned or delayed), the Company shall conduct its business and operations in the ordinary course of business consistent with past practice and use commercially reasonable efforts to (i)&nbsp;preserve intact its present business organization; (ii)&nbsp;maintain good relationships with its vendors, suppliers, and others having material business relationships with it; and (iii)&nbsp;manage its working capital in the ordinary course of business consistent with past practice. Without limiting the generality of the foregoing, and, except as contemplated in this Agreement or as described in <u>Schedule 5.5</u>, during the period from the date of this Agreement through the Closing Date, without the prior written consent of the Purchaser (which consent shall not be unreasonably withheld or delayed), the Company shall not, and shall not permit any of its Subsidiaries to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;amend any of its Charter Documents;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;split, combine, subdivide or reclassify any of its equity securities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;authorize, sell, issue or grant any equity securities or sell, issue or grant any option, warrant or right to acquire any equity securities or sell, issue or grant any security convertible into or exchangeable for equity securities, or sell, transfer or dispose of, or grant or permit any Encumbrance on, any equity interest;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except as required pursuant to applicable Law or the terms of any Company Benefit Plan in existence as of the date hereof, (A) make or grant any increases in the compensation or fringe benefits of any current or former employee or service provider of the Company or its Subsidiaries except in the ordinary course of business consistent with past practice (x) for current employees whose annual base salary or annual fee is less than $150,000 or (y) in respect of fringe benefits, increases in fringe benefits that do not result in a material increase in cost to the Company or its Subsidiaries; (B) take any action to accelerate the vesting or payment of any compensation or benefits under any Company Benefit Plan or any action to fund or secure the payment of compensation or benefits under any Company Benefit Plan; (C) amend, adopt or terminate any Company Benefit Plan other than in connection with routine, immaterial or ministerial amendments to health and welfare plans that do not materially increase benefits or result in a material increase in administrative costs; or (D) enter into, modify or terminate any collective bargaining agreement or other agreement or arrangement with any labor union, works council, labor organization or other employee-representative body.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;declare, set aside for payment or pay any dividend on, or make any other distribution in respect of its equity interests or otherwise make any payments to any holder of such interests in its capacity as such except in accordance with the terms of the Certificate of Designations of Series A Convertible Preferred Stock and the Certificate of Designations of Series B Convertible Preferred Stock;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;take or fail to take any action the result of which would cause the creation of an Encumbrance on any of its equity interests;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make any material change to its financial reporting and accounting methods other than as required by a change in GAAP;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make any material change in its Tax reporting or Tax accounting methods, including making or changing any material Tax elections except as required by applicable Law;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;acquire any Person or other business organization, division or business by merger, consolidation, purchase of an equity interest or assets, or by any other manner;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;take any action to liquidate, dissolve, or wind up its business;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;take any action that would require the consent of the Purchaser as the holder of the Series C Preferred Stock pursuant to the Certificate of Designations if such action were to occur after the Closing; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 59pt;text-indent:36pt;">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;commit itself to do any of the foregoing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">5.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Public Announcements</u>. No press release or other public announcement related to this Agreement or the transactions contemplated herein shall be issued or made without the joint approval of the Company and the Purchaser, unless such release or announcement is required by law or the rules of any securities exchange on which securities of the Company are traded (including, for the avoidance of doubt, any Current Report on Form 8-K required to be filed by the Company with the SEC describing this Agreement or the transactions contemplated herein), in which case the Purchaser shall be afforded a reasonable opportunity to review such public announcement prior to publication.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Section 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>CONDITIONS TO THE PURCHASER</u></b>&#8217;<b><u>S OBLIGATIONS</u></b>. The obligations of the Purchaser to consummate the transactions contemplated hereby pursuant to this Agreement on the Closing Date shall be subject to the satisfaction at or prior to the Closing Date of each of the following conditions, any one or more of which may be waived in writing by the Purchaser:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Fundamental Representations and Warranties</u>. All of the Fundamental Representations made by the Company in this Agreement shall be true and correct in all respects as of the Closing Date as though made on and as of the Closing Date (except to the extent such representations and warranties expressly speak as of an earlier date, in which case such representations and warranties shall be true and correct as of such date).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Performance of Closing Actions</u>. The Company shall have performed each of the Closing Actions required to be performed by them at the Closing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>No Legal Impediment to Issuance; No Material Adverse Effect</u>. No Law or Order shall have become effective or been enacted, adopted or issued by any Governmental Authority that prohibits the implementation of this Agreement or the transactions contemplated herein, and no Material Adverse Effect shall have occurred.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Section 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>CONDITIONS TO THE COMPANY</u></b>&#8217;<b><u>S OBLIGATIONS</u></b>. The obligations of the Company to issue and sell to the Purchaser the Series C Preferred Stock (including the Warrants) pursuant to this Agreement shall be subject to the satisfaction at or prior to the Closing Date of each of the following conditions, any one or more of which may be waived in writing by the Company:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Fundamental Representations and Warranties</u>. All of the Fundamental Representations made by the Purchaser in this Agreement shall be true and correct in all respects as of the Closing Date as though made on and as of the Closing Date (except to the extent such representations and warranties expressly speak as of an earlier date, in which case such representations and warranties shall be true and correct as of such date).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Performance of Closing Actions</u>. The Purchaser shall have performed each of the Closing Actions required to be performed by it at the Closing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>No Legal Impediment to Issuance</u>. No Law or Order shall have become effective or been enacted, adopted or issued by any Governmental Authority that prohibits the implementation of this Agreement or the transactions contemplated by this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Section 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>TERMINATION</u></b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination by the Purchaser</u>. This Agreement may be terminated at any time prior to the Closing by the Purchaser following the occurrence of any of the following events (each a &#8220;<u>Purchaser Termination Event</u>&#8221;) immediately upon delivery of written notice to the Company; <i>provided</i>, <i>however</i> that the Purchaser shall not be permitted to terminate this Agreement if at the time of such termination the Purchaser is in breach of any representation, warranty or covenant applicable to it in any material respect under this Agreement:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 108pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the failure of any of the conditions set forth in <u>Section 6</u> hereof to be satisfied, which failure cannot be cured or is not cured before the earlier of (A) fifteen (15) Business Days after receipt of written notice thereof by the Company from the Purchaser and (B) the Closing Date;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 108pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Company breaches any representation or warranty or breaches any covenant applicable to it in any material respect under this Agreement and if such breach is curable, it is not cured before the earlier of (A) fifteen (15) Business Days after receipt of written notice by the Company from the Purchaser and (B) the Closing Date; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 108pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any Governmental Authority of competent jurisdiction, enters a Final Order declaring this Agreement or any material portion hereof to be unenforceable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination by the Company</u>. This Agreement may be terminated at any time prior to the Closing by the Company following the occurrence of any of the following events immediately upon delivery of written notice to the Parties except as set forth below; <i>provided</i>, <i>however</i> that the Company shall not be permitted to terminate this Agreement if, at the time of such termination, the Company is in breach of any representation, warranty or covenant applicable to it in any material respect under this Agreement:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 108pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the failure of any of the conditions set forth in <u>Section 7</u> hereof to be satisfied, which failure cannot be cured or is not cured before the earlier of (A) fifteen (15) Business Days after receipt of written notice thereof by the Purchaser from the Company and (B) the Closing Date;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 108pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Purchaser breaches any representation or warranty or breaches any covenant applicable to it in any material respect under this Agreement and if such breach is curable, it is not cured before the earlier of (A)&nbsp;fifteen (15) Business Days after receipt of written notice by the Purchaser from the Company and (B) the Closing Date;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 108pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any Governmental Authority of competent jurisdiction, enters a Final Order declaring this Agreement or any material portion hereof to be unenforceable; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 108pt;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Closing does not occur on or before the Closing Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Purchaser Default</u>. Subject to <u>Section 10.19</u>, the Purchaser agrees that, in the event of a Purchaser Default, the Company shall be entitled to all remedies available at law and at equity, including to enforce rights of damages and/or specific performance pursuant to <u>Section</u>&nbsp;<u>10.18</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Mutual Termination</u>. This Agreement may be terminated by the mutual written consent of the Company and the Purchaser.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 26pt;text-indent:70pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Effect of Purchaser Termination</u>. Upon a termination of this Agreement in accordance with <u>Section 8(a)</u>, the Purchaser shall have no continuing liability or obligation to the Company and the provisions of this Agreement shall have no further force or effect with respect to the Purchaser, except for the provisions in <u>Sections 8</u>, <u>9</u>, and <u>10</u>, each of which shall survive termination of this Agreement; <i>provided</i>, <i>however,</i> that no such termination shall relieve the Purchaser from liability for its breach or non-performance of its obligations hereunder prior to the date of such termination and the rights of the Company as it relates to such breach or non-performance by the Purchaser shall be preserved in the event of the occurrence of such breach or non-performance.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Effect of Company or Mutual Termination</u>. Upon a termination of this Agreement in accordance with <u>Sections 8(b)</u> or <u>8(d)</u>, neither Party shall have any continuing liability or obligation to the other Party hereunder and the provisions of this Agreement shall have no further force or effect except for the provisions in <u>Sections 8</u>, <u>9</u>, and <u>10</u>, each of which shall survive termination of this Agreement; <i>provided</i> that no such termination shall relieve either Party from liability for its breach or non-performance of its obligations hereunder prior to the date of such termination and the rights of the other Party as it relates to such breach or non-performance by the Party shall be preserved in the event of the occurrence of such breach or non-performance.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Section 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>INDEMNIFICATION</u></b>. The Company agrees to indemnify and hold harmless the Indemnified Parties from and against any and all claims, damages, losses, liabilities and expenses (including, without limitation, fees and disbursements of counsel), that may be incurred by or asserted or awarded against any Indemnified Party, in each case arising out of this Agreement (including as a result of any breach or inaccuracy of any representation, warranty or covenant herein), the other Offering Documents, or the transactions contemplated hereby or thereby, solely to the extent such Offering Documents or transactions contemplated thereby relate to this Agreement and the Series C Preferred Equity Offering, any use made or proposed to be made with the proceeds of the Series C Preferred Equity Offering, or any claim, litigation, investigation or proceeding relating to any of the foregoing, regardless of whether any Indemnified Party is a party thereto, and the Company shall reimburse each Indemnified Party upon demand for reasonable and documented fees and expenses of counsel (which, so long as there are no conflicts among such Indemnified Parties, shall be limited to one law firm serving as counsel for the Indemnified Parties) and other expenses incurred by it in connection with investigating, preparing to defend or defending, or providing evidence in or preparing to serve or serving as a witness with respect to, any lawsuit, investigation, claim or other proceeding relating to any of the foregoing, irrespective of whether the transactions contemplated hereby are consummated, except to the extent such claim, damage, loss, liability, or expense is found in a Final Order to have resulted from such Indemnified Party&#8217;s bad faith, actual fraud, gross negligence, or willful misconduct. No Indemnified Party shall have any liability (whether direct or indirect, in contract, tort or otherwise) to the Company for or in connection with the transactions contemplated hereby, except to the extent such liability is found in a final, non-appealable order of a court of competent jurisdiction to have resulted from such Indemnified Party&#8217;s bad faith, actual fraud, gross negligence or willful misconduct. In no event, however, shall the Company or any Indemnified Party be liable on any theory of liability for any special, indirect, consequential or punitive damages. Without the prior written consent of the Indemnified Parties, the Company agrees that it will not enter into any settlement of any lawsuit, claim or other proceeding arising out of this Agreement, the other Offering Documents, or the transactions contemplated hereby or thereby, solely to the extent such Offering Documents or transactions contemplated thereby relate to this Agreement and the Series C Preferred Equity Offering, unless such settlement (i)&nbsp;includes an explicit and unconditional release from the party bringing such lawsuit, claim or other proceeding of all Indemnified Parties and (ii)&nbsp;does not include a statement as to or an admission of fault, culpability, or a failure to act by or on behalf of any Indemnified Party. No Indemnified Party shall be liable for any damages arising from the use by unauthorized persons of any information made available to the Indemnified Parties by the Company or any of its representatives through electronic, telecommunications or other information transmission systems that is intercepted by such persons. No Indemnified Party shall settle any lawsuit, claim, or other proceeding arising out of this Agreement, the other Offering Documents, or the transactions contemplated hereby or thereby without the prior written consent of the Company (such consent not to be unreasonably withheld or delayed). Notwithstanding the foregoing, an Indemnified Party shall be entitled to no indemnification by the Company for any claim, damage, loss, liability, or expense incurred by or asserted or awarded against such Indemnified Party for any violation of Law by such Indemnified Party.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Section 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>MISCELLANEOUS</u></b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Payments</u>. All payments made by or on behalf of the Company or any of their Affiliates to the Purchaser or its assigns, successors or designees pursuant to this Agreement shall be without withholding, set-off, counterclaim or deduction of any kind.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.2&nbsp; &nbsp;&nbsp;<u>Arm</u>&#8217;<u>s Length Transaction</u>. The Company acknowledges and agrees that (i)&nbsp;the Series C Preferred Equity Offering and any other transactions described in this Agreement are an arm&#8217;s-length commercial transaction between the Parties and (ii)&nbsp;the Purchaser has not assumed nor will it assume an advisory or fiduciary responsibility in the Company&#8217;s favor with respect to any of the transactions contemplated by this Agreement or the process leading thereto, and the Purchaser has no obligation to the Company with respect to the transactions contemplated by this Agreement except those obligations expressly set forth in this Agreement or the Offering Documents to which it is a party.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Survival</u>. The representations, warranties, covenants, agreements and obligations of the Parties shall survive the Closing as follows (each such survival period, a &#8220;<u>Survival Period</u>&#8221;): (i) except for Fundamental Representations and the Tax Representations, the representations and warranties made by each Party in this Agreement shall survive the Closing until the first anniversary of the Closing; (ii) Fundamental Representations shall survive the Closing until the fifth anniversary of the Closing, (iii) Tax Representations shall survive the Closing for the full period of all applicable statutes of limitations related thereto (after giving effect to any waiver or extension thereof), and (iv) the covenants, agreements, obligations and other undertakings of the Parties shall survive the Closing until fully performed in accordance with their terms. All liability of the Indemnifying Parties with respect to the representations, warranties, covenants, agreements and obligations hereunder shall be extinguished at the end of the applicable Survival Period, except to the extent that notice of an alleged breach of such representations, warranties, covenants, agreements or obligations has been provided before such date; provided that if notice is given prior to the expiration of the applicable Survival Period, the claim with respect to such representation, warranty, covenant, agreement or obligation shall continue indefinitely until finally resolved.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>No Waiver of Rights</u>. All waivers hereunder must be made in writing, and the failure of any Party at any time to require another Party&#8217;s performance of any obligation under this Agreement shall not affect the right subsequently to require performance of that obligation. Any waiver of any breach of any provision of this Agreement shall not be construed as a waiver of any continuing or succeeding breach of such provision or a waiver or modification of any other provision.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices</u>. All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by an internationally recognized overnight courier service, by email or registered or certified mail (postage prepaid, return receipt requested) to the respective Parties at the following addresses (or at such other address for any Party as shall be specified by such Party in a notice given in accordance with this <u>Section 10.5</u>).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:-36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If to the Company, to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">NextDecade Corporation</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">1000 Louisiana Street, Suite 3900</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">Houston, Texas 77002</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;"><u>Attention</u>:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Krysta De Lima, General Counsel</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:108pt;">krysta@next-decade.com</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">With a copy (which shall not constitute notice to the Company) to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">K&amp;L Gates LLP</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">300 South Tryon Street, Suite 1000</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">Charlotte, North Carolina 28202</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:36pt;"><u>Attention</u>:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sean M. Jones</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:108pt;">Sean.Jones@klgates.com</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:-36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If to the Purchaser, to the address set forth on <u>Exhibit G</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Any of the foregoing addresses may be changed by giving notice of such change in the foregoing manner, except that notices for changes of address shall be effective only upon receipt.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Headings</u>. The section and subsection headings in this Agreement are inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.7&nbsp;&nbsp;&nbsp;<u>Severability</u>. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any Law or public policy, all other terms and provisions of this Agreement shall nevertheless remain in full force and effect for so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any Party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in an acceptable manner in order that the transactions contemplated hereby are consummated as originally contemplated to the greatest extent possible.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Entire Agreement</u>. This Agreement and the agreements and documents referenced herein constitute the entire agreement of the Parties with respect to the subject matter hereof and supersede all prior agreements and undertakings, both written and oral, between the Parties with respect to the subject matter hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Successors and Assigns</u>. This Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns. Except as set forth below, neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by either Party (whether by operation of law or otherwise) without the prior written consent of the other Party. Notwithstanding the foregoing and subject to the restriction on transfer contained in <u>Section 10.10</u>, the rights, obligations and interests hereunder and the shares of Series C Preferred Stock purchased hereunder may be assigned, delegated or transferred, in whole or in part, by the Purchaser to (i) any Affiliate of the Purchaser without the consent of the Company or (ii) one or more other third parties with the consent of the Company, which consent shall not be unreasonably withheld or delayed; <i>provided</i>, <i>however</i>, that any such transferee, as a condition precedent to such transfer, becomes a Party to this Agreement and assumes the obligations of the Purchaser with respect to the transferred shares under this Agreement by executing an addendum substantially in the form set forth in <u>Exhibit A</u> (the&nbsp;&#8220;<u>Addendum</u>&#8221;) and an assumption agreement in substantially the form set forth in <u>Exhibit B</u> hereto (the&nbsp;&#8220;<u>Assumption Agreement</u>&#8221;) and deliver the same to the Company in accordance with <u>Section</u>&nbsp;<u>7.5</u>, and <i>provided</i>, <i>further</i>, that (a) with respect to a transfer to an Affiliate of the Purchaser, the Purchaser either (i) shall have provided an adequate equity support letter or a guarantee of such Affiliate-transferee&#8217;s obligations, in form and substance reasonably acceptable to the Company or (ii) shall remain fully obligated to fund the Purchase Price and (b) with respect to a transfer to a third party, the Company, acting in good faith, shall have consented in writing to such transfer (which consent shall not be unreasonably withheld, conditioned or delayed) and shall have determined, in its reasonable discretion, after due inquiry and investigation, that such transferee is reasonably capable of fulfilling such obligations, or, absent such a determination, the proposed transferee shall have deposited with an agent of the Company or into an escrow account under arrangements satisfactory to the Company funds sufficient, in the reasonable determination of the Company, to satisfy such proposed transferee&#8217;s obligations. Any transfer that is made in violation of the immediately preceding sentence shall be null and void ab initio, and the Company shall have the right to enforce the voiding of such transfer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Limitations on Transfer of Series C Preferred Stock</u>. THE SERIES C PREFERRED STOCK (INCLUDING ANY SERIES C PREFERRED STOCK ISSUED IN RESPECT OF DIVIDEND PAYMENTS THEREON) SHALL NOT BE TRANSFERRED BY THE PURCHASER TO ANY OTHER PERSON WITHOUT THE CONSENT OF THE COMPANY, WHICH CONSENT SHALL NOT BE UNREASONABLY WITHHELD OR DELAYED, EXCEPT THAT, SUBJECT TO <u>SECTION 10.9</u>, THE PURCHASER SHALL BE ENTITLED TO TRANSFER ANY OR ALL SHARES OF ITS SERIES C PREFERRED STOCK TO ANY AFFILIATE OF THE PURCHASER.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>No Third-Party Beneficiaries</u>. This Agreement shall be binding upon and inure solely to the benefit of the Parties and their respective successors and permitted assigns and, except as expressly set forth in <u>Section 9</u>, nothing herein, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit or remedy of any nature whatsoever.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendment</u>. This Agreement may not be altered, amended, or modified except by a written instrument executed by or on behalf of the Company and the Purchaser.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law</u>. This Agreement shall be interpreted, construed and enforced in accordance with the laws of the State of New York, without regard to the conflicts of law principles thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.14&nbsp; &nbsp; &nbsp;<u>Consent to Jurisdiction</u>. Each of the Parties (a)&nbsp;irrevocably and unconditionally agrees that any actions, suits or proceedings, at law or equity, arising out of or relating to this Agreement or any agreements or transactions contemplated hereby shall be heard and determined by the federal or state courts located in New York County in the State of New York; (b)&nbsp;irrevocably submits to the jurisdiction of such courts in any such action, suit or proceeding; (c)&nbsp;consents that any such action, suit or proceeding may be brought in such courts and waives any objection that such Party may now or hereafter have to the venue or jurisdiction of such courts or that such action or proceeding was brought in an inconvenient forum; and (d)&nbsp;agrees that service of process in any such action, suit or proceeding may be effected by providing a copy thereof by any of the methods of delivery permitted by <u>Section</u>&nbsp;<u>10.5</u> to such Party at its address as provided in <u>Section</u>&nbsp;<u>10.5</u> (provided that nothing herein shall affect the right to effect service of process in any other manner permitted by Law).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Waiver of Jury Trial</u>. EACH OF THE PARTIES HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT, OR ANY OTHER THEORY). EACH OF THE PARTIES HERETO HEREBY (A)&nbsp;CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B)&nbsp;ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <u>SECTION 10.14</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.16&nbsp;&nbsp;&nbsp;&nbsp;<u>Currency</u>. Unless otherwise specified in this Agreement, all references to currency, monetary values and dollars set forth herein shall mean United States (U.S.) dollars and all payments hereunder shall be made in United States dollars.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.17&nbsp;&nbsp;&nbsp;<u>Counterparts</u>. This Agreement may be executed and delivered (including by facsimile or electronic transmission) in one or more counterparts, and by the different Parties in separate counterparts, each of which when executed shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement. Signatures of the Parties transmitted by electronic mail shall be deemed to be their original signatures for all purposes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Specific Performance</u>. Each Party acknowledges that, in view of the uniqueness of the securities referenced herein and the transactions contemplated by this Agreement, the other Party would not have an adequate remedy at law for money damages in the event that this Agreement has not been performed in accordance with its terms, and therefore agrees that the other Party shall be entitled to specific performance and injunctive or other equitable relief, without the necessity of proving the inadequacy of monetary damages as a remedy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.19&nbsp;&nbsp;&nbsp;<u>Waiver of Consequential Damages</u>. Notwithstanding any provision in this Agreement to the contrary, in no event shall any Party or its Affiliates, or their respective managers, members, shareholders or representatives, be liable hereunder at any time for punitive, incidental, consequential special or indirect damages, including loss of future profits, revenue or income, or loss of business reputation of any other Party or any of its Affiliates, whether in contract, tort (including negligence), strict liability or otherwise, and each Party hereby expressly releases each other Party, its Affiliates, and their respective managers, members, shareholders, partners, consultants, representatives, successors and assigns therefrom.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">10.20&nbsp;&nbsp;&nbsp;<u>Rules of Construction</u>. The Parties and their respective legal counsel participated in the preparation of this Agreement, and therefore, this Agreement shall be construed neither against nor in favor of any of the Parties, but rather in accordance with the fair meaning thereof. All definitions set forth in this Agreement are deemed applicable whether the words defined are used in this Agreement in the singular or in the plural, and correlative forms of defined terms have corresponding meanings. The term &#8220;including&#8221; is not limiting and means &#8220;including without limitation.&#8221; The term &#8220;or&#8221; has, except where otherwise indicated, the inclusive meaning represented by the phrase &#8220;and/or.&#8221; The words &#8220;hereof,&#8221; &#8220;herein,&#8221; &#8220;hereby,&#8221; &#8220;hereunder&#8221; and similar terms in this Agreement refer to this Agreement as a whole and not to any particular provision of this Agreement. Section, subsection, clause, schedule, annex and exhibit references are to this Agreement unless otherwise specified. Any reference to this Agreement shall include all alterations, amendments, changes, extensions, modifications, renewals, replacements, substitutions, and supplements thereto and thereof, as applicable. Whenever the context may require, any pronoun includes the corresponding masculine, feminine and neuter forms.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>[No further text appears; signature pages follow]</i></p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">14</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IN WITNESS WHEREOF, the Parties have executed this Agreement as of the day and year first above written.</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 774px; margin-left: auto; margin-right: auto;">

		<tr>
			<td style="vertical-align: top; width: 445px;">&nbsp;</td>
			<td style="vertical-align: top; width: 22px;">&nbsp;</td>
			<td style="vertical-align: top; width: 285px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 445px;">&nbsp;</td>
			<td colspan="2" style="vertical-align: top; width: 323px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NEXTDECADE CORPORATION</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 445px;">&nbsp;</td>
			<td colspan="2" style="vertical-align: top; width: 323px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 445px;">&nbsp;</td>
			<td colspan="2" style="vertical-align: top; width: 323px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 445px;">&nbsp;</td>
			<td style="vertical-align: top; width: 22px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 285px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 445px;">&nbsp;</td>
			<td colspan="2" style="vertical-align: top; width: 323px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Name: Matthew Schatzman</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 445px;">&nbsp;</td>
			<td colspan="2" style="vertical-align: top; width: 323px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Title: Chief Executive Officer</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 445px;">&nbsp;</td>
			<td colspan="2" style="vertical-align: top; width: 323px;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 764px; margin-left: auto; margin-right: auto;">

		<tr>
			<td style="vertical-align: top; width: 436.5px;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 321px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 436.5px;">&nbsp;</td>
			<td colspan="2" style="vertical-align: top; width: 321px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">PURCHASER</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 436.5px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 436.5px;">&nbsp;</td>
			<td style="vertical-align: top; width: 1px;">By:</td>
			<td style="vertical-align: top; width: 299px; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 436.5px;">&nbsp;</td>
			<td colspan="2" style="vertical-align: top; width: 321px;">Name:</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 436.5px;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 321px;">Title:</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 436.5px;">&nbsp;</td>
			<td colspan="2" style="vertical-align: top; width: 321px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 436.5px;">&nbsp;</td>
			<td colspan="2" style="vertical-align: top; width: 321px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 436.5px;">&nbsp;</td>
			<td colspan="2" style="vertical-align: top; width: 321px;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>Exhibit A</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ADDENDUM</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Reference is made to that certain Series C Convertible Preferred Stock Purchase Agreement (as amended, modified or supplemented from time to time, the &#8220;<u>Agreement</u>&#8221;) by and between NextDecade Corporation, a Delaware corporation (&#8220;<u>NextDecade</u>&#8221;), and [&#9679;], a [&#9679;], or a successor thereof. Each capitalized term used but not defined herein shall have the meaning given to it in the Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Upon execution and delivery of this Addendum by the undersigned, as provided in <u>Section</u>&nbsp;<u>10.9</u> of the Agreement, the undersigned hereby becomes the Purchaser with respect to [&#9679;] shares of Series C Preferred Stock, as applicable thereunder and bound thereby effective as of the date of the Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">By executing and delivering this Addendum, the undersigned represents and warrants, for itself and for the benefit of the Company, that:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:-36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as of the date of this Addendum, the undersigned has executed and delivered an Assumption and Joinder Agreement therefor (a copy of which is attached to this Addendum);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:-36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as of the date of this Addendum, with respect to each transferee that (i)&nbsp;is an individual, such transferee has all requisite authority to enter into this Addendum and to carry out the transactions contemplated by, and perform its respective obligation under, the Agreement and (ii)&nbsp;is not an individual, such transferee is duly organized, validly existing, and in good standing under the laws of the state of its organization, and has all requisite corporate, partnership, or limited liability company power and authority to enter into this Addendum and to carry out the transactions contemplated by, and perform its respective obligations under, the Agreement;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:-36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;assuming the due execution and delivery of the Agreement by NextDecade, the Addendum and the Agreement are legally valid and binding obligations of it, enforceable against it in accordance with its terms, except as may be limited by bankruptcy, insolvency or similar laws, or by equitable principles relating to or limiting creditors&#8217; rights generally; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:-36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as of the date of this Addendum, it is not aware of any event that, due to any fiduciary or other duty to any other person, would prevent it from taking any action required of it under the Agreement and this Addendum.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">By executing and delivering this Addendum to NextDecade, the undersigned agrees to be bound by all the terms of the Agreement with respect to [&#9679;] shares of Series C Preferred Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The undersigned acknowledges and agrees that once delivered to NextDecade, it may not revoke, withdraw, amend, change or modify this Addendum unless the Agreement has been terminated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">THIS ADDENDUM SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICTS OF LAW PRINCIPLES THAT WOULD REQUIRE THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This Addendum may be executed in one or more counterparts, each of which, when so executed, shall constitute the same instrument and the counterparts may be delivered by facsimile transmission or by electronic mail in portable document format (.pdf).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[Signature on Following Page]</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IN WITNESS WHEREOF, the Parties have caused this Addendum to be duly executed and delivered by their proper and duly authorized officers as of this [&#9679;] day of [&#9679;].</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:26.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:26.7%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:26.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:26.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">TRANSFEREE WHO BECOMES THE PURCHASER</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:26.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:26.7%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:26.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:26.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">[NAME]</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:26.7%;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:26.7%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:26.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:26.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">as a Purchaser</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:26.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:26.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Name:</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>Exhibit B</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ASSUMPTION AND JOINDER AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Reference is made to (i)&nbsp;that certain Series C Convertible Preferred Stock Purchase Agreement (as amended, modified or supplemented from time to time, the &#8220;<u>Agreement</u>&#8221;), dated as of [&#9679;], by and between NextDecade Corporation, a Delaware corporation (&#8220;<u>NextDecade</u>&#8221;), and [&#9679;], a [&#9679;], or a successor thereof, and (ii)&nbsp;that certain Addendum, dated as of [&#9679;] (the &#8220;<u>Transferor Addendum</u>&#8221;) submitted by [&#9679;], as transferor (the &#8220;<u>Transferor</u>&#8221;). Each capitalized term used but not defined herein shall have the meaning given to it in the Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As a condition precedent to becoming the Purchaser with respect to [&#9679;] shares of Series C Preferred Stock, the undersigned (the &#8220;<u>Transferee</u>&#8221;) hereby agrees to become bound by all the terms, conditions and obligations set forth in the Agreement and the Transferor Addendum, copies of which are attached hereto as Annex I. This Assumption and Joinder Agreement shall take effect and shall become an integral part of the Agreement and the Transferor Addendum immediately upon its execution, and the Transferee shall be deemed to be bound by all of the terms, conditions and obligations of the Agreement and the Transferor Addendum as of the date thereof. The Transferee shall hereafter be deemed to be the &#8220;Purchaser&#8221; with respect to [&#9679;] shares of Series C Preferred Stock and a &#8220;Party&#8221; for all purposes under the Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[Signatures on Following Page]</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">IN WITNESS WHEREOF, this Assumption and Joinder Agreement has been duly executed by each of the undersigned as of the date specified below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Date: [&#9679;]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 910px; margin-left: auto; margin-right: auto;">

		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Name of Transferor</p>
			</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Name of Transferee</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Authorized Signatory of Transferor</p>
			</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Authorized Signatory of Transferee</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(Type or Print Name and Title of Authorized Signatory)</p>
			</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(Type or Print Name and Title of Authorized Signatory)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Address of Transferee:</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Attn:</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Tel:</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Fax:</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">E-mail:</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 388px;">&nbsp;</td>
			<td style="vertical-align: top; width: 96px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 406px;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>Exhibit C</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CERTIFICATE OF DESIGNATIONS</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>OF</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SERIES C CONVERTIBLE PREFERRED STOCK</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[<i>see attached</i>]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>Exhibit D</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM OF WARRANT AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[<i>see attached</i>]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>Exhibit E</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>USE OF PROCEEDS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Proceeds from the Series C Preferred Equity Offering shall be used by the Company for development activities related to the liquefaction of natural gas and the sale of liquefied natural gas (&#8220;<u>LNG</u>&#8221;) in international markets, including:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:-18pt;">&#183;Development activities related to the Rio Grande LNG terminal facility at the Port of Brownsville in southern Texas, including activities and businesses reasonably complementary or ancillary thereto and reasonable extensions thereof; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:-18pt;">&#183;Development activities conducted in overseas locations in direct support of the Company&#8217;s businesses as set forth above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:-18pt;">&#183;Development of the Company&#8217;s proprietary processes and carbon capture and storage solution and business incident thereto<b>.</b></p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>Exhibit F</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>REGISTRATION RIGHTS AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[<i>see attached</i>]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>Exhibit G</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PURCHASER NOTICE ADDRESS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">[__________________]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">[__________________]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">[__________________]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">[__________________]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ex_234785.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html><head><meta charset="utf-8"><meta name="format-detection" content="telephone=no"><!--Created on 3/17/2021 9:30:58 AM --><meta name="generator" content="RDG HTML Converter 3.4.3.0">
	<title>ex_234785.htm</title>

</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>Exhibit 10.2</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>REGISTRATION RIGHTS AGREEMENT</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This REGISTRATION RIGHTS AGREEMENT (this &#8220;<u>Agreement</u>&#8221;), dated as of [&#9679;], is made and entered into by and among NextDecade Corporation, a Delaware corporation (the &#8220;<u>Company</u>&#8221;), and certain entities listed on&nbsp;<u>Schedule I</u> (the &#8220;<u>Holders</u>&#8221;) attached hereto. Capitalized terms used but not otherwise defined in this Agreement shall have the meaning ascribed to such term in the Purchase Agreement (as defined below).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>RECITALS:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">WHEREAS, reference is made to that certain Series C Convertible Preferred Stock Purchase Agreement, dated as of [&#9679;] (the &#8220;<u>Purchase Agreement</u>&#8221;), by and between the Company and the Holders;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">WHEREAS, pursuant to Section&nbsp;2 of the Purchase Agreement, the Company issued [&#9679;] Preferred Shares (as defined herein) (which include associated Warrants) to the Holders;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">WHEREAS, the Company and the Holders wish to determine registration rights with respect to the Preferred Shares and the Warrants (and underlying securities).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NOW, THEREFORE, in consideration of the premises and the mutual promises and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IT IS AGREED as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">Section 1.<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>DEFINITIONS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">As used in this Agreement, the following terms shall have the following meanings:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Agreement</u>&#8221; shall have the meaning set forth in the introductory paragraph hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Board</u>&#8221; shall mean the Board of Directors of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Business Day</u>&#8221; shall mean any Monday, Tuesday, Wednesday, Thursday, or Friday that is not a day on which banking institutions in New York or Texas are authorized or obligated by applicable law, regulation or executive order to close.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Commission</u>&#8221; shall mean the United States Securities and Exchange Commission.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Common Stock</u>&#8221; shall mean the common stock of the Company, par value $0.0001 per share.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Company</u>&#8221; shall have the meaning set forth in the introductory paragraph hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Controlling Person</u>&#8221; shall have the meaning set forth in Section&nbsp;5(a) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Demand Notice</u>&#8221; shall have the meaning set forth in Section&nbsp;2(a)(i) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Demand Registration</u>&#8221; shall have the meaning set forth in Section&nbsp;2(b)(i) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Demand Registratio</u>n&#8221; Statement shall have the meaning set forth in Section&nbsp;2(b)(i) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Depositary</u>&#8221; shall mean The Depository Trust Company, or any other depositary appointed by the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Effectiveness Deadline</u>&#8221; shall have the meaning set forth in Section&nbsp;2(a)(i) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>End of Suspension Notice</u>&#8221; shall have the meaning set forth in Section&nbsp;3(b) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Equity Securities</u>&#8221; means (a) any capital stock, partnership, membership, joint venture or other ownership or equity interest, participation or securities in or of any Person (whether voting or non-voting, whether preferred, common or otherwise, and including any stock appreciation, contingent interest or similar right), and (b) any option, warrant, security or other right (including debt securities) directly or indirectly convertible into or exercisable or exchangeable for, or otherwise to acquire directly or indirectly, any stock, interest, participation or security described in clause&nbsp;(a) above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Exchange Act</u>&#8221; shall mean the Securities Exchange Act of 1934, as amended (or any corresponding provision of succeeding law), and the rules and regulations thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>FINRA</u>&#8221; shall mean the Financial Industry Regulatory Authority.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Holder</u>&#8221; shall mean each holder of Equity Securities of the Company, listed in Schedule I attached hereto, in its capacity as a holder of Registrable Securities, and its direct and indirect transferees. For purposes of this Agreement, the Company may deem and treat the registered holder of a Registrable Security as the Holder and absolute owner thereof, unless notified to the contrary in writing by the registered Holder thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Holders</u>&#8217;<u> Minimum Amount</u>&#8221; shall have the meaning set forth in Section&nbsp;2(a)(iii) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Legal Proceeding</u>&#8221; shall mean any action, suit, hearing, claim, lawsuit, litigation, investigation (formal or informal), inquiry, arbitration or proceeding (in each case, whether civil, criminal or administrative or at law or in equity) by or before a governmental or legal entity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Liabilities</u>&#8221; shall have the meaning set forth in Section&nbsp;5(a)(i) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Majority</u>&#8221; with respect to any group of Registrable Securities, means more than half the total number of shares of Common Stock included in such group and, for the avoidance of doubt, does not include the number of Preferred Shares or Warrants in any such group.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Maximum Threshold</u>&#8221; shall have the meaning set forth in Section&nbsp;2(d)(i) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Person</u>&#8221; shall mean any individual, partnership, corporation, limited liability company, joint venture, association, trust, unincorporated organization or other governmental or legal entity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Piggyback Registration</u>&#8221; shall have the meaning set forth in Section&nbsp;2(c)(i) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Preferred Shares</u>&#8221; shall mean the shares of Series C Convertible Preferred Stock of the Company issued pursuant to the Purchase Agreement (including any shares of Series C Convertible Preferred Stock of the Company issued as dividends thereon).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Prospectus</u>&#8221; means the prospectus or prospectuses included in any Registration Statement (including without limitation, any prospectus subject to completion and a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under the Securities Act and any term sheet filed pursuant to Rule 434 under the Securities Act), as amended or supplemented by any prospectus supplement with respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement and by all other amendments and supplements to the prospectus, including post-effective amendments and all material incorporated by reference or deemed to be incorporated by reference in such prospectus or prospectuses.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Purchase Agreement</u>&#8221; shall have the meaning set forth in the Recitals hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Registrable Securities</u>&#8221; with respect to any Holder, shall mean at any time (i) all of the shares of Common Stock into which the Preferred Shares are convertible, and (ii) all shares of Common Stock issuable upon the exercise of the Warrants, together with any class of equity securities of the Company or of a successor to the entire business of the Company which are issued in exchange for the Common Stock, the Preferred Shares or the Warrants;&nbsp;<u>provided</u>,&nbsp;<u>however</u>, that such Registrable Securities shall cease to be Registrable Securities with respect to any Holder upon the earliest to occur of (a)&nbsp;the date on which a Registration Statement with respect to the sale of such Holder&#8217;s Registrable Securities shall have been declared effective under the Securities Act and all of such Holder&#8217;s Registrable Securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement and (b)&nbsp;the date on which such securities shall have ceased to be outstanding.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Registration Expenses</u>&#8221; shall mean (a) the fees and disbursements of counsel and independent public accountants for the Company incurred in connection with the Company&#8217;s performance of or compliance with this Agreement, including the expenses of any special audits or &#8220;comfort&#8221; letters required by or incident to such performance and compliance, and any premiums and other costs of policies of insurance obtained by the Company against liabilities arising out of the sale of any securities, (b) all registration, filing and stock exchange fees, all fees and expenses of complying with securities or &#8220;blue sky&#8221; laws, all fees and expenses of custodians, transfer agents and registrars, all printing expenses, messenger and delivery expenses and any fees and disbursements of Selling Holders&#8217; Counsel, (c) expenses relating to any analyst or investor presentations or any &#8220;road shows&#8221; undertaken in connection with the registration, marketing or selling of the Registrable Securities, (d) fees and expenses in connection with any review by FINRA of the underwriting arrangements or other terms of the offering, and all fees and expenses of any &#8220;qualified independent underwriter,&#8221; including the reasonable fees and expenses of any counsel thereto, (e) costs of printing and producing any agreements among underwriters, underwriting agreements, any &#8220;blue sky&#8221; or legal investment memoranda and any selling agreements and other documents in connection with the offering, sale or delivery of the Registrable Securities;&nbsp;<u>provided</u>,&nbsp;<u>however</u>, that &#8220;Registration Expenses&#8221; shall not include any out-of-pocket expenses of the Holders (other than as set forth in clause (b) above), transfer taxes, underwriting or brokerage commissions or discounts associated with effecting any sales of Registrable Securities that may be offered, which expenses shall be borne by each Holder of Registrable Securities on a pro rata basis with respect to the Registrable Securities so sold.&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Registration Statement</u>&#8221; means any registration statement of the Company filed with the Commission under the Securities Act which covers any of the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus, amendments and supplements to such Registration Statement, including post-effective amendments, all exhibits and all materials incorporated by reference or deemed to be incorporated by reference in such Registration Statement.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Securities Act</u>&#8221; shall mean the Securities Act of 1933, as amended (or any corresponding provision of succeeding law), and the rules and regulations thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Selling Holders</u>&#8217;<u> Counsel</u>&#8221; shall mean counsel for the Holders that is selected by the Holders holding a Majority of the Registrable Securities included in a Registration Statement and that is reasonably acceptable to the Company.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Shelf Registration Statement</u>&#8221; shall have the meaning set forth in Section&nbsp;2(a)(i) of this Agreement.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Suspension Event</u>&#8221; shall have the meaning set forth in Section&nbsp;3(b) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Suspension Notice</u>&#8221; shall have the meaning set forth in Section&nbsp;3(a) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Underwritten Demand Holders</u>&#8221; shall have the meaning set forth in Section&nbsp;2(a)(iii) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Underwritten Offering</u>&#8221; shall mean a sale of securities of the Company to an underwriter or underwriters for reoffering to the public.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Warrants</u>&#8221; shall mean the warrants to purchase shares of Common Stock provided for in the Purchase Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Withdrawn Demand Registration</u>&#8221; shall have the meaning set forth in Section 2(b)(iv) of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">Section 2.<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>SHELF REGISTRATIONS, DEMAND REGISTRATIONS AND PIGGYBACK REGISTRATIONS</u></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Shelf Registration.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;<u>Filing</u>. The Company shall, as soon as practicable after the date that is ninety (90) days from the date of this Agreement, but in any event within thirty (30) days after the date that is ninety (90) days from the date of this Agreement, file a Registration Statement under the Securities Act to permit the public resale of all the Registrable Securities held by the Holders from time to time as permitted by Rule 415 under the Securities Act (or any successor or similar provision adopted by the Commission then in effect) (the &#8220;<u>Shelf Registration Statement</u>&#8221;) on the terms and conditions specified in this Section 2(a) and shall use its reasonable best efforts to cause such Shelf Registration Statement to be declared effective as soon as practicable after the filing thereof, but in any event no later than the earlier of (i) ninety (90) days (or one hundred and twenty (120) days if the Commission notifies the Company that it will &#8220;review&#8221; the Shelf Registration Statement) after the date that is ninety (90) days from the date of this Agreement and (ii) the tenth (10th) business day after the date the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Shelf Registration Statement will not be &#8220;reviewed&#8221; or will not be subject to further review (such earlier date, the &#8220;<u>Effectiveness Deadline</u>&#8221;). The Shelf Registration Statement filed with the Commission pursuant to this Section 2(a) shall be on Form S-3 or, if Form S-3 is not then available to the Company, on Form S-1 or such other form of registration statement as is then available to effect a registration for resale of such Registrable Securities, covering such Registrable Securities, and shall contain a prospectus in such form as to permit any Holder to sell such Registrable Securities pursuant to Rule 415 under the Securities Act (or any successor or similar provision adopted by the Commission then in effect) at any time beginning on the effective date for such Shelf Registration Statement. A Shelf Registration Statement filed pursuant to this Section 2(a) shall provide for the resale pursuant to any method or combination of methods legally available to, and requested by, the Holders.&nbsp; As soon as practicable following the effective date of a Shelf Registration Statement filed pursuant to this Section 2(a), but in any event within three (3) business days of such date, the Company shall notify the Holders of the effectiveness of such Registration Statement. When effective, a Shelf Registration Statement filed pursuant to this Section 2(a) (including the documents incorporated therein by reference) will comply as to form in all material respects with all applicable requirements of the Securities Act and the Exchange Act and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading (in the case of any Prospectus contained in such Shelf Registration Statement, in the light of the circumstances under which such statement is made).&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<u>Continued Effectiveness</u>. The Company shall use its reasonable best efforts to cause the Shelf Registration Statement to remain effective and to be supplemented and amended to the extent necessary to ensure that such Shelf Registration Statement is available or, if not available, that another registration statement is available, for the resale of all the Registrable Securities held by the Holders until the earliest of (A) the date all such Registrable Securities have ceased to be Registrable Securities and (B) the date all such Registrable Securities covered by such Shelf Registration Statement can be sold publicly without restriction or limitation under Rule 144 under the Securities Act and without the requirement to be in compliance with Rule 144(c)(1) under the Securities Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;<u>Underwritten Offering and Selection of Underwriters</u>. If the Holders of at least twenty percent (20%) of the then outstanding number of Registrable Securities held by the Holders (the &#8220;<u>Underwritten Demand Holders</u>&#8221;) elect to dispose of Registrable Securities under a Shelf Registration Statement or other Registration Statement pursuant to an Underwritten Offering of all or part of such Registrable Securities that are registered by such Shelf Registration Statement or other Registration Statement and reasonably expect aggregate gross proceeds in excess of $[&#9679;] (the &#8220;<u>Holders</u>&#8217;<u> Minimum Amount</u>&#8221;) from such Underwritten Offering, then the Company shall, upon the written demand of such Underwritten Demand Holder(s), enter into an underwriting agreement in a form as is customary in Underwritten Offerings of securities by the Company with the managing underwriter or underwriters selected by the Underwritten Demand Holders and shall take all such other reasonable actions as are requested by the managing underwriter or underwriters in order to expedite or facilitate the disposition of such Registrable Securities; provided, however, that the Company shall have no obligation to facilitate or participate in more than two (2) Underwritten Offerings in any twelve (12)-month period, pursuant to this Section 2(a) or Section 2(b).&nbsp; In connection with any Underwritten Offering contemplated by this Section 2(a) or Section 2(b), the underwriting agreement into which each Holder and the Company shall enter shall contain such representations, covenants, indemnities and other rights and obligations as are customary in underwritten offerings of securities by the Company. No&nbsp;Holder shall be required to make any representations or warranties to or agreements with the Company or the underwriters other than representations, warranties or agreements regarding such Holder&#8217;s authority to enter into such underwriting agreement and to sell, and its ownership of, the securities being registered on its behalf, its intended method of distribution, the accuracy of information provided by a Holder specifically for use in the Registration Statement or Prospectus, and any other representation required by law; <u>provided</u>, that each Holder other than the Underwritten Demand Holders shall be afforded five (5) Business Days to decide to include in any such Underwritten Offering up to its pro rata share of Registrable Securities based on the percentage of Registrable Securities owned by the Underwritten Demand Holders that are included in such Underwritten Offering; <u>provided further</u>, that to the extent such other Holders wish to include additional Registrable Securities held by such Holders in an Underwritten Offering in excess of their allotted proportion, such other Holders may request, within the same five (5) Business Day notice period outlined above, that the Underwritten Demand Holders consider including such additional shares as Registrable Securities.&nbsp; Upon receipt of such notice, and subject to Section 2(d)(i), the Underwritten Demand Holders may elect to include or exclude such additional Registrable Securities from the Underwritten Offering in their sole and absolute discretion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Demand Registrations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;<u>Right to Request Registration</u>. So long as the Company does not have an effective Shelf Registration Statement with respect to the Registrable Securities, the Holders of at least twenty percent (20%) of the then-outstanding number of Registrable Securities (the &#8220;<u>Demand Holders</u>&#8221;) may request registration under the Securities Act of all or part of their Registrable Securities with an anticipated aggregate offering price of at least $[&#9679;] at any time and from time to time (&#8220;<u>Demand Registration</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Within seven (7) Business Days after receipt of any such request for Demand Registration, the Company shall give written notice of such request to each other Holder of Registrable Securities, if any, and shall, subject to the provisions of Section&nbsp;2(d)(i) hereof, include in such registration up to the pro rata share Registrable Securities of each such Holder based on the percentage Registrable Securities owned by the Demand Holders that are to be included in the Demand Registration and with respect to which the Company has received written requests for inclusion therein within five (5) Business Days after the receipt of the Company&#8217;s notice; <u>provided</u>, that to the extent such other Holders wish to include additional Registrable Securities held by such Holders in the Demand Registration in excess of their allotted proportion, such other Holders may request, within the same five (5) Business Day notice period outlined above, that the Demand Holders consider including such additional shares as Registrable Securities. Upon receipt of such notice, and subject to Section&nbsp;2(d)(i), the Demand Holders may elect to include or exclude such additional Registrable Securities from the Demand Registration their sole and absolute discretion. The Company shall use its reasonable best efforts to file with the Commission following receipt of any such request for Demand Registration (but in no event more than thirty (30) days following receipt of such request) one or more registration statements with respect to all such Registrable Securities with respect to which the Company has received written requests for inclusion therein in accordance with this paragraph under the Securities Act (the &#8220;<u>Demand Registration Statement</u>&#8221;). The Company shall use its reasonable best efforts to cause such Demand Registration Statement to be declared effective by the Commission as soon as practicable after the filing thereof. The Demand Registration Statement shall be on an appropriate form and the Registration Statement and any form of Prospectus included therein (or Prospectus supplement relating thereto) shall reflect the plan of distribution or method of sale as the Holders of shares registered on such Registration Statement may from time to time notify the Company. Subject to the foregoing and to Section&nbsp;2(d)(i), following the receipt by the Company of any request for Demand Registration, all of the Registrable Securities of any Holder electing to register Registrable Securities in accordance with this paragraph shall be included in the Demand Registration Statement without any further action by any Holder. The Demand Holders who have requested a Demand Registration may cause the Company to postpone or withdraw the filing or the effectiveness of such Demand Registration at any time in their sole discretion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<u>Restrictions on Demand Registrations</u>. The Company shall not be obligated to effect any Demand Registration within ninety (90) days after the effective date of (A) a previous Demand Registration or (B) a previous registration under which any Holder or Holders had piggyback rights pursuant to Section&nbsp;2(c) hereof and in which the Holders exercising such piggyback rights were permitted to register, and sold, at least fifty percent (50%) of the Registrable Securities requested to be included therein. In addition, the Company shall not be obligated to effect any Demand Registration after the Company has effected two (2) Demand Registrations in any twelve (12)-month period if all such registrations effected by the Company have been declared and ordered effective.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;<u>Underwritten Offering and Selection of Underwriters</u>. If the Underwritten Demand Holders elect to dispose of Registrable Securities under a Demand Registration pursuant to an Underwritten Offering, then each other Holder shall be afforded the right to include in any such Underwritten Offering up to its pro rata share of Registrable Securities based on the percentage of Registrable Securities owned by the Underwritten Demand Holders that are included in such Underwritten Offering. If any of the Registrable Securities covered by a Demand Registration hereof are to be sold in an Underwritten Offering, then the Underwritten Demand Holders shall have the right to select the managing underwriter or underwriters to administer any such Underwritten Offering.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;<u>Effective Period of Demand Registrations</u>. After any Demand Registration Statement filed pursuant to this Agreement has become effective, the Company shall use its reasonable best efforts to keep such Demand Registration Statement effective for a period equal to one hundred eighty (180) days from the date on which the Commission declares such Demand Registration Statement effective (or if such Demand Registration Statement is not effective during any period within such one hundred eighty (180) days, such 180-day period shall be extended by the number of days during such period when such Demand Registration Statement is not effective), or such shorter period that shall terminate when all of the Registrable Securities covered by such Demand Registration Statement have been sold pursuant to such Demand Registration. If the Company shall withdraw or reduce the number of shares of Registrable Securities that is subject to any Demand Registration pursuant to Section&nbsp;2(d)(i) (a &#8220;<u>Withdrawn Demand Registration</u>&#8221;), the Demanding Holders of the Registrable Securities remaining unsold and originally covered by such Withdrawn Demand Registration shall be entitled to a replacement Demand Registration that (subject to the provisions of this Section&nbsp;2(b)) the Company shall use its reasonable best efforts to keep effective for a period commencing on the effective date of such Demand Registration and ending on the earlier to occur of the date (i) that is one hundred eighty (180) days from the effective date of such Demand Registration and (ii) on which all of the Registrable Securities covered by such Demand Registration have been sold. Such additional Demand Registration otherwise shall be subject to all of the provisions of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Piggyback Registrations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;<u>Right to Piggyback</u>. Whenever the Company proposes (i) to register any of its Common Stock under the Securities Act (other than a shelf registration statement on Form S-3 or a registration statement on Form S-8 or on Form S-4 or any similar successor forms thereto), whether for its own account or for the account of one or more stockholders of the Company, and the registration form to be used may be used for any registration of Registrable Securities (a &#8220;<u>Piggyback Registration</u>&#8221;), or (ii) to file a prospectus supplement to an effective shelf registration statement relating to the sale of equity securities of the Company, the Company shall give prompt (but in no event less than ten (10) days before the anticipated filing date of such registration statement or such prospectus supplement) written notice to all Holders of its intention to effect such a registration or filing, which notice shall (A) describe the amount and type of securities to be included in such offering, the intended method of distribution, and the name of the proposed managing underwriter, if any, in such offering, and (B) offer to all Holders of Registrable Securities the opportunity to register the same of such number of Registrable Securities as such Holders may request in writing within five (5) Business Days after receipt of such written notice from the Company. The Company shall, subject to Sections&nbsp;2(d)(ii) and 2(d)(iii), include in such registration or offering all Registrable Securities with respect to which the Company has received written requests for inclusion therein within five (5) Business Days after the receipt of the Company&#8217;s notice. The Company may postpone or withdraw the filing or the effectiveness of a Piggyback Registration at any time in its sole discretion upon reasonable notice to any participating Holders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<u>Withdrawal; Opt-Out</u>. Any Holder may elect to withdraw such Holder&#8217;s request for inclusion of Registrable Securities in any Piggyback Registration by giving written notice to the Company of such request to withdraw prior to the effectiveness of the Registration Statement. The Company (whether on its own determination or as the result of a withdrawal by Persons making a demand pursuant to written contractual obligations) may withdraw a Registration Statement at any time prior to the effectiveness of the Registration Statement without thereby incurring any liability to the Holders of Registrable Securities. Notwithstanding any such withdrawal, the Company shall pay all expenses incurred by the Holders in connection with such Piggyback Registration as provided in Section&nbsp;8(d). Any Holder may deliver written notice (an &#8220;<u>Opt-Out Notice</u>&#8221;) to the Company requesting that such Holder not receive notice from the Company of any proposed Piggyback Registration; <i>provided, however,</i> that such Holder may later revoke any such Opt-Out Notice in writing. Following receipt of an Opt-Out Notice from a Holder (unless subsequently revoked by such Holder), the Company shall not be required to deliver any notice to such Holder pursuant to this Section 2(c) and such Holder shall no longer be entitled to participate in a Piggyback Registration by the Company pursuant to this Section 2(c) until such Holder&#8217;s Opt-Out Notice is revoked.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;<u>Selection of Underwriters</u>. If any of the Registrable Securities of the Holders covered by a Piggyback Registration hereof are to be sold in an Underwritten Offering, then the Company shall have the right to select the managing underwriter or underwriters to administer any such offering.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Priority.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;<u>Priority on Shelf and Demand Registrations</u><i>.</i> If the managing underwriters of a requested Demand Registration or an Underwritten Offering under a Shelf Registration Statement, advise the Company in writing that, in their opinion, the number of Registrable Securities requested to be included in such Demand Registration Statement or Shelf Registration Statement exceeds the number that can be sold in such offering and/or that the number of Registrable Securities proposed to be included in any such registration would adversely affect the price per share of the Company&#8217;s equity securities to be sold in such offering (such maximum number of securities or Registrable Securities, as applicable, the &#8220;<u>Maximum Threshold</u>&#8221;), the underwriting shall be allocated among the Company and all Holders as follows: (A) first, the shares comprised of Registrable Securities, as to which registration has been requested and is required pursuant to the registration rights hereof, based on the amount of such Registrable Securities initially requested to be registered by such Holders that can be sold without exceeding the Maximum Threshold; (B) second, to the extent that the Maximum Threshold has not been reached under the foregoing clause (A), the shares of Common Stock or other securities that the Company desires to sell that can be sold without exceeding the Maximum Threshold; and (C) third, to the extent the Maximum Threshold has not been reached under the foregoing clauses (A) and (B), any additional Registrable Securities of Holders other than the Demand Holders or Underwritten Demand Holders as to which registration has been requested and that the Demand Holders or Underwritten Demand Holders, as applicable, determine, in their sole discretion, can be sold.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<u>Priority on Primary Registrations</u><i>.</i> If a Piggyback Registration is an underwritten primary registration on behalf of the Company, and the managing underwriters advise the Company in writing that in their opinion the number of securities requested to be included in such registration exceeds the Maximum Threshold, the underwriting shall be allocated among the Company and all Holders as follows: (A)&nbsp;first, the shares of Common Stock or other securities that the Company desires to sell that can be sold without exceeding the Maximum Threshold; and (B)&nbsp;second, to the extent that the Maximum Threshold has not been reached under the foregoing clause&nbsp;(A), the shares comprised of Registrable Securities, as to which registration has been requested pursuant to the registration rights hereof, based on the amount of such Registrable Securities initially requested to be registered by such Holders that can be sold without exceeding the Maximum Threshold.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, if the Holders of at least twenty percent (20%) of the then-outstanding number of Registrable Securities wish to engage in an underwritten block trade off of an effective Shelf Registration Statement, Demand Registration Statement or Piggyback Registration, such Holders may notify the Company of the block trade offering on the day such offering is to commence and the Company shall as expeditiously as possible use its reasonable best efforts to facilitate such offering (which may close as early as three (3)&nbsp;Business Days after the date it commences); <u>provided</u> that in the case of such underwritten block trade, only such Holders shall have a right to notice of and to participate in such offering.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">Section 3.<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>BLACK-OUT PERIODS</u></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding Section&nbsp;2, and subject to the provisions of this Section&nbsp;3, the Company shall be permitted, in limited circumstances, to suspend the use, from time to time, of the Prospectus that is part of a Shelf Registration Statement (and therefore suspend sales of the Registrable Securities under such Shelf Registration Statement), by providing written notice (a &#8220;<u>Suspension Notice</u>&#8221;) to the Selling Holders&#8217; Counsel, if any, and the Holders, for such times as the Company reasonably may determine is necessary and advisable (but in no event for more than an aggregate of ninety (90) days in any rolling twelve (12)-month period commencing on the date of this Agreement or more than forty-five (45) consecutive days, except as a result of a refusal by the Commission to declare any post-effective amendment to the Shelf Registration Statement effective after the Company has used all reasonable best efforts to cause the post-effective amendment to be declared effective by the Commission, in which case, the Company must terminate the black-out period immediately following the effective date of the post-effective amendment) if either of the following events shall occur: (i)&nbsp;a majority of the Board determines in good faith that (A)&nbsp;the offer or sale of any Registrable Securities would materially impede, delay or interfere with any proposed financing, offer or sale of securities, acquisition, corporate reorganization or other material transaction involving the Company, (B)&nbsp;after the advice of counsel, the sale of Registrable Securities pursuant to the Shelf Registration Statement would require disclosure of non-public material information not otherwise required to be disclosed under applicable law, and (C)&nbsp;(x)&nbsp;the Company has a bona fide business purpose for preserving the confidentiality of such transaction, (y)&nbsp;disclosure would have a material adverse effect on the Company or the Company&#8217;s ability to consummate such transaction, or (z)&nbsp;such transaction renders the Company unable to comply with Commission requirements, in each case under circumstances that would make it impractical or inadvisable to cause the Shelf Registration Statement (or such filings) to become effective or to promptly amend or supplement the Shelf Registration Statement on a post-effective basis, as applicable; or (ii)&nbsp;a majority of the Board determines in good faith, upon the advice of counsel, that it is in the Company&#8217;s best interest or it is required by law, rule or regulation to supplement the Shelf Registration Statement or file a post-effective amendment to the Shelf Registration Statement in order to ensure that the Prospectus included in the Shelf Registration Statement (1)&nbsp;contains the information required under Section&nbsp;10(a)(3) of the Securities Act; (2)&nbsp;discloses any facts or events arising after the effective date of the Shelf Registration Statement (or of the most recent post-effective amendment) that, individually or in the aggregate, represents a fundamental change in the information set forth therein; or (3)&nbsp;discloses any material information with respect to the plan of distribution that was not disclosed in the Shelf Registration Statement or any material change to such information. Upon the occurrence of any such suspension, the Company shall use its reasonable best efforts to cause the Shelf Registration Statement to become effective or to promptly amend or supplement the Shelf Registration Statement on a post-effective basis or to take such action as is necessary to make resumed use of the Shelf Registration Statement as soon as possible.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the case of an event that causes the Company to suspend the use of a Shelf Registration Statement as set forth in paragraph&nbsp;(a) above (a &#8220;<u>Suspension Event</u>&#8221;), the Company shall give a Suspension Notice to the Selling Holders&#8217; Counsel, if any, and the Holders to suspend sales of the Registrable Securities and such Suspension Notice shall state generally the basis for the notice and that such suspension shall continue only for so long as the Suspension Event or its effect is continuing and the Company is using its reasonable best efforts and taking all reasonable steps to terminate suspension of the use of the Shelf Registration Statement as promptly as possible. A Holder shall not effect any sales of the Registrable Securities pursuant to such Shelf Registration Statement (or such filings) at any time after it has received a Suspension Notice from the Company and prior to receipt of an End of Suspension Notice (as defined below). If so directed by the Company, each Holder will deliver to the Company (at the expense of the Company) all copies other than permanent file copies then in such Holder&#8217;s possession of the Prospectus covering the Registrable Securities at the time of receipt of the Suspension Notice. The Holders may recommence effecting sales of the Registrable Securities pursuant to the Shelf Registration Statement (or such filings) following further written notice to such effect (an &#8220;<u>End of Suspension Notice</u>&#8221;) from the Company, which End of Suspension Notice shall be given by the Company to the Holders and to the Selling Holders&#8217; Counsel, if any, promptly following the conclusion of any Suspension Event and its effect.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any provision herein to the contrary, if the Company shall give a Suspension Notice with respect to any Shelf Registration Statement pursuant to this Section&nbsp;3, the Company agrees that it shall extend the period of time during which such Shelf Registration Statement shall be maintained effective pursuant to this Agreement by the number of days during the period from the date of receipt by the Holders of the Suspension Notice to and including the date of receipt by the Holders of the End of Suspension Notice and provide copies of the supplemented or amended Prospectus necessary to resume sales, with respect to each Suspension Event; <u>provided</u> that such period of time shall not be extended beyond the date that Common Stock covered by such Shelf Registration Statement are no longer Registrable Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">Section 4.<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>REGISTRATION PROCEDURES</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;In connection with the filing of any Registration Statement or sale of Registrable Securities as provided in this Agreement, the Company shall use its reasonable best efforts to, as expeditiously as reasonably practicable:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;prepare and file with the Commission the Registration Statement, within the relevant time period specified in Section&nbsp;2, on the appropriate form under the Securities Act, which form, subject to Section 2(a), (1) shall be selected by the Company, (2)&nbsp;shall be available for the registration and sale of the Registrable Securities by the selling Holders thereof, (3)&nbsp;shall comply as to form in all material respects with the requirements of the applicable form and include or incorporate by reference all financial statements required by the Commission to be filed therewith or incorporated by reference therein, and (4)&nbsp;shall comply in all respects with the requirements of Regulation S-T under the Securities Act, and otherwise comply with its obligations under Section&nbsp;2 hereof;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;prepare and file with the Commission such amendments and post-effective amendments to each Registration Statement as may be necessary under applicable law to keep such Registration Statement effective for the applicable period; and cause each Prospectus to be supplemented by any required Prospectus supplement, and as so supplemented to be filed pursuant to Rule&nbsp;424 (or any similar provision then in force) under the Securities Act and comply with the provisions of the Securities Act, the Exchange Act and the rules and regulations thereunder applicable to them with respect to the disposition of all securities covered by each Registration Statement during the applicable period in accordance with the intended method or methods of distribution by the selling Holders thereof;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp; (1)&nbsp;notify each Holder of Registrable Securities, at least five&nbsp;(5) Business Days after filing, that a Registration Statement with respect to the Registrable Securities has been filed and advise such Holders that the distribution of Registrable Securities will be made in accordance with any method or combination of methods legally available by the Holders of any and all Registrable Securities; (2)&nbsp;furnish to each Holder of Registrable Securities and to each underwriter of an Underwritten Offering of Registrable Securities, if any, without charge, as many copies of each Prospectus, including each preliminary Prospectus, and any amendment or supplement thereto and such other documents as such Holder or underwriter may reasonably request, including financial statements and schedules in order to facilitate the public sale or other disposition of the Registrable Securities; and (3)&nbsp;hereby consent to the use of the Prospectus or any amendment or supplement thereto by each of the selling Holders of Registrable Securities in connection with the offering and sale of the Registrable Securities covered by the Prospectus or any amendment or supplement thereto;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;use its reasonable best efforts to register or qualify the Registrable Securities under all applicable state securities or &#8220;blue sky&#8221; laws of such jurisdictions as any Holder of Registrable Securities covered by a Registration Statement and each underwriter of an Underwritten Offering of Registrable Securities shall reasonably request by the time the applicable Registration Statement is declared effective by the Commission, and do any and all other acts and things which may be reasonably necessary or advisable to enable each such Holder and underwriter to consummate the disposition in each such jurisdiction of such Registrable Securities owned by such Holder; <u>provided</u>, <u>however</u>, that the Company shall not be required to (1) qualify as a foreign corporation or as a dealer in securities in any jurisdiction where it would not otherwise be required to qualify but for this Section&nbsp;4(a)(iv), or (2) take any action which would subject it to general service of process or taxation in any such jurisdiction where it is not then so subject;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(v)&nbsp;&nbsp;&nbsp;&nbsp;immediately notify each Holder of Registrable Securities under a Registration Statement and, if requested by such Holder, confirm such advice in writing promptly at the address determined in accordance with Section&nbsp;8(f) of this Agreement (1)&nbsp;when a Registration Statement has become effective and when any post-effective amendments and supplements thereto become effective, (2)&nbsp;of any request by the Commission or any state securities authority for post-effective amendments and supplements to a Registration Statement and Prospectus or for additional information after the Registration Statement has become effective, (3)&nbsp;of the issuance by the Commission or any state securities authority of any stop order suspending the effectiveness of a Registration Statement or the initiation of any proceedings for that purpose, (4)&nbsp;if, between the effective date of a Registration Statement and the closing of any sale of Registrable Securities covered thereby, the representations and warranties of the Company contained in any underwriting agreement, securities sales agreement or other similar agreement, if any, relating to the offering cease to be true and correct in all material respects, (5)&nbsp;of the happening of any event or the discovery of any facts during the period a Registration Statement is effective as a result of which such Registration Statement or any document incorporated by reference therein contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading or, in the case of the Prospectus, contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading (which information shall be accompanied by an instruction to suspend the use of the Registration Statement and the Prospectus (such instruction to be provided in the same manner as a Suspension Notice) until the requisite changes have been made, at which time notice of the end of suspension shall be delivered in the same manner as an End of Suspension Notice), (6)&nbsp;of the receipt by the Company of any notification with respect to the suspension of the qualification of the Registrable Securities, for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose and (7)&nbsp;of the filing of a post-effective amendment to such Registration Statement;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;furnish Selling Holders&#8217; Counsel, if any, copies of any comment letters relating to the selling Holders received from the Commission or any other request by the Commission or any state securities authority for amendments or supplements to a Registration Statement and Prospectus or for additional information relating to the selling Holders;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(vii)&nbsp;&nbsp;&nbsp;&nbsp;make every reasonable effort to obtain the withdrawal of any order suspending the effectiveness of a Registration Statement at the earliest possible moment;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(viii)&nbsp;&nbsp;&nbsp;&nbsp;furnish to each Holder of Registrable Securities, and each underwriter, if any, without charge, at least one conformed copy of each Registration Statement and any post-effective amendment thereto, including financial statements and schedules (without documents incorporated therein by reference and all exhibits thereto, unless requested);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(ix)&nbsp;&nbsp;&nbsp;&nbsp;cooperate with the selling Holders to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold and not bearing any restrictive legends; and enable such Registrable Securities to be in such denominations and registered in such names as the selling Holders or the underwriters, if any, may reasonably request at least two (2) Business Days prior to the closing of any sale of Registrable Securities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(x)&nbsp;&nbsp;&nbsp;&nbsp;upon the occurrence of any event or the discovery of any facts, as contemplated by Sections&nbsp;4(a)(v)(5) and 4(a)(v)(6) hereof, as promptly as practicable after the occurrence of such an event, use its reasonable best efforts to prepare a supplement or post-effective amendment to the Registration Statement or the related Prospectus or any document incorporated therein by reference or file any other required document so that, as thereafter delivered to the purchasers of the Registrable Securities, such Prospectus will not contain at the time of such delivery any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, or will remain so qualified, as applicable. At such time as such public disclosure is otherwise made or the Company determines that such disclosure is not necessary, in each case to correct any misstatement of a material fact or to include any omitted material fact, the Company agrees promptly to notify each Holder of such determination and to furnish each Holder such number of copies of the Prospectus as amended or supplemented, as such Holder may reasonably request;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(xi)&nbsp;&nbsp;&nbsp;&nbsp;within a reasonable time prior to the filing of any Registration Statement, any Prospectus, any amendment to a Registration Statement or amendment or supplement to a Prospectus, provide copies of such document to the Selling Holders&#8217; Counsel, if any, on behalf of such Holders, and make representatives of the Company as shall be reasonably requested by the Holders of Registrable Securities available for discussion of such document;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(xii)&nbsp;&nbsp;&nbsp;&nbsp;obtain a CUSIP number for the Registrable Securities not later than the effective date of a Registration Statement, and provide the Company&#8217;s transfer agent with printed certificates for the Registrable Securities, in a form eligible for deposit with the Depositary, in each case, to the extent necessary or applicable;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;enter into agreements (including underwriting agreements) and take all other customary appropriate actions in order to expedite or facilitate the disposition of such Registrable Securities whether or not an underwriting agreement is entered into and whether or not the registration is an underwritten registration:&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:144pt;">1.&nbsp;&nbsp;&nbsp;&nbsp;make such representations and warranties to the Holders of such Registrable Securities and the underwriters, if any, in form, substance and scope as are customarily made by issuers to underwriters in similar Underwritten Offerings as may be reasonably requested by them;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:144pt;">2.&nbsp;&nbsp;&nbsp;&nbsp;obtain opinions of counsel to the Company and updates thereof (which counsel and opinions (in form, scope and substance) shall be reasonably satisfactory to any managing underwriter(s) and their counsel) addressed to the underwriters, if any (and in the case of an underwritten registration, each selling Holder), covering the matters customarily covered in opinions requested in Underwritten Offerings and such other matters as may be reasonably requested by the underwriter(s);&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:144pt;">3.&nbsp;&nbsp;&nbsp;&nbsp;obtain &#8220;comfort&#8221; letters and updates thereof from the Company&#8217;s independent registered public accounting firm (and, if necessary, any other independent certified public accountants of any subsidiary of the Company or of any business acquired by the Company for which financial statements are, or are required to be, included in the Registration Statement) addressed to the underwriter(s), if any, and use reasonable efforts to have such letter addressed to the selling Holders in the case of an underwritten registration (to the extent consistent with Statement on Auditing Standards No. 72 of the American Institute of Certified Public Accounts), such letters to be in customary form and covering matters of the type customarily covered in &#8220;comfort&#8221; letters to underwriters in connection with similar Underwritten Offerings;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:144pt;">4.&nbsp;&nbsp;&nbsp;&nbsp;enter into a securities sales agreement with the Holders and an agent of the Holders providing for, among other things, the appointment of such agent for the selling Holders for the purpose of soliciting purchases of Registrable Securities, which agreement shall be in form, substance and scope customary for similar offerings;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:144pt;">5.&nbsp;&nbsp;&nbsp;&nbsp;if an underwriting agreement is entered into, cause the same to set forth indemnification provisions and procedures substantially equivalent to the indemnification provisions and procedures set forth in Section&nbsp;5 hereof with respect to the underwriters and all other parties to be indemnified pursuant to said Section&nbsp;or, at the request of any underwriters, in the form customarily provided to such underwriters in similar types of transactions; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:144pt;">6.&nbsp;&nbsp;&nbsp;&nbsp;deliver such documents and certificates as may be reasonably requested and as are customarily delivered in similar offerings to the Holders of a Majority of the Registrable Securities being sold, and the managing underwriters, if any;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;make available for inspection by any underwriter participating in any disposition pursuant to a Registration Statement, Selling Holders&#8217; Counsel and any accountant retained by a Majority of the Registrable Securities being sold, all financial and other records, pertinent corporate documents and properties or assets of the Company reasonably requested by any such Persons, and cause the respective officers, directors, employees, and any other agents of the Company to supply all information reasonably requested by any such representative, underwriter, counsel or accountant in connection with a Registration Statement, and make such representatives of the Company available for discussion of such documents as shall be reasonably requested by the Company; <u>provided</u>, <u>however</u>, that the Selling Holders&#8217; Counsel, if any, and the representatives of any underwriters will use its reasonable best efforts, to the extent reasonably practicable, to coordinate the foregoing inspection and information gathering and to not materially disrupt the Company&#8217;s business operations;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(xv)&nbsp;&nbsp;&nbsp;&nbsp;a reasonable time prior to filing any Registration Statement, any Prospectus forming a part thereof, any amendment to such Registration Statement, or amendment or supplement to such Prospectus, provide copies of such document to the underwriter(s) of an Underwritten Offering of Registrable Securities; within five (5) Business Days after the filing of any Registration Statement, provide copies of such Registration Statement to Selling Holders&#8217; Counsel; make such changes in any of the foregoing documents prior to the filing thereof, or in the case of changes received from Selling Holders&#8217; Counsel by filing an amendment or supplement thereto, as the underwriter or underwriters, or in the case of changes received from Selling Holders&#8217; Counsel relating to the selling Holders or the plan of distribution of Registrable Securities, as Selling Holders&#8217; Counsel, reasonably requests; not file any such document in a form to which any underwriter shall not have previously been advised and furnished a copy of or to which the Selling Holders&#8217; Counsel, if any, on behalf of the Holders of Registrable Securities, or any underwriter shall reasonably object; not include in any amendment or supplement to such documents any information about the selling Holders or any change to the plan of distribution of Registrable Securities that would limit the method of distribution of the Registrable Securities unless Selling Holders&#8217; Counsel has been advised in advance and has approved such information or change; and make the representatives of the Company available for discussion of such document as shall be reasonably requested by the Selling Holders&#8217; Counsel, if any, on behalf of such Holders, Selling Holders&#8217; Counsel or any underwriter;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;use its reasonable best efforts to cause all Registrable Securities to be listed or quoted on any national securities exchange on which the Company&#8217;s Common Stock is then listed or quoted;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(xvii)&nbsp;&nbsp;&nbsp;&nbsp;otherwise comply with all applicable rules and regulations of the Commission and make available to its security holders, as soon as reasonably practicable, an earnings statement covering at least twelve (12) months which shall satisfy the provisions of Section&nbsp;11(a) of the Securities Act and Rule 158 thereunder;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(xviii)&nbsp;&nbsp;&nbsp;&nbsp;cooperate and assist in any filings required to be made with the FINRA and in the performance of any due diligence investigation by any underwriter and its counsel (including any &#8220;qualified independent underwriter&#8221; that is required to be retained in accordance with the rules and regulations of the FINRA);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(xix)&nbsp;&nbsp;&nbsp;&nbsp;if Registrable Securities are to be sold in an Underwritten Offering, to include in the registration statement, or in the case of a Shelf Registration, a Prospectus supplement, to be used all such information as may be reasonably requested by the underwriters for the marketing and sale of such Registrable Securities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(xx)&nbsp;&nbsp;&nbsp;&nbsp;cause the appropriate officers of the Company to (i) prepare and make presentations at any &#8220;road shows&#8221; and before analysts and rating agencies, as the case may be, (ii) take other actions to obtain ratings for any Registrable Securities and (iii) use their reasonable best efforts to cooperate as reasonably requested by the underwriters in the offering, marketing or selling of the Registrable Securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company may (as a condition to a Holder&#8217;s participation in a Shelf Registration, Demand Registration or Piggyback Registration) require each Holder of Registrable Securities to furnish to the Company such information regarding the Holder and the proposed distribution by such Holder of such Registrable Securities as the Company may from time to time reasonably request in writing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Each Holder agrees that, upon receipt of any notice from the Company of the happening of any event or the discovery of any facts of the type described in Section&nbsp;4(a)(v) hereof, such Holder will forthwith discontinue disposition of Registrable Securities pursuant to a Registration Statement relating to such Registrable Securities until such Holder&#8217;s receipt of the copies of the supplemented or amended Prospectus contemplated by Section&nbsp;4(a)(v) hereof, and, if so directed by the Company, such Holder will deliver to the Company (at the Company&#8217;s expense) all copies in such Holder&#8217;s possession, other than permanent file copies then in such Holder&#8217;s possession, of the Prospectus covering such Registrable Securities current at the time of receipt of such notice.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">Section 5.<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>INDEMNIFICATION</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnification by the Company</u>. The Company agrees to indemnify and hold harmless each Holder, and the respective officers, directors, partners, employees, representatives and agents of any such Person, and each Person (a &#8220;<u>Controlling Person</u>&#8221;), if any, who controls (within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act) any of the foregoing Persons, as follows:&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;against any and all loss, penalty, liability, claim, damage, judgment, suit, action, other liabilities and expenses whatsoever (&#8220;<u>Liabilities</u>&#8221;), as incurred, arising out of or based on any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement (including any final, preliminary or summary Prospectus contained therein or any amendment or supplement thereto) pursuant to which Registrable Securities were registered under the Securities Act, including all documents incorporated therein by reference, or any other disclosure document produced by or on behalf of the Company or any of its subsidiaries including reports and other documents filed under the Exchange Act, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading, or arising out of or based on any untrue statement or alleged untrue statement of a material fact contained in any Prospectus (or any amendment or supplement thereto) or the omission or alleged omission therefrom at such date of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;against any and all Liabilities, as incurred, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; <u>provided</u> that (subject to Section&nbsp;5(d) below) any such settlement is effected with the written consent of the Company, which consent shall not be unreasonably withheld; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:108pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;against any and all expense whatsoever, as incurred (including the fees and disbursements of counsel chosen by any indemnified party), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever arising out of or based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under subparagraph (i) or (ii) above; <u>provided</u>, <u>however</u>, that this indemnity agreement shall not apply to any Liabilities to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written information furnished to the Company by the Holder expressly for use in a Registration Statement (or any amendment thereto) or any Prospectus (or any amendment or supplement thereto).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The indemnity in this Section 5(a) shall be in addition to any liability the Company may otherwise have. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Holder or any indemnified party and shall survive any transfer of such securities by such Holder. The Company shall also indemnify underwriters, selling brokers, dealer managers and similar securities industry professionals participating in the offering, their officers and directors and each Person who controls such Persons (within the meaning of the Securities Act and the Exchange Act) to the same extent as provided above with respect to the indemnification of the indemnified parties.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnification by the Holders</u>. Each Holder severally, but not jointly, agrees to indemnify and hold harmless the Company and the other selling Holders, and each of their respective officers, directors, partners, employees, representatives and agents, against any and all Liabilities described in the indemnity contained in Section&nbsp;5(a) hereof, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in a Registration Statement (or any amendment thereto) or any Prospectus included therein (or any amendment or supplement thereto) in reliance upon and in conformity with written information such Holder furnished to the Company by such Holder expressly for use in the Registration Statement (or any amendment thereto) or such Prospectus (or any amendment or supplement thereto); <u>provided</u>, <u>however</u>, that no such Holder shall be liable for any claims hereunder in excess of the amount of net proceeds received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices of Claims, etc</u>. Each indemnified party shall give notice as promptly as reasonably practicable to each indemnifying party of any action or proceeding commenced against it in respect of which indemnity may be sought hereunder; <u>provided</u>, <u>however</u>, that failure to so notify an indemnifying party shall not relieve such indemnifying party from any liability hereunder to the extent it is not materially prejudiced as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement. An indemnifying party may participate at its own expense in the defense of such action; <u>provided</u>, <u>however</u>, that counsel to the indemnifying party shall not (except with the consent of the indemnified party) also be counsel to the indemnified party. Other than in the case of any actual or potential conflict that may arise from a single counsel representing more than one indemnified party, the indemnifying party or parties shall not be liable for the fees and expenses of more than one counsel (in addition to any local counsel) separate from their own counsel for all indemnified parties in connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances. No&nbsp;indemnifying party shall, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whosoever in respect of which indemnification or contribution could be sought under this Section&nbsp;5 (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnification Payments</u>. If at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section&nbsp;5(a)(ii) effected without its written consent if (i) such settlement is entered into more than forty-five (45) days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least thirty (30) days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Contribution</u>. If the indemnification provided for in this Section&nbsp;5 is for any reason unavailable to or insufficient to hold harmless an indemnified party in respect of any Liabilities referred to therein, then each indemnifying party shall contribute to the aggregate amount of such Liabilities incurred by such indemnified party, as incurred, in such proportion as is appropriate to reflect the relative fault of the Company, on the one hand, and the Holders, on the other hand, in connection with the acts, statements or omissions which resulted in such Liabilities, as well as any other relevant equitable considerations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:37pt;">The relative fault of the Company on the one hand and the Holders on the other hand shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Holders and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:37pt;">The Company and the Holders agree that it would not be just and equitable if contribution pursuant to this Section&nbsp;5 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section&nbsp;5. The aggregate amount of Liabilities incurred by an indemnified party and referred to above in this Section&nbsp;5 shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission or alleged omission. Notwithstanding the provisions of this Section 5(e), no Holder shall be liable for any claims hereunder in excess of the amount of net proceeds received by such Holder from the sale of Registrable Securities pursuant to any such Registration Statement.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:37pt;">No Person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:37pt;">For purposes of this Section&nbsp;5, each Person, if any, who controls a Holder within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act shall have the same rights to contribution as a Holder, and each director of the Company, and each Person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act shall have the same rights to contribution as the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">Section 6.<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>HOLDBACK AGREEMENT</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Each Holder agrees not to effect any sale, transfer, or other actual or pecuniary transfer (including heading and similar arrangements) of any Registrable Securities or of any other equity securities of the Company, or any securities convertible into or exchangeable or exercisable for such stock or securities, during the period beginning seven (7) days prior to, and ending ninety (90) days after (or for such shorter period as to which the managing underwriter(s) may agree), the date of the underwriting agreement of each Underwritten Offering made pursuant to a Registration Statement other than Registrable Securities sold pursuant to such Underwritten Offering, provided that (i) notwithstanding the foregoing, the duration of the foregoing restrictions shall be no longer than the duration of the shortest restriction generally imposed by the underwriters on any of the Company, the officers, directors or any other affiliate of the Company or any other stockholder of the Company on whom a restriction is imposed or with whom the Company has granted registration rights for any of its equity securities; and (ii) the Holders shall not be subject to the foregoing restrictions if and to the extent that the managing underwriter(s) agree to waive the restriction set forth in such underwriting agreement for any of the Persons set forth in the immediately preceding clause (i); <u>provided</u> <u>further</u>,<i> </i>that none of the restrictions in this Section 6(a) shall apply to a Holder if such Holder has provided an Opt-Out Notice to the Company in accordance with Section 2(c)(ii) prior to receiving notice of such Underwritten Offering and has not revoked such Opt-Out Notice; and (b) the Company agrees not to effect any public sale or distribution of its equity securities (or any securities convertible into or exchangeable or exercisable for such securities) during the seven (7) days prior to and during the ninety (90)-day period beginning on the effective date of any underwritten Demand Registration (or for such shorter period as to which the managing underwriter or underwriters may agree), except as part of such Demand Registration or in connection with any employee benefit or similar plan, any dividend reinvestment plan, or a business acquisition or combination and to use all reasonable efforts to cause each holder of at least five percent (5%) (on a fully diluted basis) of its equity securities (or any securities convertible into or exchangeable or exercisable for such securities) which are or may be purchased from the Company at any time after the date of this Agreement (other than in a registered offering) to agree not to effect any sale or distribution of any such securities during such period (except as part of such Underwritten Offering, if otherwise permitted). Each Holder agrees to enter into any agreements reasonably requested by any managing underwriter reflecting the terms of this Section&nbsp;6.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">Section 7.<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>TERMINATION</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Survival</u>. This Agreement and the rights of each Holder hereunder shall terminate upon the date that all of the Registrable Securities cease to be Registrable Securities. Notwithstanding the foregoing, the obligations of the parties under Section&nbsp;5 of this Agreement shall remain in full force and effect following such time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">Section 8.<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>MISCELLANEOUS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Covenants Relating To Rule 144</u>. For so long as the Company is subject to the reporting requirements of Section&nbsp;13 or 15 of the Securities Act, the Company covenants that it will file the reports required to be filed by it under the Securities Act and Section&nbsp;13(a) or 15(d) of the Exchange Act and the rules and regulations adopted by the Commission thereunder. If the Company ceases to be so required to file such reports, the Company covenants that it will upon the request of any Holder of Registrable Securities (a) make publicly available such information as is necessary to permit sales pursuant to Rule 144 under the Securities Act, (b) deliver such information to a prospective purchaser as is necessary to permit sales pursuant to Rule 144A under the Securities Act and it will take such further action as any Holder of Registrable Securities may reasonably request, and (c) take such further action that is reasonable in the circumstances, in each case, to the extent required, from time to time, to enable such Holder to sell its Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by (i) Rule 144 under the Securities Act, as such Rule may be amended from time to time, (ii) Rule 144A under the Securities Act, as such rule may be amended from time to time, or (iii) any similar rules or regulations hereafter adopted by the Commission. Upon the request of any Holder of Registrable Securities, the Company will deliver to such Holder a written statement as to whether it has complied with such requirements and of the Securities Act and the Exchange Act (at any time after it has become subject to the reporting requirements of the Exchange Act), a copy of the most recent annual and quarterly report(s) of the Company, and such other reports, documents or stockholder communications of the Company, and take such further actions consistent with this Section&nbsp;8(a), as a Holder may reasonably request in availing itself of any rule or regulation of the Commission allowing a Holder to sell any such Registrable Securities without registration.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Cooperation</u>. The Company shall cooperate with the Holders in any sale and or transfer of Registrable Securities including by means not involving a registration statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>No Inconsistent Agreements</u>. The Company has not entered into and the Company will not after the date of this Agreement enter into any agreement which is inconsistent with the rights granted to the Holders of Registrable Securities pursuant to this Agreement or otherwise conflicts with the provisions of this Agreement. The rights granted to the Holders hereunder do not and will not for the term of this Agreement in any way conflict with the rights granted to the holders of the Company&#8217;s other issued and outstanding securities under any such agreements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Expenses</u>. All Registration Expenses of any Holder shall be borne by the Company, whether or not any Registration Statement related thereto becomes effective or other sale takes place.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendments and Waivers</u>. The provisions of this Agreement may be amended or waived at any time only by the written agreement of the Company and the Holders of a Majority of the Registrable Securities. Any waiver, permit, consent or approval of any kind or character on the part of any such Holders of any provision or condition of this Agreement must be made in writing and shall be effective only to the extent specifically set forth in writing. Any amendment or waiver effected in accordance with this paragraph shall be binding upon each Holder of Registrable Securities and the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices</u>. All notices and other communications provided for or permitted hereunder shall be made in writing by hand delivery, registered first-class mail, facsimile, email or any courier guaranteeing overnight delivery: (a) if to a Holder, at the most current address given by such Holder to the Company by means of a notice given in accordance with the provisions of this Section&nbsp;8(f); and (b)&nbsp;if to the Company, to NextDecade Corporation, Attention: Krysta De Lima (facsimile: (832) 403-2198; email: Krysta@next-decade.com). All such notices and communications shall be deemed to have been duly given: (i) if personally delivered, at the time delivered by hand; (ii) if by email, on receipt of a read receipt email from the correct address, twenty-four (24) hours from delivery if sent to the correct email address and no notice of delivery failure is received, or on receipt of confirmation of receipt from the recipient; (iii) if mailed, two (2) Business Days after being deposited in the mail, postage prepaid; (iv) if sent by facsimile (<u>provided</u> confirmation of transmission is mechanically or electronically generated and kept on file by the sending party), when receipt is acknowledged; and (v) if by courier guaranteeing overnight delivery, on the next Business Day if timely delivered to an air courier guaranteeing overnight delivery.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;<u>Successor and Assigns</u>. This Agreement shall inure to the benefit of and be binding upon the successors and assigns of the Company. If any transferee of any Holder shall acquire Registrable Securities, in any manner, whether by operation of law or otherwise, and such transferee executed a joinder to this Agreement, then such Registrable Securities so acquired by such transferee shall be held subject to all of the terms, and entitled to all of the benefits, of this Agreement, and by executing such joinder such transferee shall be conclusively deemed to have agreed to be bound by and to perform all of the terms and provisions of this Agreement, including the restrictions on resale set forth in this Agreement, and such transferee shall be entitled to receive the benefits hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(h)&nbsp;&nbsp;&nbsp;&nbsp;<u>Obligations Limited to Parties to Agreement</u>. Each of the parties hereto covenants, agrees and acknowledges that no Person other than the Holders and the Company shall have any obligation hereunder and that, notwithstanding that one or more of the Holders may be a corporation, partnership or limited liability company, no recourse under this Agreement or under any documents or instruments delivered in connection herewith or therewith shall be had against any former, current or future director, officer, employee, agent, general or limited partner, manager, member, stockholder or affiliate of any Holder or any former, current or future director, officer, employee, agent, general or limited partner, manager, member, stockholder or affiliate of any of the foregoing, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise by incurred by any former, current or future director, officer, employee, agent, general or limited partner, manager, member, stockholder or affiliate of any of the Holders or any former, current or future director, officer, employee, agent, general or limited partner, manager, member, stockholder or affiliate of any of the foregoing, as such, for any obligations of the Holders under this Agreement or any documents or instruments delivered in connection herewith or therewith or for any claim based on, in respect of or by reason of such obligation or its creation, except in each case for any transferee or assignee of a Holder hereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;<u>Specific Enforcement</u>. Without limiting the remedies available to the Holders, the Company acknowledges that any failure by the Company to comply with its obligations under Section&nbsp;2 hereof may result in material irreparable injury to the Holders for which there is no adequate remedy at law, that it would not be possible to measure damages for such injuries precisely and that, in the event of any such failure, a Holder may obtain such relief as may be required to specifically enforce the Company&#8217;s obligations under Section&nbsp;2 hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(j)&nbsp;&nbsp;&nbsp;&nbsp;<u>Counterparts</u>. This Agreement may be executed in any number of counterparts and by the parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(k)&nbsp;&nbsp;&nbsp;&nbsp;<u>Headings</u>. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(l)&nbsp;&nbsp;&nbsp;&nbsp;<u>GOVERNING LAW</u>. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAW OF THE STATE OF DELAWARE REGARDLESS OF THE LAW THAT MIGHT OTHERWISE GOVERN UNDER APPLICABLE PRINCIPLES OF CONFLICTS OF LAW THEREOF.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(m)&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability</u>. In the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions contained herein shall not be affected or impaired thereby.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 36pt;text-indent:72pt;">(n)&nbsp;&nbsp;&nbsp;&nbsp;<u>Jurisdiction and Venue</u><i>; WAIVER OF JURY TRIAL</i>. The undersigned irrevocably consents to the exclusive jurisdiction and venue of the courts of the State of Delaware or the federal courts located in the State of Delaware in connection with any matter based upon or arising out of this Agreement, agrees that process may be served upon it in any manner authorized by the laws of the State of Delaware and waives and covenants not to assert or plead any objection which it might otherwise have to such manner of service of process. The undersigned waives, and shall not assert as a defense in any legal dispute, that (a) it is not personally subject to the jurisdiction of the above named courts for any reason, (b) such Legal Proceeding may not be brought or is not maintainable in such court, (c) its property is exempt or immune from execution, (d) such Legal Proceeding is brought in an inconvenient forum or (e) the venue of such Legal Proceeding is improper. THE UNDERSIGNED UNCONDITIONALLY WAIVES ANY RIGHT TO TRIAL BY JURY ON ANY CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS AGREEMENT. IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF JURY TRIAL IS PROHIBITED, THE UNDERSIGNED SHALL NOT ASSERT IN SUCH LEGAL DISPUTE A NONCOMPULSORY COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT. FURTHERMORE, THE UNDERSIGNED SHALL NOT SEEK TO CONSOLIDATE ANY SUCH LEGAL DISPUTE WITH A SEPARATE ACTION OR OTHER LEGAL PROCEEDING IN WHICH A JURY TRIAL CANNOT BE WAIVED.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>[Signature page follows]</i></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; width: 1178px;">

		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="width: 33%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="width: 356px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">NEXTDECADE CORPORATION</td>
			<td style="width: 428px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="width: 356px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 428px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 20px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">By:</td>
			<td style="width: 331px; border-bottom: thin solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 428px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="width: 356px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Name: Matthew Schatzman</td>
			<td style="width: 428px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="width: 356px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Title:&nbsp; Chief Executive Officer</td>
			<td style="width: 428px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 252pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b><i>[Signature Page to Registration Rights Agreement]</i></b></p>
</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; width: 1178px;">

		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="width: 33%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="width: 356px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">[Holder]</td>
			<td style="width: 428px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" style="width: 356px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 428px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 34px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">By:</td>
			<td style="width: 363px; border-bottom: thin solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 428px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 34px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Name:&nbsp;</td>
			<td style="width: 363px; border-bottom: thin solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 428px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 34px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Title:</td>
			<td style="width: 363px; border-bottom: thin solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td style="width: 428px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 252pt;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b><i>[Signature Page to Registration Rights Agreement]</i></b></p>
</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>SCHEDULE I</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">HOLDERS</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">[&#9679;]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ex_234768.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head><meta charset="utf-8"><meta name="format-detection" content="telephone=no"><!--Created on 3/17/2021 2:24:38 PM --><meta name="generator" content="RDG HTML Converter 3.4.3.0">
	<title>ex_234768.htm</title>

</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%; text-align: right;"><b>Exhibit 99.1</b></td>
		</tr>
		<tr>
			<td>
			<div><img alt="capture4.jpg" src="capture4.jpg"></div>
			</td>
			<td>&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NextDecade Announces Issuance of Preferred Equity</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">HOUSTON (BUSINESS WIRE) -- March 18, 2021 -- NextDecade Corporation (NextDecade or the Company) (NASDAQ: NEXT) announced today that it has agreed to sell $24.5 million of Series C Convertible Preferred Stock (Series C Preferred Stock). The Series C Preferred Stock is being issued in a private placement to funds managed by York Capital Management, Avenue Capital Group, and Bardin Hill Investment Partners. NextDecade intends to use proceeds to finalize commercial agreements needed to achieve a final investment decision on Rio Grande LNG in 2021, to advance the work of its NEXT Carbon Solutions business, including developing one of the largest carbon capture and storage (CCS) projects in North America to reduce GHG emissions at Rio Grande LNG, and for general corporate purposes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;NextDecade is pleased to solidify its balance sheet with additional development capital from existing and new institutional investors as we progress to an expected FID at Rio Grande LNG in 2021,&#8221; Matt Schatzman, NextDecade&#8217;s Chairman and Chief Executive Officer. &#8220;This preferred equity capital raise coincides with the formation of NEXT Carbon Solutions and affirms NextDecade&#8217;s leadership in efforts to reduce global greenhouse gas emissions. This capital will facilitate the advancement and realization of transformative and impactful contributions that NEXT Carbon Solutions expects to make to the global energy industry and the quest toward a net-zero future.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The offer and sale of the Series C Preferred Stock has not been, and will not be, registered under the Securities Act of 1933 (Securities Act), or any other securities laws, and the Series C Preferred Stock cannot be offered or sold except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any other applicable securities laws. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities, in any state or jurisdiction in which such offer, solicitation or sale of these securities would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"># # #</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>About NextDecade Corporation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">NextDecade Corporation (NextDecade) is committed to providing the world access to cleaner energy. NextDecade, through its wholly owned subsidiaries Rio Grande LNG and NEXT Carbon Solutions, is developing a 27 mtpa LNG export facility in South Texas along with one of the largest carbon capture and storage projects in North America. The Rio Grande LNG facility is expected to be the largest and greenest U.S. LNG export solution linking Permian Basin and Eagle Ford Shale natural gas to the global LNG market. NextDecade&#8217;s common stock is listed on the Nasdaq Stock Market under the symbol &#8220;NEXT.&#8221; NextDecade is headquartered in Houston, Texas. For more information, visit www.next-decade.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Contact</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Patrick Hughes</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">phughes@next-decade.com</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">+1 (832) 209-8131</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NextDecade Forward-Looking Information</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">This press release contains forward-looking statements within the meaning of U.S. federal securities laws including, in particular, statements about the Company&#8217;s private placement of Series C Preferred Stock and the use of proceeds thereof. The words &#8220;anticipate,&#8221; &#8220;contemplate,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;can have,&#8221; &#8220;likely,&#8221; &#8220;continue,&#8221; &#8220;design&#8221; and other words and terms of similar expressions are intended to identify forward-looking statements, and these statements may relate to the business of NextDecade and its subsidiaries. These statements have been based on NextDecade&#8217;s current assumptions, expectations, and projections about future events and trends and involve a number of known and unknown risks, which may cause actual results to differ materially from expectations expressed or implied in the forward-looking statements. These risks include uncertainties about progress in the development of NextDecade&#8217;s LNG liquefaction and export projects and the timing of that progress; NextDecade&#8217;s final investment decision (&#8220;FID&#8221;) in the construction and operation of a LNG terminal at the Port of Brownsville in southern Texas (the &#8220;Terminal&#8221;) and the timing of that decision; the successful completion of the Terminal by third-party contractors and an approximately 137-mile pipeline to supply gas to the Terminal being developed by a third-party&#894; NextDecade&#8217;s ability to secure additional debt and equity financing in the future to complete the Terminal; the accuracy of estimated costs for the Terminal; statements that the Terminal, when completed, will have certain characteristics, including amounts of liquefaction capacities; the development risks, operational hazards, regulatory approvals applicable to the Terminal&#8217;s and the third-party pipeline's construction and operations activities&#894; NextDecade&#8217;s anticipated competitive advantage and technological innovation which may render its anticipated competitive advantage obsolete; the global demand for and price of natural gas (versus the price of imported LNG); the availability of LNG vessels worldwide; changes in legislation and regulations relating to the LNG industry, including environmental laws and regulations that impose significant compliance costs and liabilities; NextDecade&#8217;s ability to develop and implement carbon capture and storage or similar technology to reduce anticipated carbon emissions from the Terminal; the 2019 novel coronavirus pandemic and its impact on NextDecade&#8217;s business and operating results, including any disruptions in NextDecade&#8217;s operations or development of the Terminal and the health and safety of NextDecade&#8217;s employees, and on NextDecade&#8217;s customers, the global economy and the demand for LNG; risks related to doing business in and having counterparties in foreign countries; NextDecade&#8217;s ability to maintain the listing of its securities on a securities exchange or quotation medium; changes adversely affecting the business in which NextDecade is engaged; management of growth; general economic conditions; NextDecade&#8217;s ability to generate cash; compliance with environmental laws and regulations; the result of future financing efforts and applications for customary tax incentives; and other matters discussed in the &#8220;Risk Factors&#8221; section of NextDecade&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019 and other subsequent reports filed with the Securities and Exchange Commission, all of which are incorporated herein by reference. Additionally, any development of the Terminal remains contingent upon completing required commercial agreements, acquiring all necessary permits and approval, securing all financing commitments and potential tax incentives, achieving other customary conditions and making a final investment decision to proceed. The forward-looking statements in this press release speak as of the date of this release. Although NextDecade believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that the expectations will prove to be correct. NextDecade may from time to time voluntarily update its prior forward-looking statements, however, it disclaims any commitment to do so except as required by securities laws.</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>next-20210317.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 3/18/2021 10:54:58 AM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:next="http://www.next.com/20210317" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.next.com/20210317">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="next-20210317_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="next-20210317_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="next-20210317_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.next.com/20210317/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="next_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>next-20210317_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 3/18/2021 10:54:58 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.next.com/20210317/role/statement-document-and-entity-information" xlink:href="next-20210317.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.next.com/20210317/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>next-20210317_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 3/18/2021 10:54:58 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>next-20210317_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 3/18/2021 10:54:58 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.next.com/20210317/role/statement-document-and-entity-information" xlink:href="next-20210317.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.next.com/20210317/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>capture4.jpg
<TEXT>
begin 644 capture4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$$17AI9@  34T *@    @ !0$2  ,
M   !  $   $[  (    /   (5H=I  0    !   (9IR=  $    >   0WNH<
M  <   @,    2@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M     $=A8F4@1W5T:65R<F5Z    !9 #  (    4   0M) $  (    4   0
MR)*1  (    #.#0  )*2  (    #.#0  .H<  <   @,   (J      <Z@
M  @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" !% 44# 2(
M A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1
M @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152
MT? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D
M969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0
M'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%
M! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D
M-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T
M=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$
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M#6.&P#JTJE1NW)TMOO\ =L76QBIU(02OS=;^G^9_1T#FBOYY_P#@Y7LXIO\
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MT;Z/1GFYWPR\'AH9AA*T:^'FW%3BFFI)7Y9Q>L96U2U36J9UH.:*_-W]B?\
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MPYX=7X,^)OAO\"_@CIO@'PUKVFW6EQ7]Q)!I\MFD\31-)'8V:>4DBARRGSV
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M1<(175RE)))):]^R(/\ @E8D=EXT^+-G8MNT6VO[7[$ VY /,O%7'UC6/GT
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MM@QP2M"!.JD,PVC+C(8X'<]:J_\ #R'X.?\ 0U3?^"6__P#C-=U\/_BGX/\
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M49=>SL=F#PN59AD^)R7 XJ=>LFZ]-2I\CYHK]XD^>;;G#6VFL;G2_P#!4/\
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M.D:?X^^',FD0Z'KWPRT^P2#-@F6EC6VB4FZ+R-)*)XU>YC>7;LE@W)7R3?\
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MEV<FU^+*^IZ1:ZU936UY;PW5O<+LEAF021R+Z%3P1[&N-M/V7_AK8:BMY!X
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M^7DN[=A>SCS<UM>YW%%%%24%%%% !1110 4444 %%%% !1110 4444 %%%%
K!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>next20210311_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="next-20210317.xsd" xlink:type="simple"/>
    <context id="d20218K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612720</identifier>
        </entity>
        <period>
            <startDate>2021-03-17</startDate>
            <endDate>2021-03-17</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20218K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20218K">0001612720</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20218K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20218K">2021-03-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20218K">NEXTDECADE CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20218K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20218K">001-36842</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20218K">46-5723951</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20218K">1000 Louisiana Street, Suite 3900</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20218K">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20218K">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20218K">77002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20218K">713</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20218K">574-1880</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20218K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20218K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20218K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20218K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20218K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20218K">NEXT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20218K">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20218K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140191118338328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 17, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">NEXTDECADE CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Mar. 17,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-36842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">46-5723951<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">1000 Louisiana Street, Suite 3900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">77002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">574-1880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NEXT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001612720<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  PX<E('04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  ,.')2@CIRRNX    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2L0P$(=?17)O)VE!)71[43PI""XHWD(RNQML_I",M/OVIG6WB^@#>,S,+]]\
M ]/I*'5(^)Q"Q$06\]7D!I^ECAMV((H2(.L#.I7KDO"EN0O)*2K/M(>H](?:
M(S2<7X-#4D:1@AE8Q97(^LYHJ1,J"NF$-WK%Q\\T+#"C 0=TZ"F#J 6P?IX8
MC]/0P04PPPB3R]\%-"MQJ?Z)73K 3LDIVS4UCF,]MDNN["#@[>GQ95FWLCZ3
M\AK+KVPE'2-NV'GR:WMWOWU@?<,;4?&V$K=;?B,YETW[/KO^\+L(NV#LSOYC
MX[-@W\&ON^B_ %!+ P04    "  ,.')2F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M  PX<E),, -T-P0  %H0   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
ME9A=<^(V%(:OM[]"PU4[D\26^<P.,$. =)G-)BS0[DX[O1"V $ULB4KR$OY]
MCPS8[-0<DQO\);UZ='3T2J*[4_K5;#BWY"V)I>G5-M9N/WJ>"3<\8>9.;;F$
M+RNE$V;A4:\]L]6<15FE)/8"WV]Y"1.RUN]F[Z:ZWU6IC87D4TU,FB1,[Q]X
MK':]&JV=7LS$>F/="Z_?W;(UGW/[QW:JX<G+52*1<&F$DD3S5:\VH!\?@H:K
MD)7X4_"=.;LGKBM+I5[=PR3JU7Q'Q&,>6B?!X/*##WD<.R7@^/<H6LO;=!7/
M[T_JCUGGH3-+9OA0Q=]$9#>]6J=&(KYB:6QG:O>)'SO4='JABDWV2W:'LHUF
MC82IL2HY5@:"1,C#E;T= W%6H=ZX4"$X5@@R[D-#&>6(6=;O:K4CVI4&-7>3
M=36K#7!"NE&96PU?!=2S_9$*4PBR)0,9D;&TPN[)1!Y&&Z+6]2PTXHIZX5'P
MX2 87!#\PO0=H>T;$O@!_;FZ!VPY8) #!IE>O0KPC(K\_02ER,3RQ/R#M%'/
MVZAG;30NM''H]PV9\;4P5C-H[9DEO*SSN-#S^/MB-!X.1F,R?)E-7V:#Q>3E
M&2%LY(0-5/@4A1NRV&]+P?#ZG=O/"$4SIVA>23'E6BB7,!&!M"L%PJ5.:?++
MAP\5B=+*X5I7#>)$ADIOE<XRY8;,+? 1I<E0I=+J/5RC4EY<?31&$-LY8OLJ
MQ$<1<_*<)DNNRTAP$=^GM_56IQ$@0)T<J',5T(*]D4D$(RM6(CQ,L<MXN&2C
M==ML!_7[)C:F]SG?_55\@RC2W)C\AF3S_T66#B0N27W?)T\J%48PR2 ]-%@G
MI$DJ($WJ][Z/8%._<%7_?>!#9ZR0A0NU*S=57.^3<DN!Q-C.')^^CRV?(E.M
M?@@9ED:U0G3Q'6,KS)X&[V.;*F-93/X2VXL3MT*RW?9];*[08I6@N+MG8SB
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MI6J//X7W*+F?&^[_$L4/4$L#!!0    (  PX<E*7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ ##AR4CJJHN=  0
M/ (   \   !X;"]W;W)K8F]O:RYX;6R-45UKPS ,_"O&/V!)RU98:09CW4=A
M;&4=?7=BI1&UK6"K[=9?/R4AK+"7/<DZB=/=>7&BN"^)]NK+NY *W3"W\RQ+
M50/>I"MJ(<BDIN@-2QMW66HC&)L: /8NF^;Y+/,&@[Y;C%SKF%TVQ% Q4A"P
M [8(I_0[[UIUQ(0E.N3O0O=O!UIY#.CQ#+;0N5:IH=,+13Q38.,V523G"CT9
M!EN(C-4?>-.)_#1EZA$VY8<1(86>Y4)88TS<;_3\1C0>09:'[L#TA(XA+@W#
M<Z1#BV'7T8B+[,)&G\-8AQ#G\3\Q4EUC!4NJ#AX"#SE&<)W D!ILDU;!>"CT
MN*+N@U6/@24DM0H#E>QV3N7TR@ZN6>1>9!CG*(.XLH/P4:V%&@/8-SF0!)?D
MJG547>EYIM<WDUM)Z.#<@V#OX96,'<V/'W?W U!+ P04    "  ,.')2)!Z;
MHJT   #X 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P
M#(6O$N4 -5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=N
MH+;S)$9K!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFB
MG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6
M<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ ##AR
M4F60>9(9 0  SP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O
M$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1
ML.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3K
MU3.T<F^I>.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY8
M4(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"
MJ;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R
M]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>
M?P%02P$"% ,4    "  ,.')2!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (  PX<E*".G+*[@   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   (  PX<E*97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ ##AR4DPP W0W!   6A   !@
M         ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   (  PX<E*#J:4#U $  #(&   -              "  7H,  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ ##AR4I>*NQS     $P(   L
M ( !>0X  %]R96QS+RYR96QS4$L! A0#%     @ ##AR4CJJHN=  0  / (
M  \              ( !8@\  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M  PX<E(D'INBK0   /@!   :              "  <\0  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (  PX<E)ED'F2&0$  ,\#   3
M              "  ;01  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(  /X2      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="next20210311_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.next.com/20210317/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="next20210311_8k.htm">next20210311_8k.htm</File>
    <File>ex_234721.htm</File>
    <File>ex_234759.htm</File>
    <File>ex_234768.htm</File>
    <File>ex_234785.htm</File>
    <File>ex_234853.htm</File>
    <File>next-20210317.xsd</File>
    <File>next-20210317_def.xml</File>
    <File>next-20210317_lab.xml</File>
    <File>next-20210317_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "next20210311_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "next-20210317_def.xml"
     ]
    },
    "inline": {
     "local": [
      "next20210311_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "next-20210317_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "next-20210317_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "next-20210317.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "next",
   "nsuri": "http://www.next.com/20210317",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "next20210311_8k.htm",
      "contextRef": "d20218K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.next.com/20210317/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "next20210311_8k.htm",
      "contextRef": "d20218K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.next.com/20210317/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001437749-21-006394-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-21-006394-xbrl.zip
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MS /)@9^X9(R-*_SUM9YY7$J!GU+2QIFZOS[9>N+@M&5D0?^<3+VA^MGB-]J
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M$1CBZ !DSJNU($ IBL49EE7&N?K$;LU!%'VK<B O^W;]I[Q=%8[QZI 9ABA
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MU2TT@M#Q VXZ61$>T)7E'K5P#CBGJQPJ4"TB!P)NOE#B?+]^L[OE>)L3;/2
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MOWIYSJ B[;JE\XRH_*D:$<_'!O1@W\-'FP700@K[UY7 Q(*3/4S,/L_:<AU
M-KIVUZOVL=#*?=U:#-R$'!+(N&G'):[#%N:<2*"F\1#%R,)%C6\52$SY3VL3
M>S*+5Z8LK776'18ZZMEB_IE9$PLL6E&12_R [@FV'G-#%/A[*N4$94"-&*"O
M/O=W+<_'5T]<AHRJK?I2X11D^@0R=I8G-!I37]>I/B:8NYESM9:NE[)O=#HC
M+F+*:=:8**2RB!G!(5_$_* E,BHB8-&IJL_%]B0+^?L#&!B8=B3>/O7E?GI#
M$(")S_)R(N(SSL!)?& M+^:L')GZ,1#II:C _:34,W2E;73&8S_P9>\U'X[,
MU(O3V9ZSEJW/R<<V<6IP,R4$!NU'EF8Q]00+)801;J#:):RHO!!29*%<RWM0
MH'AB'![MGHA*L\^S7/(B5#FT/;"Q,QI?7_70JO=Z<+J]SI?!10 Y+M;+*>]6
M@4*1=Q2_P#\EB%B)<Q+5DEPSI+X@<Z@#NWV=3#PJTK[,\)I(8C(-HID0KBS1
M1(3Z%*L?\2-&*<*<?AQL($(Q]E-:<N+*;W+QADJ73UR3U>AXG/$O9&?-L]B;
M)$"ORX7H55K/E+E;'D"72>@:^<:JC9R))"CY8593)L!]!EO49F,/N[$?)^IB
MVZ,RC 664W6BYV5<5K??J6N]4VPFP7RQ1P4@'J9UP;8X:YB%3?+!Q0L1/7"<
M)*?2R[1@7E<J"IQ^+#W/*J%[]BBMX^\R*;(I;MQ+]_G6EKNUM=5P*C@?5!];
M<_<H 80VF*>O=MC<<#P?+5_F,VX7IK2ACCK-!H$_A*> BL 6R=O!OO/VZ6"?
ME, ",4G%N ZCK#<DI:S<EZW<ER2WMH&1JWV;_=[*D;F4J[Q!1Z8EI.=IF$OO
M//MN?Z55NK2BK4G;?L\INK_FFS2JLA/N.6G9&)H$Z(+#V!](JX#Z/"5DFFBY
M^+=L^K2^]-2]U:21A1AYE3'RHS)&7J\R1E89(W,Z,V'&""GF'J4E](R3W<E/
MMLP? ;%Z4##-#HQB5^4P\9P3]B >*M#JXR$7Q_+ I]R8#^4+M1I8RCP4:R->
M[G \(E255:0OJ Z&1=C^,\8JEK[Z1-4@F<YJ@D:7@ +2G.9R9%E^E%?U%Q#2
M+0=SN?(>*YBHE0[J+"-D#%D"E@O_R-I+70C-%,:VB@K)UZIE+QO]\ROHC)>:
M+FE<C!$\J9D/^S1;*13U^,W1A:P[XE:11F&E65V$'UM(SHL%L_-MY9)!7?LQ
M]6:2CF8=(OE^-5Q!$0?!FP^>S#XZB^,8!9U7N>GTC.)'Y-4Z@ 9=33BDEIJ>
M@8!W)B,J_(@@'R4&AC" @HZ(25YS/<L+[J)X9G.-D9': HU44I^N\1)<.W_?
M2^S6U%J3\1-F]_@1!#@:;X,O49+"41#*#]S'FB*C7F\YZ[ZJI'6'@BPF3'CE
MV<X#-&:EK0J1$M2A)>#M!@1T[E1]NB3]2,I<DF5&-R#I1QT5L3?J6N[AT6SH
MV8$(K1KFA2MF9^H-.1(,Q5T-,C0OE_R+>>^J@9A%X<@E9^(,EB+C7>?%+KY^
M)9I[Q0O<'/L[G]*:W2:"?. <X,VYUB*NA@2J#GI+D%!9JBPQA?#MZW*6^#LY
M.8<1!Q@GEPJKU;^-)@B\W=L_4^"$XB*ZOE4/2"OC)4HTIZ(<E%"VX8) M"7<
M+1.Z?>[]R" X)20F]#:'8H-!8> [N,%3$0]I.[8VMW]>U\YCR4<T\QHTHCH8
M@@ZBM'C!, LD3-/\K:M,4 B%1V&QH0RQ%3[>?@IFQLVTUN*=CNQ&)!H @,_Y
M0Q2>B]TOC0GJ)P+[)M!VLCU12%&(G,Y%Y(\0"<3IDM+T>*X<+(,?1%X\XM N
MAQP-M=)6U#$SG>5);-&T.B<'52]YW/D 1*8,+]]3VA A'M;GRH!9DC"^[28,
MKS^+HI$S]BAK)N)HSH6,36' *::S'3D>;7_J77GY7$6.T9%@ X(Q!E +S9/8
MP,CS@G22?"S_H?I1Q8:]I#HZX1)E6TR-V)PCR>A4HH?(A0N>W<;#>Q09JB 1
MZXN'LM*?>I3;=9KG3SRN4UNVCE!)H!/JV7ID<\L^:?N#+F!:0"UZI<7"Z-Q*
M@#QJ7^#LY^AD8&YIP$*C_L3.3 L90@W^2S:,QD)HXK(<4= ],E/&<KS7K>DA
MLL*B1V?!LW-,6FI'0<C'C_/X',W/,#6T5[NI8.UYD V44:PS'OV0JJ\2091/
MSQ\UI_I7S:@O0\2P1/O ,/OWG,\*D_!1.@/8>QH6\JJ;TJ#KK!6I4Y&';9"
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M6>V%?/OI1R 7$LWYGZ^=3[WW/=BBWE'_M'?Z%;_5^>2\^_HG/-=#?OW4(SK
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MZH- (D;$%[+RBS%E$BF2@%-'2R.^FWLJU^OTBG*LO_^!IC151QG;O:@U[5?
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M>%%CP!/*.YY?$2"U%Y"L>3V=O)!BQ*8#(<+%RKHR>L[^*%AZX\T:6:'AY)/
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ML(7S#+LY1WZ8)HU:P?)RU(N6'+5U7Y2 JOC$7;U@:<\$]6!'=Y,*9EY7N[:
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ML27PCT$TFNV_?7J>3H+]_P]02P,$%     @ ##AR4CSY'=#=+@  B/8   T
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M@#/<FC1+PZ*014&JK#H3&S(<X>%VSB/^X"!(;6N2(#>XD0E#6GN^\# *<VL
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M,AZST$3E[2X[*$VP^L6;G1T.<C5.X P=SV8R4F&"NZ<)1"H-6UKIJ8DJV4B
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MFZ"S2FDQ)DYM?N,Q+&SZJ$W.6 ZB(,&/LP3X=O%8 QYWNR$P%%4-40<LV!H
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MLY5?^U(5=2F5H84<WI9Y<2PY4.GB\ _G7)BS$J<@BRN39NNG4.L@R9*D,-/
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MG"=JST!\.D(55\Y+G82\"G:V<$9Q/JIFR(I'O!Y">*#S7&;S1&HYHNIZN!3
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M#"9G_1\]?GQ8K6@V*7)-@Z.EUEGI_'4NG98F'!CR]6+4.78&GU1N5$HWU>:
M7ECJKOH_[@FMGV/&6Y7)7(EC8VQM,NSQP?M:XB]A)^+"J8ER#N%W^KG681%-
MLUW*[]?$_/[7R/G;:V)EA_<__7QU_=.Y>/KFYZL/YZ=75^(?'RY/=P DXI-T
MV4P,7_8$HPQ&.AHZL:ZR@!8 EGC:&;=.A!D]+BMI%CMX=GSU]OCO!^+\])_7
M.T(FQ>8BV%PN,%<& 4^?22_DU"E^@+ K"O&GO>>#'P0.6= >4/\5@A%G/6F
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M*\[JSOI)_;5K$@*N5/.&,EVDYV3L4*6WT.%QE\6.HN;[L44+ANSL?6P_QJW
MB[KX+Z@9:8S1;T5M%;2L=3E $\5VH%3;IMVU5P\XO(PD#WAK\IS*]U0X9(Q
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MY3U7'GGEA2K"C']'(Y'8@UY[),(\)-L/NV6B7QESXY*M,*L?TCHD9AS SMT
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M59'KTHX,AA^G8GA1:(8#,@42 -7&TU-%4L$LV:3]FKYL'AU"?\W:MS_B_V#
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M%DBI4.UG7"SC 1VI0=NIZ>87$-T&)ZXKQ!#+#(W/2XV5;'GZ)HKIZK$+L*?
M!2+;.N>8BB%LH^?1WVDYS2IK9H@S@T1MA89FQM&LL9VS5N"J%9CM@/6@?8\@
M)CC>?@Y"?:)5V :""U,,"/YRUXMB(@S$/?@,?"UDH.<'<+C?\<KU]16C]"0N
MY2CVPG>UYE3Q.W68_$8WG3$A?C9B+U U]STK2>1)+?!'#X^2ZVI!E2_9"&6S
M94K:>EQYW:;T@*.N7!=.=-"0DF&TQ@,8F@OP^74_TO 6O!!5K>]@,H[H$RR9
M7*2+MZ;PZ).M> ID-T28^560R1S9RM3JA26.#&M#\3RS%"9!C 3.JR5#$>S
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MAJ\52?T\0_EK#EN<7H'2#=WZZW>G;U__])T^\CJ-ZTM$:&S_CV(Q'F7)N!9
MAGQ#6 SZ"L$@7EMOS@>F,1>^(8'+P'E Z][+\:.RN)[]<H0QB-.WQQ_>VW>
M*^ Z[Y\_O[PL]<&GO;?]1Z\'_=Y/CWIOSON#'X,HNXYNJCVP <LX*1%NDB=>
M9V#.$GZKW>FG/50*$?#R7]OT/W!?-/IX419@\3SR?YH9@'<'W0. H_C9KW]^
MLG^4YA\7#H 9AVYPSLP""@/Z)@3ULDS''0"=N5 <?)5O=AL&KY,\&<,F.\VB
M?%::)1$8IQOII@8%D\DT*VZ2!*Q0OFT*M^DMZ Z4O:H[F2*8?*0^WGB\B9_[
M@\.S7@B-0JML"6M;'"J=3).\8K4:&Q?G9#0"!7U:9.D(1.BT+"[*:()_P/?I
M*$$SHXSR"];1T7*V6CW[TJ S8' T-1GFJNC7!30!3R.3 !J%3CS""#)=7$57
MZ-4/R;A(<S$<DD]@71!&Q>TIW'T)TU),6.:'")F#WL#@/Q)?:0@&# +8Z.(J
M O/AAEXLS1MIX2H:R5]5"L=&ED17\%YQ6HDQ G\G47VIHX4O5C7PTOCVET4U
M1;M5[(\P0-_N*,KPGKS&?[-TG,"8ZU@$&,NPZ!'^V33( TW1IJH[.(].8;!M
MSIIAE8H7F;P7>$UQG2=EQ;8A=W:D?F:X;0ASO@GCJ LI*W".D[@9J>F$TA^C
MZ?AB8YR+Q+YSK(%0?_1A;-/23/ZTJ.I']BO<LE>)C)3 &> J_NO1,*HPQ 8C
M@[-SQ>";89$WU=TL/VP.UKI9[/SB_!O&")N,S%#C%G(FQ6F%NV*?IUUQ.J>=
MP@<ZW:&P)VWC$;PI[+M/FS*?:1544^A!(=ZF291JD'-XTYYM^F=,DTX;.#!A
MC H?H#$+,7;! "]E*-!(-J^=X"(P_D3L6IS -.(B-:]"/\C($.("&H'-@ XO
MTTA+J6IUT%N5\-/&S>9,9*5S2<]K _43<@.,*"Y,2XPV,^T<V9]KI\:17'./
M#$>\6*>,O6,T>\?,CQQT:J/6[&5SPU ^LJ@]VQQ^S]BG=)E.#6X0)QV:@@Y?
M%R8ZQA&L*G0T>A I55+Q06$B:WZ<#9N"BTL8QP1W*#4""Z1,0'&M4 R3>$')
M0V=(488&@%!<PUM!/[DQO&84-16+4_[.@2M$XW&4XB8Q4IHV;QZI_($]:&*%
MUY<,%-$HH!70. QPZ55!\D><9B2E;_T:PQM'$(U G.!A[DM$$F[7:;5^U@["
MMG#A!*<EB.Y9%>N_=[=>/'N\NV;C,A?K^^T;@]_"Z.6C9C(DE:8[%*4^<([T
M)Q6I$(@F"E'$U1<1_I6E">HW691.T"/.JA0F>^"/>!,L6'5O)_:):S?65VE9
MY!-2I(-]'*WN,9>!C$8RD"3!41C+%U63LIXV2A*V1U*0#="9"]%B3]#81AUW
M@H<>##K8*B R&.M^HV /T-R3"]P8-DSA'+SVRS$=3_J @NR-"I&!(]"F\F:J
M'R\*$%#Z>GAFPM&7Z(\Y!C#Y^Z(I1S#L<32!Q5/1B\#A4-\XW^A9D>:_-JSP
M1S4\.4]N*ARNG>=@-I,*B/!9.K9 ^8LR/'4VX<!(R6];-'B$P:%"*A]K]ZHE
M$T82;N.S'(_M(MB(-E4B5 AEQM\'"6F,U Z=5'!^-VB>%(R>>1?])RKC G3\
M]R!]8*5D%:@OP\U@E):PSMGZJ$AW56T&NI.:8,Y56F0:22IY1J"O[K=\G;]V
MCJ)KRBS8&&TZ&)X)C!$,'(SX52*:>)E<-!GA.06 @W/)&JN=7^A-.IE2()BT
MHG#V:=5:;U4<@(Z="H9O-)V"YD0P3;S(6TZ@5'&8,91554AF&XM$!5;3+!&"
M2E4S7,TE>L?U"Q"D$U4^$]LSVM@SV\K9PFCKL3,$#D 8$<96P18)-2W%=HJ>
MT\#(PCD(&^F2XY/1.$%_@6VR_98_DD^'.N9N#;MS*GX4Y>OAV6N_AAW5O7M2
M:5&2]M@- 8)FC%93F8CDJRJ2?'&*I\M0!KI!P[3&AQF[& U1_@"70A?1AT&C
M?T&7PDQB @#V\A)>.1-?4V?/<,>1 0YZ=%'&'Y-D2GU Z4K!8='J*X15X%#@
M&(*Z"^UCLP+(X&"NV!3X?<>SUFRWH1^@.P#25^_.P#IF#G,PVQ)T![)FTF-W
MP<Z+YT_(Y(@FZ B(UTUD^<Z4;LU"3OX-->98-7#@%$F\R<@C/S%@1?=&6O'F
MXS2]*, M"J)1O"WE$K_NDYTGUAT3KYUV^(E=O;B<N_?"F;&L _=B7ON/O;4O
M.2#P G1NP+\V>:0DT">+)M(." D#,G729!<T=SCOB:@",MM5,T*16V"H!XZ<
M>MUFYTV*ZBCIU1T["]50/%=R4%JG4S@_22.@J]F),H+#F2:*O,WH\0M0L:UB
MMHO6;3 1P"BZU<#Q!K4@*CRXJ%]T>>%,&+R^!-75\RH5>>6F&::S;EXO><ZB
M-:K@,6:V8_[:R_35B0/$HO;^WL#[ZD&_YXF^E]^GKT"M@J8>;^V:%GH"NY0;
M^CD\<T2'V%[P#V@K3C&QUM[YV-QY7&">WAB4R]IK^XFY8A^MJUS W+TI[-\K
M4ASLM4_MM9$;U*%KZ#:Z[)FYC+H4'%:82XG^ &I*P@[=D^#DIMUF&FS^VMR)
M>++R1-A7?O+90_]DT=#K4#U9;?37;#._=:U^&?5Z#JYYG& >6T;>  K1H2]C
M"HO#?(192J 7(1TSK.I?@7:24N2QH$ DR-(<C9))DZ>C=,IA%$V>T[ZP=>YZ
M)$(][M"!@:=:#!8Y&@_LAHZTYW#G!6;3H?MD&I5B2 Q!G8^:D+'L(<4-4O+B
MT\,I!8\[@H_]=P,F_B//'4(V77J%^%'B"TD^)>6(W11XA^T:;*3H$_MT)FHX
M=+P?-]GQ(.<]I#=T]J"I U82C?&O8,J9[I;#M$8#$GME;CE+LO&C@1TN=P.N
MV?+N-,Y::_M'<AUQJKE>/=&K0^?+ZZBJ$^\;R?<>X;=U\2D=F6NJ H6Q?B+E
MC7ZW=S#M DI=5,L$2BRYXF!\:FXY1[HZG4CBJZ*(9#5$IT3%T2?Y6\QGRDV4
M]]DCI].TR&Y&EQDLM)R]2^GT,LEOLLHEQ#C=?UWYT31H&[[L:I:>.\Z:-,8^
M@1%21C'*[8V$NP=*4UED28.Q<OTSN+R)2Y )Y9!B;/9[$!IQ,R(/9=D@NC#-
MQ L"(JB,1@80#@.#>Q+V?\5*;S'F..'&V'6LF2$/37_1O9U,&!E!<Q2*OR="
M:8%A-WQ'1'L@*P$85#: -KPAPXD\-XGB'\AQX3L8*:S>#'^5X]8JZ]Q\D\7!
M!4HN4"/I<NO0LS.^R"DEW9[K]!$7D>-P>@#*+0/*+6IX!N?EP<06<3A]]VKW
M 7KW +V;/9P.X?M)+MFR;98>ZSAPM'24-19PP^<*87I8,T]+XYB\2EQ\#:,"
M\"]2=N@O4&AR4L#P;W@Z@[4FR61(?PA ZK+(8HQ*;(  @T,OP\0W(BI(1+8B
M@$ABBY4P%X!HZ\9&(,$* PILKC&Y;*>*M #S(T[855&%UFW!BCI'@.%[UW0+
M74@1ZGY$>A%?I=R$"3RI-]<!+ZQ;6.0P!ZWDBK@F^E>MA-D%B><*(2'(R(@A
M7:-$0UMB$QH:A+5@/T"%D9:^>&29$V*CMTG^CJLB QL''I'=&&(E5H-,S)?T
MI31+5#LB5B"0:\E'#C5D:3(61> <20N#G1T=Z0\Y85;/:L+<H:LU#(S=O;.]
M$R3U%K3T[ZTVB\_K*/]8-M,:IK^5X+%IO,*TJ8V=1U:<Q!W1KJ/T5&Z"8*>R
MFA!! -(B-NJ-:K.@OPC =\0&MSH>X%YXY48B5QS:C%+BS&$ $;2+5P41>3\S
MYIV*T% 'L86=@IG-F5/GAF?"'UM:DJF&@^Q%,M*A1((P ,@1<M;YW#[";P5(
M-@NE(MZ6*W*6*"IJ!/\6((C0X@6!F9 ]RJWI&!CK$I_BKAD)YT8N:10)8O7-
MF\ ZZ?15@H)M([W:U(4#_U<A7@Q-X;K6^+2JN!R-M@12D5UF>#^,YD6$TR!8
MFHYQA*?!PR;11WB81/,RD<$T*&,99X5MHW^4,%^4(E["W1@)I-L9,TG/UM!E
M4TX+QD4D# $26]K($SAP"IG-C===VVV84" )K.)AA@YR' 9\E6OTLL.-.(:@
MP8M6K4M,7B1COK"(M?DX&=9BD"4WVG#<)!@T7 MY1F8DPD1$='FR2H?;88DC
M>>%?;X287LW+3&4:"D>1:SY.N+4G:*EV;0D)>+>V1*N%4(0F7MR2=U\JXW3[
M,V"R+>1>;_[^0L,?H9F1W=CG/EZC0I9?/&KH-3S1[=VS)PQ5,\*U-=62OH [
M,4XK=*PE3(E5I9\0E/1L>Q-)#BI9- 7'5=!\'Q&%U92]A.PHPQ_GB@*'>FF(
MJ%UA ET[-:Y.*/<>,>BG,M_=IH,EITK=F\PB(4.["BD90T*#Z#"4!!S$5F?1
MM;DJ'3N(&?::C8KI#?^L(4GQR6KT0&[@+\:,:3*7J-<F)#\6?(F0M_(C6WA7
M"'F3C_03D4'C;UEQ0<IJ7&"J@GX-WQ;FTA@$C-A'M^Q3Y70*764(?!$>O6LT
M;"4% &1%535)+(](/J&W"#[*]6R9?:HYJ4C:9-09.[+X.J\KH9<(U/Z(4I,V
M.K: J2&59,FX+X._:0^P?Z(4E D&E"48%,M((S:T3&K#3#E.8TEE2'.'(<&"
MA^#W"$<]$2L,[ADE4_+3%9-IFEE=PVM@ I9B$5/^U.@R3U'@"08H;DKS=Z6\
M>RR>D?7NT65Q;?UN@G7@M\,%N&:[_B?E 9S=Z4OBJXGFJQ@JP2 :([T'*#@P
M58AJ,K)6#'$GL%=P8$_HIH*=K1W8]VN8$P_'_->.BJDV()B-$(5QZ CF,+B
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M&'$ 5:O E@7+&[I(7EA/7/]W)72ONQY7Q_?BAA^NFP%NA^K<6DG=F]XSH]H
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MH I%*S_-?8 GO)QN4JBQ+,@4IJ"S0T!,@];?9Q&[K,;99C>3L3<5K3BF^Y
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M G2J9PAJS]*QZS<QW9L9*A,3+(C#GN])8IC 87)3L%Y/$=Y:\NMM6ZZ_ IT
M_.8>;(N[(RD\#5\Z0D<^(O%=5_KPQL[-BQ^V7WM3LWX'R!W2XN+YW+EJC(LI
MBE%(5K6!C'?Z#Q:"Z@G?9YD9$% 2S'\RTJ]2+B_;[,(*9M:Y60BP_R-_[]/1
MQB>B<8Q%8$U>%24].$[<19DEZ%ZQ?&2'@S/=826:@I0#9F\NIC ,]C8A'Q._
M&]P;KIB1 -L(27;\4#PCBV:<9GZ'<6OYG5@IEA2Q"QZS!!C=1$U[9&MKN(=^
M"_I:&T.9YUM8"8_C>=.,OP1#I%0#+D[5$>*$1:LEB# CEL6S[54'+YH:\^KE
MI['!R"-]Q6?#7-1+Q#TMLBME;WJP F@!)K^)%3"G'&M7,JX-*]Z^CAY1,!KE
M(,H(%5':&L8^*2KYK&/VY3%$9]R4M10NI+7,[KU-,@'\:G)*PDI*C]:@%3?H
MK10R37# !2VY6I0!-S=CQFA?-PHC(L(5&*AJS'MM6B:V[K 9#=A965-)P0#D
M8S5?;)JB LHL:W;:*J]TAV^BF-T<ZZ]5C(XP2M]B?5+-'+^.FUL=SZPBPHN-
M]6W#@.25LLV)6'&\JRMW@."Y5^TNP'AA83\W5:4K?>5K+YI[)]KFN-^6$"L@
M]BP:%N6#M^VW]_G,JY$F,B;#>6!OC5)J!D-X%SBOO42T-9RFNW/->=$W/-:P
M,,!']+-?%^5'K.(SG8*9:SYGQ75<7'/0-"M&'Q&M][G*5[?NM3IDD0^')D>J
M)UDM2H8D4$"X[ *NON*,*\EVS- C^/F='M[,(#:PCQ;EB!5)BF:*/Q@OU6VP
MF*+R>K2QGM;.(?1UA]0M8;3 -,3HDP].6 U%3$06/]ZW4?RVBM2Y>X$XR.%M
M#:&+Y[K!21Q0::ZJ#7SEJS>B,?H8A"U#&"'D""$D$U>:M&@A00K]NP$U3U.4
M8JXBQ$TSS(B.(O&;.%ZA;L.5Z2;Q30A(A9(&<X2UI_QE3IM=Q :^)+Q;4AF<
M57'-( ?K>(3&,2^9,D4$^VL23VKN/2Q?2G,%&8C(F)PA9<*;&,-+X@0(79.+
M8<%$5R46G<<$JA+6JZW)-1R^$@P3H6PT&^XJP&%8 +V;Y_MK(4V0.R]4+3O\
M_".,_!Q:X(ZA1(H.7^;L<(DT:"GX\"FN U0'UQ%["',F&F]J/DYL8@F=)KBW
MXIEU;_)ANN!T.*A<A$.MO)A"*,@7TMT5XZYLX0 -XG7.FY(CZ=>F3*LX9;<H
MXZQ2K&&<<-NXF[UYIB$U.-FT;N4*X*6I%"MPFV[-<P:OP\XBWFTN*FBJZ-C9
MTYFRJLJ"'N;XH+@-[.Y-,HN07+\SXTX546^Y&29E _D[:I//X!SAKYAJPEZ[
MV-@*O/1YNMKWR&.ZEWB28]'[6/TZ3/K/3 36VQ1T1Q//41@V)1*168)F#03L
M;#W;WMEY] 3&; T7RMW%@CX'FL\Y/7#JZ=KP8S0OGCW=N/0#J>LW0W<7:7"W
M%0)C[=;2Z)RF51GF7M[D\P\0)X*40L.2ZA!-D#K=;G24QW#D8HX6HESIN80A
MX0BA1]2#42;&FA"89#)DA(E'3HBNXCPEO &;='@$3)MR6E1\!@L1O!ZF?')U
MPTDT/89[JAPUM5,\?6-G4];E$CFR\W1[]]&S8$,6O4+;35EUBLO5I%LAR#D3
M'V("*X/(LMAVWMU$0R@R%3#9=#7DZB&.I*6M<S''H9(AI3ROUF^S"$H3FF'"
M_$!2=4D!R12('<J1SN0^-]363(U1TG6P+-3%_?3]=!N[N\MYOPXIS$9#I'NO
M-ZIG0?DZ9T31U6TY+0ZMD$GDT6Y3E(7#B3C)"FA);8]&EIY18$6<^Y24$^R0
MQ1AQO">M?'7,@-T=]<^K;$/9U+I5=+EQ,E37J. &V7GQ9'M=5L]RQJ:3-[U]
MTI\&PO[N^4V.G6SBU6)N3-/!MBO%&Z)< \36JDR"#SEGPN&3SVJPQ"[@6]*F
M>A.PWD81KK93 B'1EU/4V$MFMRN*K(+N6H\ )KZ5[."!YDZ&L#HP#_$\*4LX
M1*I)L/'AK!><]LX'AR?G06__?%/7PN[V]DX8G%(5'%0S@YWMYX^>@H0U'"K/
M0KIH<V8O=; SF'==V10UMJ=K65J+4I(SG0&\34R=2C22A3B3#L&[C>QI[@\T
MHFG6%1ZT1#*\X?>+/1KRXZ:-I>J@#-OIS/.ZY5-HT4#F>6+U:U81NGA?S C[
MB9JMRI=&*:R=I'XG3;.5BX8C((6!I'!?4UD[($ZBC$SZPN>SLSW53L$]<J"S
MMX,3-?/<X&!2JLME 1;S7JW+.I%]%4M<USGP:3MMG6TA]3&=]/M%B32@,!CL
M$J^LY'O^7$W<#UL_;06O$5E8LF3<W=Y9&[&XG"KL=5E\Q/R/-XF2J7^.]2%1
M )ZT(35)*EGJ$ L+P&I69[3W$.^OWF9PK^.$(QNN)JC?C4R)NZIK?]WVG+>>
M17>WT7&-??ZZ#I"')",WR>C%0Y+10Y*1BC8#/=U:W69_.7P%\F[0/QWTS_K'
MY[WSPY/CLZ!W?!#\W!L,>L?GA_VSX.1-</ZN'YQ^&.R_ZYWU!R@27WX_?-4N
MSFR*^7IU?*N6_ZU-S6^+8X4S[FJ\Z VLM$C4B(%?+CB<WY;SBQ2\#@Y(,W61
MA8N+#YO@"[N1I#8#]@V1J?3 T"M5A?C^/)LI'K1)W1P7&=9%NG<!QJZ5^&1K
MB>G1-D/<- N<A;^[\%]KS-JE9O#?5'I<TC2DP!*<2UJ'//F45FII_'9T(K9;
M<T&S;#)0R,ZP'-D*=L2O+FJ$%RXA%=ZE:?<+F1*R;UI<$QP-@U+&;U80.0RV
MUR*R59H6"DDJ1TLW_\I:Z(-/MI:H@ZVE*H8,S\=>T&>.'11/>\$_<-6E+GV/
MOV#1*+3$.::JKY#%.45D;M1S0N!3F&A8SZB)S9EJ4B38O=I2W83C<P1"C1BV
M0A.B%GL.?Z&JC_@;(;>=6C36-.HNXB#Y$P(DI!>> _ 5F\L.QPPV0-/PD;@;
M@8_TH*[;YG?21KE)*,@0_4=B_61]Z9Z1<(Z8L.C&-)2*^BQ3LJ-0*/"R.\C'
MYM:K-3U8A'U>86@^"PH]H\?C!'G-^C*4NR<B5'IGK>76L(!&UABX<^1NB7#)
M>SK!=*\SEH*1G8"W*.GA]&U>50YGCA9D GF$WO/J:2PHG.$XKBEHF1?7Y!B'
M@627*[H^V-WJQB97JY_A=$U+:3@%-!!T1L4QUD1H+Z&2; GMXP)#&N,L-:6-
M/%D5FE7*JWN9"&HMW;A0U[IUB1M4E7I$.QTW[DK"@CUM=FOSU+W A-Q'\B*\
M=F%YN4] )R9\Q>3(#GI)5&GG+3S7A4.!RT3W F@1Q6&/G+<C_XTH9F9[$K82
M([1.TCCTJQ,IZ?:&IE4HZ<FB\D<>QRMS*SK5CR3AU+2]J9$ P8TQKAXZ@4^S
M59T0C4^*$LIW#EU9MC0GL<TC?'43"7S"5X?6E<Y8ET]*RD)A,;80NIX3S6Y9
M7XAKAQ=W4R:A0?"'-O05<DD"$D[RE[#YA5(\F8K\Y*-+#)683"J4?673$3O#
M=Y[CSM&(7E':BYQETK4VR/01V11R0,;->L $#I>VVRF%0!F,BQM7E3TTS4E5
M8U.*0W<%\0B/P-)2WQFS>LD*#:VS-70J>.E:7)F__0Y-@C61TTL(,%MR>I\W
M*5LJ%/6!\W^QQ/X"@:WBP;\<)0)Q:;IB(T1A2KT)?77'[C<AI!^'JBH.L?B6
M4S&><]1MU1PEOI^?$CD#%;"91ZK^L=IBJ:AD__ Q8_ &MSD6,)2WTL:76N]#
M] 2&.E@DO%:3,.9!_D5^LXZW9@VGPT/@LG^I-$RO=XW&72JR.KUSYJXU$6A+
M^$1; LV.J>^Y9)&&4?+S]@Z10!,"J"*'72 5'8HUQ6&#!"L^3<L \QAVGCSI
MZ6H\LT7->B/&1NEAB7H,61UT*P:5B\[FGA*+P<8.4J+LXG\>XW^8X63CATW'
MA37SL'WL?\Y,+-LO]BA&.77WC04Y<:_.%K2&CSO8U#Q*BG,Z;A%X7R[B1?"O
M:$B\B5IJ75_Y9D&1MVADF3S\':A=F@6^6&^#N7ML0O3&HT% ;@H5!U0T!=E:
M$;^")$0&P5+!:[2JTW3-X)KLL"4\I*T==M:,&;M>4Z"@FN=[J^QU<IIMB%M%
M76[D)Z/$ W/E*)JF> P0SAT/0K:QF>.^VC0^*]@TH'N@Q(0[HI&T)EJ)D@&W
M'5==2ZM-&NGT#2N*W%!B<A?H01FE.=2Q%BO%<#C=(MSE!KUZ!P>'&.[J'07[
M)__H'_>.S\],9&L=!O#I;:(TCHX^F23EB.F5!ZIWD(Z 100DX\XIZNO2 OO"
M59!C9.DJZ3QMDY'[C-(^(^%GD.[!F6/*=[ !2I+5I#:]JL*..N8K6UR1PJF
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MO(!6/-/)Z/*KV01\OZ%E]A0BKP9FV^H@7FGX9Z+V+AR%U'5;Z-1M#19,?8V
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M-'D#SW=;V^B18GMOS_)T.&[9MP@5N+_9W(_;*1<R<L?PU4$RPLVZ7Y33HA3
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MW= +6%<()HF!^!:\"??O="3G\V,= 8B0PAW"_\Z;2O-CO0&(@:Z"'N>/@SZ
M" GHDN%YM[XUP;EBM1] 0X_A*^P3=NFI2[]_@ASNZY?I\\U)0ZS_KBVKS<DT
MG5>?]O<J35/XE;A9V]@>7LL<_>W-H>G&W"79L=6:KPW/_Y57?LQHP>JBC>H:
MM-:( ;I9];+^[KGM(4CGH/S*3L$@\9*R[C,1G1FK*8,NT^H:TLX=M3NK[R%
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M/TL?Q_"<HK><TR(TRD,KZK!QT,]W\_@J(L%$=T>\5_ &)BN7XA3P/8?>KJ7
M21'>1XM;UTZK* M4P'%L<PTX_$T*.*XW=])9"-_@5,?Q#BNTB3,0OA[I;LA
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M9;][S;O$1NJW_NNFW6]=MW!!$COQ,0LJQI!^E^VK=N?K@Y3^O3W\EK(<=7#
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M-\3SY77RE5K4X;>@^I9+S9\2%CT"RF=T?];/*$.0J\9@F(]BH-0J[">MK@Z
M@#\DZB'^-<__'U!+ 0(4 Q0    (  PX<E*@Q2>UL5(  #Q< @ -
M      "  0    !E>%\R,S0W,C$N:'1M4$L! A0#%     @ ##AR4CSY'=#=
M+@  B/8   T              ( !W%(  &5X7S(S-#<U.2YH=&U02P$"% ,4
M    "  ,.')2.-0/F#4.   Y*P  #0              @ 'D@0  97A?,C,T
M-S8X+FAT;5!+ 0(4 Q0    (  PX<E*C9.]QRE8  #X% @ -
M  "  420  !E>%\R,S0W.#4N:'1M4$L! A0#%     @ ##AR4B6NSG3.>
M2@$#  T              ( !.><  &5X7S(S-#@U,RYH=&U02P$"% ,4
M"  ,.')2.@:V&X8#  "3#@  $0              @ $R8 $ ;F5X="TR,#(Q
M,#,Q-RYX<V102P$"% ,4    "  ,.')2)4//\^ $  "(+0  %0
M    @ 'G8P$ ;F5X="TR,#(Q,#,Q-U]D968N>&UL4$L! A0#%     @ ##AR
M4GS78;O_!0  X#P  !4              ( !^F@! &YE>'0M,C R,3 S,3=?
M;&%B+GAM;%!+ 0(4 Q0    (  PX<E+3,]"5>@0  !HN   5
M  "  2QO 0!N97AT+3(P,C$P,S$W7W!R92YX;6Q02P$"% ,4    "  ,.')2
M>1%<(FL?  ".PP  $P              @ '9<P$ ;F5X=#(P,C$P,S$Q7SAK
:+FAT;5!+!08     "@ * ' "  !UDP$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
